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Zusammenfassung 
 
Die vergleichende Analyse des Genoms der vier E. coli Stämme MG1655, CFT073, O157-EDL933 und 
Sakai hat einen detaillierten Einblick in das Verständnis von Expansion und Verkleinerung von E. coli 
Genomen geliefert. In der vorliegenden Arbeit wurden die DNA Polymorphismen analysiert die in den 
Gen Regionen von bgl/Z5211-Z5214, c1955-c1960 und lac vorkommen und zwar in  25 septischen, 32 
uropathogenen, 1 asymptomatischen Bakteriuria, 81 Mensch kommensalen und 32 Tier kommensalen E. 
coli Stämmen, im Vergleich zu den vier sequenzierten Genomen. 
 
Auf der Basis der Ergebnisse an bgl/Z5211-Z5214 konnten die typisierten E.coli Stämme in fünf 
Haupttypen und einen Subtypen gruppiert werden: MG1655 Typ, CFT073 Typ, O157 Typ, vierter Typ, 
fünfter Typ und gemixter Typ. Ungefähr 20 % der Stämme haben eine bgl Region ähnlich zu MG1655, 
26% ähnlich zu CFT073, 20% haben eine Z5211-Z5214 ähnlich zu O157, 20% haben eine upstream 
Sequenzen ähnlich zu O157, gefolgt von einer bgl und downstream-artigen Region ähnlich zu MG1655 
(mit Mischling yieI Gens). 11% der Stämme, mit der Ausnahme eines yieI Gens, haben MG1655 
Sequenzen in der upstream Region, bgl und auch downstream Region. Mix Typ Stämme haben eine 
Mixtur von MG155, CFT073 und O157 in der bgl/Z5211-Z5214 Region. 
 
Weiterhin wurden drei unterschiedliche ß-Glukosid Nutzungstypen gefunden. 35% der Stämme 
papillieren wie MG1655, 16% der Stämme öfter als MG1655 und 15% zeigen schwache Bgl+ (relaxed) 
Phänotypen. Alle Stämme mit dem relaxed Phänotyp zeigten ein CFT073 artiges bgl operon, was 
andeutet daß die CFT073 bgl Sequenz eine Vorraussetzung für den schwachen Phänotyp ist und nicht 
umgekehrt. Mutationen in Genen die für den generellen zellulären Metabolismus benötigt werden, wie 
etwa Aminosäure Synthese oder Nukleotid Biosynthese, führten zu einer Verändernung des relaxed 
Phänotyps. Die Ergebnisse zeigen auch, daß Sequenz Variation in der bgl Promotor Region in den 
CFT073 bgl/Z Typ Stämmen keinen signifikanten Einfluß auf die bgl Expression im E.coli K-12 
Hintergrund hat. 
 
Es konnte auch ein zusätzliches ß-Glukosid System identifiziert werden. Dieses System entspricht der 
c1955-c1960 Region des CFT073 Chromosoms. Die Analyse der c1955-c1960 Region zeigte, daß 97 
von 171 Stämmen das c1955-c1960 System besitzen. In den Stämmen mit dem CFT073 bgl Typ kam 
das c1955-c1960 System vorzugsweise vor. Es konnte gezeigt werden, daß das c1955-c1960 System 
Gene für die ß-Glukosid Nutzung kodiert. Es hat einen CAP abhängigen Promotor und ist durch 
Glukose katabolisch reprimiert. 
 
Um zu untersuchen, ob der bgl/Z5211-Z5214 Lokus Korrelationen mit anderen Zucker Nutzungs 
Systemen zeigt, wurden Lactose Nutzungs Phänotypen analysiert. Neun der 171 Stämme zeigte einen 
Lac- Phänotyp, wobei sechs dem O157 Typ (bgl/Z5211-Z5214) entsprechen. Diese Untersuchungen 
zeigen die genetische Diversität von E.coli Stämmen. Die Ergebnisse ergeben einen Einblick in die 
Frage, ob sich die bgl/Z5211-Z52124 Region als Marker für eine neue Typisierungsstrategie von E.coli 
Isolaten eignet. 
 
 
 
 
 
 
 
Summary 
     Comparative genomics of the four E.coli strains MG1655, CFT073 and O157-EDL933 and Sakai has 
provided a wealth of information in understanding the continual expansion and retraction of E.coli 
genomes in detail. In this study, a systematic analysis was performed to assess the DNA polymorphisms 
at the region of bgl/Z5211-Z5214 island encoded systems, c1955-c1960 island encoded system and lac 
region in 25 septicemic, 32 uropathogenic, 1 asysmptomatic bacteriuria, 81 human commensals and 32 
animal commensal E.coli strains and were compared to that seen in the four sequenced E.coli strains. 
     Based on the observations E.coli strains were typed at the bgl/Z5211-Z5214 locus into five main 
types and one sub type: MG1655 type, CFT073 type, O157 type, fourth type, fifth type and mixed type. 
Approximately, 20% of the strains have bgl region like MG1655, 26% have bgl region like CFT073, 
20% have Z5211-Z5214 region like O157, 20% have upstream sequence like O157 followed by bgl and 
downstream like MG1655 (with hybrid yieI gene) and 11% of the strains with the exception of 
downstream yieI gene have MG1655 sequence in the upstream, bgl and in the downstream region. 
Mixed type strains have mixture of sequences from MG1655, CFT073 and O157 in the bgl/Z5211-
Z5214 region. 
     In addition, three different types of β-glucoside utilization phenotypes were seen. 35% of the strains 
papillate like MG1655, 16% of the strains papillate more frequently than MG1655 and 15% showed 
weak Bgl+ (relaxed) phenotype. All the strains that showed relaxed phenotype carried CFT073 type bgl 
operon, indicating CFT073 bgl sequence is important for relaxed phenotype and not vice versa. 
Mutations in the genes that are necessary for general cellular metabolism like amino acid biosynthesis 
and nucleotide biosynthesis abolished the relaxed phenotype. The analysis also demonstrated that the 
sequence variations seen at the bgl promoter region in the CFT073 bgl/Z type strains does not 
significantly influence the bgl expression in E.coli K-12 background.  
     Furthermore, an additional β-glucoside system was identified. This system corresponds to c1955-
c1960 region of the CFT073 chromosome. The analysis of c1955-c1960 region revealed that 97 out of 
171 strains carried c1955-c1960 system. The presence of c1955-c1960 was observed to be predominant 
in the strains that carry CFT073 type bgl.  In a second line of investigation, it was demonstrated that 
c1955-c1960 system encodes genes for β-glucoside utilization. It carries a CAP dependent promoter and 
is catabolically repressed in the presence of glucose.  
     In order to analyze whether the typing at the bgl/Z5211-Z5214 locus has any correlations with the 
other sugar utilizing systems, the lactose utilization phenotypes were determined. Nine out of 171 strains 
showed Lac- phenotype, in which six of them belong to O157 type (at bgl/Z5211-Z5214). Taken 
together, the analysis demonstrates the genetic diversity among the E.coli strains. Moreover, it may 
provide an insight in considering bgl/Z5211-Z5214 island region as a marker for devising a novel strain-
typing method for E.coli isolates. 
III 
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II. Introduction 
 
     Strains of the Escherichia coli species display a wide range of genome variations with some 
strains differing by more than 1 Mb (Bergthorsson and Ochman, 1998). These differences could 
be attributed to: i) the acquisition of foreign DNA, including integration of genetic entities like 
pathogenicity islands and genomic islands; ii) deletions and duplications of the existing genes; 
and iii) accumulation of repetitive DNA, such as insertion sequences and transposons into the 
chromosome. Horizontal gene transfer of DNA is acknowledged to be a key player for the 
generation of genome variations in E.coli (Lawrence and Roth, 1996; Ochman et al., 2000). The 
availability of the genome sequences of four E.coli strains has provided a wealth of information 
in understanding the genetic diversity among the natural isolates (Blattner et al., 1997; Welch et 
al., 2002; Perna et al., 2001; Hayashi et al., 2001). However, the mechanisms involved in the 
genetic differences between the strains of E.coli are not completely understood. Analyzing 
variations in carbohydrate fermentation systems may provide a useful starting point for 
investigation of genome variations. Hence, in this study a systematic approach was carried out to 
analyze the genetic variations in 171 commensal and pathogenic strains at three loci that 
comprise of β-glucoside operon (bgl) or Z5211-Z5214 genomic islands, c1955-c1960 genomic 
island and lac region. 
 
1.  Pathogenicity islands, genomic islands and bacterial evolution 
     Over the past decade, considerable insight has been gained into the role of accessory genetic 
elements to the process of bacterial evolution. A type of genetic element called as ‘pathogenicity 
island’ (PAIs) has been shown to contribute to the molecular evolution of bacterial pathogens 
(Falkow, 1996). PAIs are chromosomal clusters of pathogen-specific virulence genes that are 
characteristically found in pathogenic strains and also rarely in nonpathogenic variants. Some of 
the features of pathogenicity islands include GC content that differs from the rest of the bacterial 
genomes, insertion at the 3’ end of the tRNA genes, the presence of flanking direct repeats and 
insertion elements, ability to encode mobility genes such as integrases, transposases and origins 
of plasmid replication (Hacker et al., 1997; Blum et al., 1994). 
     Pathogenicity islands belong to the group of ‘Genomic islands’ (Dobrindt et al., 2004). 
Genomic islands are called as symbiosis, fitness, metabolic or resistance islands depending on the 
functions they encode and the advantages they confer relative to the specific lifestyle of a 
bacterium (Hentschel and Hacker, 2001; Hacker and Carniel, 2001). It may also carry genes of 
unknown function. An evolutionary advantage of genomic islands is that large number of genes - 
Introduction 2
for example entire operons that confer new traits - can be horizontally transferred into the 
genome of the recipient that allows the recipient for more successful adaptation and increased 
fitness in a specific ecological niche (Fig. 1). Thus, the occurrence and genetic organization of 
genomic islands reflect the importance of gene acquisition and genome reduction events for the 
evolution of bacterial pathogens, as well as of non-pathogenic microorganisms. Recent studies 
have elucidated that genomic islands and other horizontally transferable structures are more 
commonly found in those bacteria that are present in niches colonized by diverse bacterial 
species rather than in isolated or sparsely populated environments (Dobrindt et al., 2004). 
 
 
Figure 1: Evolution of bacterial variants by acquisition and loss of genetic information. Genome structure 
reflects the bacterial life style. Genome reduction is common in intracellular bacteria such as obligate intracellular 
pathogens and endosymbionts, and contributes to the evolution of strictly host-dependent bacterial variants-as 
bacteria rely on the host cell to compensate for the gene functions that are lost. Gene acquisition by horizontal 
transfer between different species, involves mobile genetic elements, such as plasmids, genomic islands (GEIs) and 
bacteriophages (not shown), and increases the versatility and adaptability of the recipient.  This is common in 
extracellular bacteria, such as facultative pathogens and symbionts, and the acquisition of genes in this way allows 
bacteria to adapt to a new or changing environment.  In addition to these processes, point mutations and genetic 
rearrangements constantly contribute to evolution of new gene variants in all types of bacteria. HGT, horizontal gene 
transfer. Figure is taken from Dobrindt et al., 2004. 
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2.  E.coli, a model to study bacterial genome evolution 
 
     The species Escherichia coli represents an exceptional model to study the contribution of 
genomic islands to the evolution of bacterial genomes in detail (Lawrence and Ochman, 1998). 
E.coli is remarkably a diverse species as numerous ecotypes that live as harmless commensals in 
intestines of humans and animals exist (Ochman and Selander, 1984). In addition, other distinct 
genotypes including the enteropathogenic, enterohemorrhagic, enteroinvasive, enterotoxigenic 
and enteroaggregative E.coli cause significant morbidity and mortality as human intestinal 
pathogens. Extra-intestinal E.coli is another varied group of life-threatening pathogens that 
include distinct clonal groups responsible for neonatal meningitis/sepsis and urinary tract 
infections. Todate, genomes of four E.coli strains: the laboratory strain E.coli K-12 MG1655 
(Blattner et al., 1997) with a genome size of 4.6 Mb, uropathogenic strain CFT073 (Welch et al., 
2002) with genome size of 5.2 Mb and two variants of enterohemorrhagic strain O157-EDL933 
(Perna et al., 2001) and Sakai (Hayashi et al., 2001) with genome sizes of 5.4 Mb have been 
sequenced.   
 
Figure 2: Shared E.coli proteins. Comparison of the predicted proteins of the three E.coli strains shows the number 
of orthologs in each shared category and numbers of strain-specific proteins. Hypervariable proteins and proteins 
spanning island-backbone junctions were excluded from the analysis. Number of proteins counted: K-12, 4,288; 
CFT073, 5,016; EDL933, 5, 063. In the totals for the three strains, orthologous proteins are counted only once. 
Orthologous proteins meet the same match criteria used for designation of backbone. Total numbers of proteins 
analyzed in each strain are indicated: MG1655 (56%), CFT073 (65.5%) and EDL933 (66.1%). Figure modified from 
Welch et al., 2002. 
 
Comparative genomics of the four sequenced E.coli genomes has revealed that approximately 60 
to 70% of the genome is composed of a conserved ‘core genome’ which contains the genetic 
information that is required for essential cellular functions. The remaining 30 to 40% is 
composed of ‘flexible’ gene pool, which encodes additional traits consisting of pathogenicity 
56% 65.5% 
66.1% 
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islands and genomic islands that can be beneficial under certain circumstances (Welch et al., 
2002; Fig. 2). Moreover, the genome size variations (up to 1Mb) seen in the natural E.coli 
isolates (Bergthorsson and Ochman, 1998) has revealed an extensive evidence for the horizontal 
transfer events in the genetic variability among E.coli isolates. Thus, E.coli serves as an excellent 
model to understand the genetic basis for pathogenicity and the evolutionary diversity and its 
impact on bacterial evolution. 
 
3. Phylogeny and strain typing of E.coli 
 
     A set of 72 reference strains of Escherichia coli (ECOR strains) isolated from a variety of 
hosts and geographical locations has been established for use in studies of variation and genetic 
structure in natural populations. These strains are representative of the range of genotypic 
variation in the species as a whole (Ochman and Selander, 1984). The phylogenetic relationships 
among the 72 ECOR strains was studied by the neighbor-joining (NJ) method applied to a 
genetic distance matrix  based on electrophoretically detected allelic variation at 38 enzyme-
coding loci (for e.g. Alchohol dehydrogenase, Malate dehydrogenase etc.,). The principle 
underlying the analysis is that any allelic difference in electrophoretic mobility results from at 
least one codon difference at the nucleotide level. Under the assumption that codon changes 
occur independently, standard genetic distance is an estimate of the mean number of net codon 
differences per genetic locus (Selander et al., 1986, Herzer et al., 1990 and references therein). 
Thus, based on the genetic distance matrix ECOR strains have been phylogenetically classified 
into 5 groups: A, B1, B2, D and E (Herzer et al., 1990). Group A is predominant with K-12 and 
K-12 like strains (25 strains) isolated from humans. Group B1 is predominant with strains 
isolated from non primate mammals (16 strains). Group B2 is predominant with strains isolated 
from humans and other primates (15 strains). Group D is a heterogenous group with mixture of 
strains from humans, non primates and other primates (12 strains). The fifth group E is a variant 
from the other four types that consists of strains from humans and non primate mammals (4 
strains).  
          In the past decade or so, several studies have used genome comparison techniques like 
macro-restriction analysis, PFGE (Pulsed Field Gel Electrophoresis), genomic subtraction, RFLP 
(Restriction fragment length polymorphism), analysis of DNA sequences of housekeeping genes 
and DNA microarray analysis to assess the genetic variability and phylogenetic relatedness 
among E.coli isolates (Bonacorsi et al., 2000; Melkerson-Watson et al., 2000; Rode et al., 1999; 
Lecointre et al., 1998; Milkman and Bridges, 1993; Pupo et al., 1997; Akman and Aksoy, 2001; 
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Dobrindt et al., 2003; Fukiya et al., 2004). Using RFLP and nucleotide sequencing, Herbelin and 
coworkers (2000) have assessed the DNA polymorphism in the mutS-rpoS region and inferred an 
evolutionary history of divergence of this region among the isolates of E.coli. The study was 
focused on a collection of E.coli strains comprising of enteropathogenic, enterohemorrhagic and 
ECOR strains. Their results showed that the length of the genomic sequence between the mutS 
and rpoS genes is variable in the natural E.coli isolates (Herbelin et al., 2000). Based on the 
variations seen, the authors have proposed an evolutionary model that categorizes E.coli strains 
into four main types and one sub type. The grouping from their analysis correlated with the 
phylogenetic classification of ECOR strains.  
 
4.  Impact of genome variations on the utilization of carbon source in E.coli 
 
 
     Carbohydrates are excellent carbon sources for all bacteria. In E.coli, a vast amount of 
information is available on the components of the pathways necessary for the utilization of 
various carbohydrates. The pathways of carbohydrate utilization follow the same theme in all the 
natural E.coli isolates. However, the impact of genetic variability within the genome may have an 
influence on the metabolic properties of the carbohydrate utilization systems. Horizontal gene 
transfer even at very low levels produces a mosaic chromosome. As a result, species-specific 
traits such as those encoded by horizontally transferred genes (e.g., lactose utilization, indole 
production) attributes to the phenotypic characterization of E.coli (Lawrence and Ochman, 1998). 
Analyzing the genetic variations in the carbohydrate systems may provide an insight in 
understanding the role of horizontal gene transfer in shaping the ecological and pathogenic 
character of E.coli.  
     Three of the loci that encode genes required for the utilization of carbohydrates that show 
variations in the four published E.coli sequences are ; i) bgl/Z5211-Z5214 island encoded region 
at ~84 min on the MG1655 chromosome (Blattner et al., 1997) includes β-glucoside utilization, 
bgl (in MG1655 and CFT073) and Z5211-Z5214 (in O157-EDL933 and Sakai) islands. ii) The 
region between marB and ydeD at 34.8 min on the MG1655 chromosome includes c1955-c1960 
island encoded system (characterized in this work) that is present in CFT073 and absent in the 
other three strains. iii) The lac operon at 7.8 min on the MG1655 chromosome is conserved in all 
the four sequenced strains (Fig. 3). 
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Figure 3: Schematic representation of the three loci analyzed in the current study. Horizontal lines represent the 
linear chromosomes of MG1655, CFT073 and two variants of O157-EDL933 and Sakai. The two variants of O157 
are identical to one another at the three loci. Positions of the three loci are relative to the MG1655 chromosome and 
are indicated as 7.8 min (7.8’), 34.8 min (34.8’) and 84 min (84’). The β-glucoside (bgl) genomic island is present in 
MG1655 and CFT073. O157 carries Z5211-Z5214 genomic island in place of bgl. The c1955-c1960 genomic island 
is present in CFT073 and absent in the other three strains. The lac operon (lac) is conserved in all the four sequenced 
E.coli strains.  
 
5.  The bgl/Z5211-Z5214 locus in E.coli 
     The bgl operon in MG1655 and CFT073 contains six genes (bglG, F, B, H, I and K) (Schnetz 
et al., 1987; Welch et al., 2002) (Fig. 4) in which the first three genes are necessary and sufficient 
for the utilization of aryl β-glucosides like arbutin and salicin (Prasad and Schaefler, 1974; 
Schnetz et al., 1987; Mahadevan et al., 1987). The gene products of the bgl operon are the 
positive regulator and antiterminator BglG, the β-glucoside specific permease EIIBgl (or BglF), 
the phospho-β-D-glucosidase BglB, Porin like protein BglH, endo-1-4-xylanase homology 
protein BglI and glucosamine-6-phosphate-isomerase homology protein BglK (Fig. 4). In 
contrast to MG1655 and CFT073, strains O157-EDL933 and Sakai have Z5211-Z5214 region in 
place of bgl. The Z5211-Z5214 region contains four ORF’s that encode proteins of unknown 
functions (Perna et al., 2001; Hayashi et al., 2001) (Fig. 4).  
 
Figure 4: Structure of the bgl/Z5211-Z5214 locus in the four sequenced E.coli strains. The genes in MG1655 
bgl region are presented by open black arrows (Blattner et al., 1997), genes of the CFT073 bgl region are presented 
in black (Welch et al., 2002), and genes of the O157-EDL933 (Perna et al., 2001) and Sakai (Hayashi et al., 2001) 
Z5211-Z5214 region are presented by hatched black arrows. CFT073 lacks the yieJ gene at the 3’ end of the bgl 
operon (indicated by dotted lines). Strains O157-EDL933 and Sakai are identical to one another at this locus, and 
lack the yieJ and yieI genes. Genes present in upstream and downstream of the bgl/Z5214-Z5211 locus are shown 
with different arrows (open, black, hatched) indicating sequence variations between the strains.  
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The alignment of bgl/Z5211-Z5214 region including the upstream and downstream regions in the 
four sequenced E.coli strains shows that CFT073 lacks the yieJ gene. Strains O157-EDL933 and 
Sakai lacks the yieJ and yieI genes and are identical to one another at this locus (Fig. 4). 
Furthermore, the nucleotide sequence alignment including the upstream and downstream regions 
in the four sequenced E.coli strains show that sequence variations are seen in and around the 
bgl/Z5211-Z5214 region in the four sequenced strains. To this end, the nucleotide sequence 
alignment of the bgl/Z5211-Z5214 island encoded systems with its flanking regions distinguishes 
the four sequenced E.coli strains. 
 
6.  Crypticity of the bgl operon 
     An interesting feature of the E.coli bgl operon is its crypticity (silent) (Schaefler and Maas, 
1967; Reynolds et al., 1981) i.e. it is neither expressed nor induced under all laboratory 
conditions. However, Khan and Isaacson (1998) have reported that the expression of bgl operon 
is seen when septicemic E.coli strain i484 infects mouse liver. Why the operon is silent in the 
laboratory conditions and what may cause it to be expressed in the host, remains to be an open 
question.  
     The silencing of the bgl operon is determined at the bgl promoter and within the region of 
bglG gene. The abundant nucleoid-associated protein H-NS, that affects the expression of many 
genes (Ussery et al., 1994), is essential for silencing of the bgl operon (Dole et al., 2002; Dole et 
al., 2004; Defez and de Felice, 1981) (Fig. 5). It represses the CRP/cAMP dependent bgl 
promoter (Schnetz, 1995, Schnetz and Wang, 1996; Mukerji and Mahadevan, 1997; Caramel and 
Schnetz, 1998) as well as region downstream to the promoter, where it causes a strong polarity of 
the bglG gene leading to low expression of bglG and further downstream genes (Dole et al., 
2002, Dole et al., 2004; Fig. 5). In addition to H-NS, Fis a pleiotropic DNA bending protein, 
RpoS a stationary phase sigma factor, Crl, transcriptional-regulator-like proteins LeuO and BglJ, 
the protease Lon, RNA binding protein Hfq and H-NS homologue StpA are also necessary for 
silencing of the bgl operon (Finkel and Johnson, 1992; Caramel and Schnetz, 2000; Schnetz, 
2002; Tsui et al., 1994; Giel et al., 1996; Free et al., 1998; Ueguchi et al., 1998; Ohta et al., 1999; 
Dole et al., 2004). Spontaneous mutations that activate the bgl operon map close to the CRP-
dependent promoter that include deletion of an AT-rich silencer upstream of the promoter, 
integration of insertion elements, and point mutations that improve the CRP-binding site 
(Reynolds et al., 1986; Reynolds et al., 1981; Schnetz and Rak, 1992; Schnetz, 1995; Lopilato 
and Wright, 1990; Mukerji and Mahadevan, 1997).  
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Figure 5: Model of the H-NS-mediated repression of the bgl operon at two levels (Dole et al., 2004). H-NS binds 
upstream of the promoter and represses the transcription initiation. In addition, H-NS binds within the coding region 
of the first gene, approximately 600 to 700 bp downstream of the transcription initiation site, where it induces a Rho-
dependent polarity (Dole et al., 2004). Hfq and Lon reduce the H-NS-induced polarity. 
 
Todate, no information is available at the genetic and molecular level for the organization and 
expression of bgl genes in the naturally occurring E.coli isolates. Analyzing the impact of genetic 
variations at the bgl/Z5211-Z5214 locus on the organization and expression of bgl genes might 
give an insight on the reasons for the maintenance of the operon in a cryptic state. Moreover, it 
may help in elucidating the complex pleiotropic regulation of the bgl operon. 
 
7.  β-glucoside utilization system in other organisms  
     The β-glucosides such as Salicin, Cellobiose, Arbutin and Esculin are abundantly found in 
nature. They can be found in foods containing plant extracts. The general structure of these 
compounds is a glucose moiety with various groups attached at the C-1 hydroxyl of the glucose 
core. The β-glucosides are used as a carbon source by many bacteria. In Shigella (a close relative 
of E.coli) the genes encoding the proteins for utilization of aryl-β-glucosides are organized as in 
E.coli. However, in Shigella the bglB gene is inactivated by an insertion element and thus two 
step mutations are necessary to allow the utilization of salicin (Kharat and Mahadevan, 2000). In 
Erwinia chrysanthemi a plant pathogen, the arb genes encoding the gene products required for 
the utilization of β-glucosides (arbutin) are homologous to E.coli bgl operon. However, the arb 
genes are not cryptic as bgl. This difference in Erwinia could be due to the divergence of the 
promoter region in comparison to E.coli (el Hassouni et al., 1990). The divergence in the 
utilization of β-glucosides in Erwinia chrysanthemi and E.coli could also be because of their 
different natural habitats (Fig. 6). Klebsiella aerogenes carry bgl genes as in E.coli. However, the 
bgl operon of K. aerogenes is not cryptic. This is due to the differences at the bgl promoter region 
in the K.aerogenes (Raghunand and Mahadevan, 2003). Gram positive bacteria have shown to 
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contain β-glucoside systems similar to those of the Gram-negative bacteria. In Bacillus subtilis, 
the bglPH operon is responsible for the utilization of β-glucosides. Expression of this operon is 
regulated by LicT a BglG homolog encoded at a separate locus (Kruger and Hecker, 1995; 
Schnetz et al., 1996). 
 
Figure 6: Overview of β-glucoside utilization systems present in diverse bacteria. Shown is the different β-
glucoside systems present in diverse groups of bacteria. The names of the genes or the systems involved in β-
glucoside utilization are indicated.  
 
Clostridium longisporum, a ruminal Gram-positive bacterium carries an aryl-β-glucoside uptake 
and utilization system that is composed of several abg (aryl-β-glucoside) genes (Brown and 
Thomson, 1998).  The other systems involved in the utilization of the β-glucosides are the 
salCAB operon in Azospirillum irakense (Faure et al., 2001), the bglPCA regulon in 
Streptococcus mutans (Cote and Honeyman, 2002), the cglT and xglS genes in 
Thermoanaerobacter brokii (Breves et al., 1997), bgl operon of Pectobacterium carotovorum 
(An et al., 2004) and the bvr locus in Listeria monocytogenes (Brehm et al., 1999). None of the β-
glucoside systems mentioned above are cryptic. Recent report from Kilic and co-workers (2004) 
have reported that Streptococcus gordonii have four separate genetic loci that encodes genes for 
the utilization of β-glucosides. In addition, the authors have also reported that the genes required 
for β-glucoside utilization are associated with adhesion, biofilm formation and in vivo gene 
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expression. This data suggest a unique role for β-glucoside utilization systems in the environment 
inside the host.  
 
8. Aim of the thesis 
     There is growing evidence that genomic diversity is high among the natural E.coli isolates. 
Genetic entities like genomic islands play a profound role in these processes. An enhanced 
understanding of the role of genomic islands may provide an insight into how genome dynamics 
can contribute to bacterial evolution in general. In the present study we took advantage of the 
readily available genome sequences of MG1655, CFT073 and O157-EDL933 and Sakai and we 
have systematically analyzed the two island encoded regions: the bgl/Z5211-Z5214 locus and 
c1955-c1960 locus in a repertoire of 171 naturally occurring E.coli isolates.  
     The E.coli isolates used in the current study comprises of 99 clinical (25 septicemic, 22 
uropathogenic, 52 human commensals) and the 72 strains of the ECOR collection (10 
uropathogenic, 1 asysmptomatic bacteriuria, 29 human commensals and 32 animal commensal). 
A combination of PCR, Southern hybridization and nucleotide sequencing was used to 
characterize the genetic variations at bgl/Z5211-Z5214 locus and c1955-c1960 locus and 
compared the variations seen to that in the four sequenced E.coli strains. In addition, β-glucoside 
utilization phenotypes of all the strains were analyzed. In order to know whether the bgl/Z5211-
Z5214 locus analysis has any correlations with the other carbohydrate utilizing systems, all the 
strains were analyzed for their lactose utilization phenotypes. With the approaches undertaken the 
current study addresses a method of typing E.coli strains at bgl/Z5211-Z5214 genomic island. 
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III. Results 
 
1. Analysis of the bgl/Z5211-Z5214 genomic island in naturally occurring 
E.coli 
     (This section, in part, is in preparation for a publication) 
 
1.1 Variations at the bgl/Z5211-Z5214 locus in the four sequenced E.coli strains 
     Comparative genomics of four sequenced E.coli strains K-12 MG1655, CFT073 and two 
variants of O157 (EDL933 and Sakai) shows that the bgl and the Z5211-Z5214 locus are 
alternative genomic islands in E.coli. Strains MG1655 and CFT073 carry the bgl genomic island 
while the O157 strain, carries the Z5211-Z5214 genomic island at the same chromosomal map 
position (Fig. 4, Introduction). Alignment of the bgl/Z5211-Z5214 region (including upstream 
and downstream regions) from the four sequenced strains showed variations between the strains 
(Fig. 7).   
 
Figure 7: Nucleotide sequence alignment of bgl/Z5211-Z5214 regions which are different in the sequenced 
E.coli strains.  Structures are represented as described in Figure 4 (Introduction).  Nucleotide changes are shown as 
non-capitals and amino acid variations are shown in bold. A) Comparison of the phoU region of MG1655 
(AE000449: 8290-8227), CFT073 (AE016769: 175747-175684) and O157-EDL933 (AE005603: 8244-8181). 
Deduced amino acid sequences of MG1655 and CFT073 are shown at the top and O157 at the bottom.  The dotted 
line indicates the 5’ end of Z5211-Z5214 region. In the schematic presentation shown to the left bglG’ and Z5214’ 
indicate the 5’ end of the bglG and Z5214 genes respectively. B) Comparison of the bglK-yieI region of MG1655 
(AE000449: 78-1 + AE000448: 10332-9685) and CFT073 (AE016769: 167538-167429). CFT073 lacks the yieJ 
gene and carries an additional 18 bp sequence in comparison to MG1655.  Deduced amino acid sequences of BglK 
(at the top) and YieI (at the bottom) are also shown. C) Comparison of the yieH region of MG1655 (AE000448: 
9181-9121), CFT073 (AE016769: 166919-166859) and O157-EDL933 (AE005603: 804-744). Deduced amino acid 
sequence is shown as in A. Dotted lines indicate the 3’ end of Z5211-Z5214 region. Z5211’ indicates 3’ end of 
Z5211. O157-EDL933 and Sakai possess identical sequences at the regions shown in A and C. 
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The upstream phoU gene is conserved in all the four sequenced strains. However, nucleotide 
sequence alignment of the phoU region showed variations between the strains (Fig. 7A). The 
nucleotide sequence alignment of the downstream region of bgl/Z5211-Z5214 locus also showed 
variations between the strains (Fig. 7B and C). Strain CFT073 lacks the yieJ gene and carries an 
additional 18 bp in comparison to MG1655 (Fig. 7B). Both the O157 strains lack yieJ and yieI 
genes and are identical to each other at the bgl Z5211-Z5214 locus (Fig. 7C). 
 
1.2 Typing of 171 E.coli isolates at the region of bgl/Z5211-Z5214 genomic islands 
     In order to analyze whether the variations at the bgl/Z5211-Z5214 locus seen in the four 
sequenced strains are also present in the E.coli isolates a total of 171 E.coli strains encompassing 
99 clinical (Table 6a, Appendix) and the 72 strains of the ECOR collection (Table 6b, Appendix) 
were analyzed at this locus. Strains were analyzed by PCR with bgl or Z5211-Z5214 specific 
oligos (Fig. 37, materials and methods and Table 4, Appendix), nucleotide sequencing and 
Southern hybridization using bgl specific probes (see materials and methods).   
     Based on the analysis the strains were typed into five main types and one sub type at 
bgl/Z5211-Z5214 region (Fig. 8). Approximately, 20% of the strains that have MG1655 like 
nucleotide sequences in the upstream, bgl, and downstream regions are grouped as MG1655 type 
(Fig. 8A to K).  26% of the strains that have CFT073 like sequences in the upstream, bgl and 
downstream regions are grouped as CFT073 type (Fig. 8L to N). 20% of the strains that have 
Z5211-Z5214 locus are grouped as O157 type (Fig. 8O and P). 20% of the strains that have the 
upstream sequence like O157 followed by bgl and downstream sequences like MG1655 are 
grouped as fourth type (Fig. 8Q to W). 11% of the strains that have upstream, bgl like MG1655 
and downstream like MG1655 with 5’end of the yieI gene like CFT073 are grouped as fifth type 
(Fig. 8X to Z). In addition to these five main types, 3% of the strains have mixed sequences of 
MG1655, CFT073 and O157 in the bgl/Z5211-Z5214 region and are grouped as mixed type in 
this study (Fig. 8AA to AD). The phoU gene that is upstream of bgl/Z5211-Z5214 is conserved in 
all the isolates analyzed; however, the downstream region is variable. 
     Eleven out of 33 MG1655 bgl/Z type strains show alterations in the bgl region by insertions of 
IS1, IS2, IS629, IS186 and ISEc8 (insertion associated fragment from pheV locus of CFT073) 
and deletions within the bgl/Z5211-Z5214 locus (Fig. 8B to K). Strains U3633, E10096 and 
U4418 have same insertion site for ISEc8 fragment (Fig. 8B and C). Likewise, strains E291 and 
E292 have same insertion site for IS629 (Fig. 8H and I) suggesting that the strains could be 
derivatives of each other. Two strains out of 46 CFT073-type show alterations by insertion of 
IS1397 and IS1294 associated deletion (Fig. 8M and N respectively). 
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Figure 8: bgl/Z5211-Z5214 locus and β-glucoside utilization phenotypes of 171 commensal and pathogenic 
E.coli strains. Strains were analyzed by PCR; sequencing and Southern hybridization using bgl specific probes. 
Structures are represented as shown in Figure 4 (see introduction). Based on the structural analysis strains were 
grouped into five main types and one sub type. Total number of strains and number of ECOR strains in each type are 
shown. The β-glucoside utilization phenotypes on BTB salicin plates at 37°C are also shown. +++ indicates weakly 
Bgl+ at day 3 incubation (relaxed phenotype), ++ more papillae than MG1655, + papillae like MG1655, (+) weak 
Bgl+ at day 2 incubation and – indicates no/late papillae. MG1655 type 33 strains:  A) 22 strains have intact bgl 
locus like MG1655, in which 6 strains (F287, F1215 (t1 +105ta), E476, ECOR2, ECOR5, ECOR13) show more 
papillae, 11 strains (F785, E10097, E10099, E10082, E10085, E166, E444, E180, ECOR10, ECOR11, ECOR25) 
papillate like MG1655 and the remaining 5 strains (E10090, ECOR1, ECOR3, ECOR8, ECOR14) does not papillate.  
B) 2 strains (U3633, (++)) and (E10096, (+)) have insertion of 2456 bp ISEc8 (insertion associated) fragment 
(AE016766: 83067 to 85522) with 6 bp target site duplication (yieJ: 256-261 (numbering relative to the translational 
start)).  C) Strain U4418 (++) carries an IS1 with a 9 bp target site duplication (yieJ: 304-312) and also carries the 
ISEc8 fragment as in strains shown in B.  D) Strain E167 (+) carries an IS2 insertion with 5bp target site duplication 
(bglH: 33-37).  E) Strain ECOR12 (++) carries an IS2 insertion with 4bp target site duplication (bglH: 934-937).  F) 
Strain E345 (+) carries an IS629 and associated deletion from bglI: 917 to bglK: 105 (AE000449: 1078-604) and 
carry a second IS629 in inverted orientation with a 3 bp target site duplication (yieI: 235-237).  G) Strain U5107 (++) 
carries an IS629 and associated deletion from bglK: 106 to yieJ: 573 (AE000449: 603-1 + AE000448: 10332-10311).  
H) Strain E291 (-) carries an IS629 insertion with a target site duplication of 3 bp (yieJ: 547-549).  I) Strain E292 (+) 
carries an IS629 and associated deletion from yieJ: 546 to yieI: 355 (AE000448: 10284-9577).  J) Strain E164 (++) 
carries an IS1 and associated deletion from bglI: 33 to yieH: 238 (AE000449: 1962-1 + AE000448: 10332-8728).    
K) Strain U2366 (-) carries an IS186 with 8bp target site duplication (bglB: 352-359).  CFT073 type 46 strains: L) 
44 strains have intact bgl locus like CFT073, in which 26 strains (i484, F1, F385, F560, W7483, U2388, U2873, 
U3362, U4437, E10079, E10091, E182, E175, E452, ECOR23, ECOR32, ECOR51, ECOR52, ECOR53, ECOR54, 
ECOR55, ECOR57, ECOR60, ECOR63) show a relaxed phenotype, 5 strains (St5119, U3145, E176, E471, 
ECOR56) show more papillae, 14 strains (U3454, U3407, E10094, E478, E457, E177, E178, E464, E466, ECOR59, 
ECOR61, ECOR62, ECOR64, ECOR65) papillate like MG1655 and 1 strain (E475) does not papillate. M) Strain 
E422 (+) carries an IS1397 with 3 bp target site duplication (AE016769: 167486-167488). N) Strain F911 (-) carries 
an IS1294 and associated deletion from bglF: 931 to yieH: 256 (AE016769: 173583-166484). O157 type 33 strains:  
O) 32 strains have intact Z5211-Z5214 locus like O157, in which one strain (ECOR49) show weak Bgl+ phenotype 
(day 2) of the remaining 31 strains, 22 strains (F645, F905, St5679, U3292, U4409, U5070, E10093, E10098, E460, 
E173, E10100, E472, E10084, E424, E10089, E179, E10095, ECOR37, ECOR38, ECOR39, ECOR40, ECOR43, 
ECOR44, ECOR47, ECOR48, ECOR50) does not papillate and 9 strains (E10100, E472, E10084, E424, ECOR35, 
ECOR36, ECOR41, ECOR42, ECOR46) show late papillae.  P) Strain W7716 (-) carries an IS1 insertion and 
associated deletion (AE005603: 8093-1600). Fourth type 34 strains have upstream region like O157, followed by 
MG1655 type bgl and downstream with 5’ end of the yieI gene like CFT073.  Q) 24 strains have intact bgl like 
MG1655, 5 of these (U4191, U3104, ECOR19, ECOR45, ECOR67) show more papillae, 15 strains (F557, F742, 
V9261, V10744, U3622, U4252, U5033, E10087, ECOR7, ECOR26, ECOR27, ECOR28, ECOR70, ECOR71, 
ECOR72) papillate like MG1655 and in the remaining four strains, 3 strains (E10077, F569, U3372) show late 
papillae and one strain (St4723) does not papillate. R) Strain W9887 (++) carries an IS1 insertion with 9bp target site 
duplication (bglH: 97-105). S) Two strains ECOR20 (t1 +102gt) (-), ECOR21 (-) carries an IS1 insertion with 9bp 
target site duplication (bglB: 1060-1068). T) Strain ECOR18 carries an IS1 insertion with 9 bp target site duplication 
(AE000449: 8196-8204) and also carries IS1 associated deletion (AE000449: 8165-6293). U) Strain ECOR9 carries 
an IS1 associated deletion from bglB: 862 to bglH: 1602 (AE000449: 4224-2003). V) Strain ECOR17 carries an IS1 
insertion and associated deletion from bglt1 to bglK: 597 (AE000449: 8016-112). W) 4 strains (U2183, (+), ECOR58 
(+), ECOR69 (+), and V9343, (late papillae)) have MG1655 sequence and lacks yieJ as CFT073.  Fifth type 20 
strains have mixture of sequences from MG1655 and CFT073. The upstream, bgl and downstream (with the 
exception of 5’ yieI gene like CFT073) are like MG1655. X) 16 strains have intact bgl locus and downstream like 
MG1655 with 5’ end of yieI gene like CFT073. In which 3 strains (F775, W8987 (t1 +102ga), E294) show more 
papillae, 9 strains (W9763 (t1 +102ga), E10092, E174, ECOR15, ECOR22, ECOR33, ECOR34, ECOR68, ECOR30) 
papillate like MG1655 and in the remaining 4 strains,  3 strains ECOR16, ECOR24 and ECOR29 show late papillae 
and strain ECOR6 does not papillate. ? indicates sequence information is not known in that region. Y)  3 strains 
(E10086 (+), ECOR4 (+), ECOR31 (+)) have MG1655 sequence and lacks yieJ gene as in CFT073 and have 5’ of 
the yieI gene like CFT073. Z) Strain U4417 (-) carries an IS1 and associated deletion from bglG: 297 to yieI: 153 
(AE000449: 7655-1 + AE000448: 10332-9375) and carries 5’ end of yieI gene like CFT073. Mixed type 4 strains 
have mixture of sequences from MG1655, CFT073 and O157. AA) Strain E165 (+) has an upstream region and bgl 
like MG1655 followed by the downstream sequence like CFT073 with no yieJ gene (sequence of CFT073 starts at 
AE016769: 167468). AB) Strain E467 (+) have upstream and bgl like CFT073 followed by downstream sequences 
like MG1655 (sequence of MG1655 starts at AE000448: 10339) with 5’ yieI gene like CFT073. AC) 2 strains E7370 
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(+++) and ECOR66 (+++) have upstream, bgl and downstream like CFT073 with 5’ end of the yieI gene like 
MG1655. AD) Strain E10083, (-) has neither bgl nor Z5211-Z5214. However, it has some O157 sequence beyond 
the upstream breakpoint and downstream sequence in the yieH gene is like MG1655. The deletion in E10083 
(AE005603: 8120 to 780) is associated with the insertion of 9 additional bases (5’ TTTCTTTAT) in between the 
deletion endpoints. Text direction in the insertion elements represents the relative orientations of the insertion 
elements according to their defined left and right ends. Strain names are shown as indicated in Table 6 (Appendix). 
 
     Out of 33 O157 bgl/Z type strains, one strain has an IS1 insertion and associated deletion 
within Z5211-Z5214 region (Fig. 8P). Nucleotide sequencing at the downstream region of the 
fourth bgl/Z type strains revealed that all the 34 strains have yieJ and yieH sequences like 
MG1655. However, the yieI gene is with hybrid sequences i.e., the 5’ end of the yieI gene is like 
CFT073 (with 6 additional base pairs in comparison to MG1655 yieI sequence) and the 3’end is 
like MG1655. Out of these 34 fourth bgl/Z type strains, 10 strains show alterations by insertions 
of IS1 and deletions within the bgl/Z5211-Z514 locus (Fig. 8Q to W). 16 Strains in the fifth bgl/Z 
type have upstream and intact bgl operon like MG1655 followed with MG1655 downstream 
structure and 5’ end of yieI gene like CFT073 (Fig. 8X). Strains E10086, ECOR4 and ECOR31 
that have upstream and bgl like MG1655 lacks the yieJ gene like CFT073 and possess the 5’ part 
of the yieI gene like CFT073 (Fig. 8Y). Strain U4417 carries an IS1 associated deletion and has 
upstream, bgl, and downstream like MG1655 with 5’ end of yieI gene like CFT073 (Fig. 8Z).    
     Strains in the mixed bgl/Z type differ from the other types in having a mixture of sequences 
from MG1655, CFT073 and O157. Strains E7370 and ECOR66 have upstream, bgl and 
downstream like CFT073 but carries 5’ end of the yieI gene like MG1655 (Fig. 8AC). One of the 
mixed type strain E10083 does not have neither the bgl nor the Z5211-Z5214 genes however, the 
upstream phoU sequence is like O157 followed by the 5’ part of Z5211-Z5214 region and the 
downstream yieH sequence is like MG1655 (Fig. 8AD). The details of the structural and 
phenotype analysis are presented below. 
 
1.3 β-glucoside (salicin) utilization phenotypes of E.coli isolates 
 
     Aryl-β-glucosides are used as a carbon source by many bacteria (Kharat and Mahadevan, 
2000; El Hassouni et al., 1992; Schnetz et al., 1996; Faure et al., 2001; Cote et al., 2000; Brown 
and Thomson, 1998; Breves et al., 1997; Brehm et al., 1999). In E.coli K-12 utilization of β-
glucosides like arbutin and salicin requires the expression of bgl operon. Wild type E.coli K-12 
cells are phenotypically Bgl-. However, upon spontaneous activation Bgl+ mutants arise as 
papillae (Schaefler and Malamy, 1969). To understand whether the variations seen at the 
bgl/Z5211-Z5214 locus in the 171 E.coli isolates have an impact on the β-glucoside utilization, 
the strains were analyzed for their phenotypes on BTB salicin plates at 37°C. Phenotypes were 
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noted daily up to 5 days (see materials and methods). Three different types of papillation 
phenotypes were seen (Fig. 9).  
 
          35% of the strains papillate like K-12 MG1655 with 10-30 papillae’s (in the conditions we 
have analyzed) are grouped under MG1655 like phenotype. 16% of the strains that papillate more 
frequently than MG1655 with 100-200 papillae’s are grouped under more papillae phenotype.  In 
contrast to the other two types, 15% of the strains showed a weak Bgl+ phenotype on day 3 (Fig. 
9) which is assigned as relaxed phenotype in the current study. Strains that show relaxed 
phenotype papillate when incubated at 28°C (data not shown). In addition to these three types, 
one strain (ECOR49) that has Z5211-Z5214 locus showed a weak Bgl+ phenotype on day 2 of 
incubation at 37°C. Among the other remaining 33% some of the strains either papillate late 
(after day 5), or do not papillate even after prolonged incubation (up to day 10) on BTB salicin 
plates.  
 
1.4 Nucleotide polymorphism at the upstream region of bgl/Z5211-Z5214 
      
     Nucleotide sequence alignment of bgl/Z5211-Z5214 region (including upstream and 
downstream regions) from the four sequenced strains showed sequence variations between the 
strains (Fig. 7). Based on the sequence variations at the upstream and the downstream regions, the 
four sequenced strains can be distinguished from each other (Fig. 7). In addition, alignment of the 
Figure 9: Phenotypes on BTB salicin plates 
at 37°C. All the 171 E.coli strains were 
streaked on Bromthymol blue (BTB) salicin 
indicator plates and incubated at 37°C. 
Following day 1 incubation images were 
taken using Zeiss stemi 2000-C Microscope 
and the observations were recorded up to day 
5. Shown are the representative images of the 
three different papillation phenotypes seen. 
E.coli K-12 MG1655 strains are 
phenotypically Bgl- at day 1 (seen as blue 
colonies). Upon further incubation (from day 
2 onwards) spontaneous Bgl+ mutants arise 
(seen as orange papillae). 60 strains show K-
12 MG1655 like phenotype where the 
number of papillaes seen were comparable to 
that of MG1655 (MG1655 phenotype). 27 
strains papillate more frequently than 
MG1655 (more papillae), 26 strains show 
weakly Bgl+ phenotype at day 3 (relaxed 
phenotype) where the entire colony surface is 
covered with numerous tiny orange papillae. 
1 strain show weak Bgl+ on day 2 incubation 
and in the remaining 57 strains, 16 strains 
papillate late after day 5 incubation and 41 
strains do not papillate even after prolonged 
incubation. (Table 6, Appendix). 
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nucleotide sequence of the bgl operon from MG1655 and CFT073 also do show variations. The 
strain CFT073 carries around 12 bp changes in the bgl promoter region in comparison to 
MG1655 (Fig. 10). To analyze whether these polymorphisms are present in the E.coli isolates, the 
nucleotide sequence at the upstream and bgl promoter region was determined. The strains were 
analyzed by PCR with bgl specific primers (Fig. 37 materials and methods, Table 4, Appendix) to 
see whether they carry the bgl operon. In the strains that carry the bgl operon the sequence of the 
upstream region (phoU gene) and the bgl regulatory region were amplified by PCR with bgl 
specific primers and the PCR fragments were sequenced. The strains that showed no PCR product 
with bgl specific primers and carry no bgl (negative PCR) were analyzed by ST-PCR (for the 
presence of Z5211-Z5214) and the obtained PCR products were sequenced.  
     Based on the nucleotide sequence alignment with the published sequences of MG1655, 
CFT073 and O157, the strains were grouped into four types at the upstream and 5’end of the 
bgl/Z5211-Z5214 locus: MG1655 type, CFT073 type, O157 type and fourth type. 
       
            
 
 
A
B
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Figure 10: Nucleotide sequence alignment of the upstream region of the bgl and Z5211-Z5214 islands.  A) 
Schematic presentation of the upstream region of bgl island in MG1655 and CFT073, Z5211-Z5214 island in O157 
(EDL933 and Sakai). Fourth types have upstream sequence like O157 followed by MG1655 bgl sequence. Structures 
are represented as described in Figure 4 (introduction). The dotted line indicates the 5’ end of Z5211-Z5214 region. 
The bglG’ and Z5214’ indicate the 5’ end of the bglG and Z5214 genes respectively.  B) Nucleotide sequences of 
171 strains were aligned and compared with the published sequences of MG1655, CFT073 and O157. Representative 
strains in each type along with the strains that have specific base-pair changes are shown (refer Table 6, Appendix). 
Conserved nucleotides in comparison to MG1655 are shown as dots. Base pair changes in each strain are shown. 
Deduced amino acid sequence of MG1655 PhoU and BglG is shown at the top of the alignment.  Horizontal arrows 
above the sequence represent the inverted repeats in the phoU and bgl terminator t1.  Promoter Pbgl is marked by a 
brace.  The CAP binding site is underlined.  BglG binding site (RAT) is shown as a line above the sequence. Typing 
of the strains based on the nucleotide sequence alignment is shown at the left. Strains of MG1655 type have sequence 
like MG1655; Strains of fourth type possess phoU gene sequence like O157 followed by MG1655 bgl sequence. 
Strains of CFT073 type have 11 to 12 base pair changes in the bgl promoter region. The sequence variations seen in 
the strains of O157 type at the end of phoU and the vertical line mark the start of Z5211-Z5214 region. Strain 
E10083 neither carries bgl nor Z5211-Z5214; however, some of the Z5211-Z5214 sequence (with additional 15 bp, 
see alignment) is present till the breakpoint (∆). Numbering below each alignment is relative to the transcription start 
site of the bgl operon. Number of strains in each sequence types is shown. Strain names are listed as in Table 6 
(Appendix). 
 
Strains that have MG1655 bgl sequence are grouped as MG1655 type. Some of the MG1655 
bgl/Z type strains have single nucleotide change in the bgl terminator t1 (Fig. 10B). Strains of the 
MG1655 and CFT073 bgl/Z type differ at 11 to 12 bp in the bgl promoter region (Fig. 10B). 
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Strains of the O157 bgl/Z type have Z5211-Z5214 region as in O157. In addition to these three 
types, a group of strains (fourth bgl/Z type) that have sequence variations in the phoU gene (as in 
O157) followed by MG1655 bgl sequence was observed. The strains that have specific variations 
within each type are shown in the alignment (Fig. 10B and Table 6, Appendix). 
 
1.5 Nucleotide polymorphism at the downstream region of bgl/Z5211-Z5214   
     The grouping of the E.coli strains based on the alignment of the nucleotide sequences of the 
upstream region aggravated an interest to analyze the nucleotide sequences at the downstream 
region. Hence, for the strains in the fourth bgl/Z type the nucleotide sequence for the downstream 
region of bgl/Z5211-Z5214 was determined. In addition, ST-PCR was performed for the strains 
of O157 bgl/Z type (Table 6a, Appendix) and the PCR products were sequenced. Based on the 
nucleotide sequence alignment with the published sequences of MG1655, CFT073 and O157, the 
strains were grouped into five types at the downstream and 3’end of the bgl/Z5211-Z5214 locus: 
MG1655 type, CFT073 type, O157 type, fourth type and fifth type (Fig. 11). Most of the strains 
that were typed based on the nucleotide sequence alignment of the upstream region were found to 
be clustered into the same type in the alignment of the downstream sequences (Table 6, 
Appendix).  
     The downstream sequences in the yieJ and yieH genes of the fourth bgl/Z type strains are like 
MG1655 (with few sequence variations). However, the yieI gene is with a mixture of sequences 
from CFT073 and MG1655. The strain CFT073 has additional 6 bp AGTACC in the yieI gene in 
comparison to MG1655 (Fig. 11C). The yieI gene observed in the fourth type strains has these 
additional six bases and a stretch of CFT073 sequence at the 5’ end of the gene. However, the 
3’end of the yieI gene is like MG1655 (Fig. 11C and 8Q to W). In addition, nucleotide 
sequencing results revealed that twenty strains have downstream sequences like MG1655 with 
the exception of carrying hybrid yieI gene. This group is named as fifth bgl/Z type in the current 
study (Fig. 8X to Z). Fifth bgl/Z type strains have upstream and bgl like MG1655 followed by 
downstream like MG1655 with hybrid yieI gene. 
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Figure 11: Nucleotide sequence alignment of the downstream region of bgl/Z5211-Z5214.  A) Comparison of the 
bglK-yieI region of MG1655 and CFT073 is shown. CFT073 lacks the yieJ gene and carries an additional 18 bp 
sequence in comparison to MG1655. B) Comparison of the yieH region of MG1655, CFT073, O157 and fourth type. 
Fourth type and fifth type are identical to one another at the downstream region. Dotted lines indicate the 3’ end of 
Z5211-Z5214 region. Z5211’ indicates 3’ end of Z5211. O157-EDL933 and Sakai possess identical sequences at the 
regions shown in A and B. C) Nucleotide sequences of the strains were aligned and compared with the published 
sequences of MG1655 (AE000449: 80-1+ AE000448: 10332-9118), CFT073 (AE016769: 167540-166856) and 
O157 (AE005603: 779-741). Base pair changes and conserved nucleotides are represented as in Fig. 10. Deduced 
amino acid sequence of MG1655 BglK, YieI, YieH (top of the alignments); CFT073 BglK, YieI (bottom) and YieH 
(top); O157 YieH (bottom) is shown. Horizontal line represents the hybrid yieI part. In fourth and fifth type apart 
from the sequence shown with the horizontal line the rest of the sequences are like MG1655 (with few sequence 
variations). Typing of the strains based on the nucleotide sequence alignment is shown at the left. Representative 
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strains in each type along with the strains that have specific base-pair changes are shown.  Strains of fourth type 
possess bglK sequence like MG1655 followed by MG1655 downstream sequence (except the 5’end of yieI gene). 
O157 type strains have sequence variations in the yieH gene as in O157. The vertical line marks the 3’end of Z5211-
Z5214 region. Strain E10083 neither carries bgl nor Z5211-Z5214; ∆ represents the downstream breakpoint till the 
upstream sequences (shown in Fig. 10). Deletion of 12bp in strains U2183, ECOR58 and E10086 are shown as 
∆12bp. Number of strains in each sequence types is shown. Refer Table 6 for more details. 
 
     Furthermore, apart from the five main types seen, a sub-type of strains (Table 6, Appendix) 
that have mixture of sequences from MG1655, CFT073 and O157 in the bgl/Z5211-Z5214 locus 
was observed. This sub-group is designated as a mixed bgl/Z type in this study (Fig. 8AA to AD) 
for e.g. strain E165 that has upstream and bgl sequence like MG1655 has downstream sequences 
like CFT073 (Fig. 11C and Fig. 8AA). In addition, hybrid yieI gene was also observed in mixed 
bgl/Z type strains (Fig. 8AB and AC). The strains of O157 bgl/Z type have yieH gene sequence as 
in O157 (Fig. 11). 
 
1.6 Southern hybridization analysis for the strains that did not papillated on BTB salicin 
plates. 
     Out of the 99 clinical strains, 24 strains did not papillate on BTB salicin plates at 37°C (Table 
6a, Appendix). All these strains were analyzed by Southern hybridization with various bgl region 
specific probes (Figure 12 and Fig. 41, Appendix). 18 out of 24 strains are of O157 bgl/Z type 
(determined by ST-PCR, Fig. 8O and P). The templates used for probe preparation were isolated 
either as PCR products from MG1655 cells or by restriction analysis of pFDX733 or pFDY52 
(see materials and methods).  Hybridization to the genomic DNA from O157 bgl/Z type strains 
with bgl specific probes (probe C, D, E, F, G, and H, see Fig.41IV to X , Appendix) did not give 
any signals as seen in MG1655 (used as control) indicating the lack of bgl operon in this group of 
strains.  However, with probes A, B, I and J signals were seen as expected in case of O157 (Fig. 
12 and Fig.41I to III, XI to XV Appendix), indicating the presence of intact Z5211-Z5214 region 
(Fig. 8O). The presence of Z5211-Z5214 region correlates to upstream and downstream 
sequencing analysis of O157 bgl/Z type strains (Fig. 10 and 11). Strains W7716 and E10083 have 
Z5211-Z5214 sequences, however, unexpected signals were seen in both the strains indicating 
either insertions or deletions within the Z5211-Z5214 region (Fig. 12, Fig. 8P, 8AD and Fig.41I 
to III, XII to XV, Appendix).  In addition to O157 bgl/Z type, 6 strains that have bgl operon 
(determined by upstream and downstream nucleotide sequencing) and do not papillate were also 
analyzed by Southern hybridization with bgl specific probes (Fig. 8A, 8H, 8K, 8Q, 8Z, and Fig. 
12). Strain U4417 that has upstream bgl sequences like MG1655, gave unexpected signals with 
probes A, C and I (Fig. 8Z, Fig. 12 and Fig.41II, V, XII). No signals were seen with probe D, F, 
H indicating a possible deletion within the bgl operon (Fig.41VI, VII, Appendix). 
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Figure 12: Southern analysis of the bgl/Z5211-Z5214 region in E.coli isolates.  Strain names are indicated as 
listed in Table 6 (Appendix).  Letters corresponds to the structures shown in Fig. 8. Restriction sites are indicated as 
black lines, the regions used as probes are shown as black bars: probe A (NcoI-SspI), B (S145/S201), C (S157/S201), 
D (DraI-EcoRV), E (NcoI-NcoI), F (PvuII-HindIII), G (EcoRI-EcoRI), H (Eco81I-PvuII), I (EcoRI-SalI), J 
(S335/S336). + indicates presence, - indicates absence, (+) indicates signal of unexpected size in comparison to 
MG1655. Strains that have O157 sequences are indicated by vertical black line at the left. Primers used for probe 
preparation are named as listed in Table 4 (Appendix). Gel images are shown in Figure 41 (Appendix). 
 
     To map the deletion point in strain U4417, PCR was carried out with the primer matching in 
the upstream region (bglG gene) and the other in downstream region (yieI gene). The obtained 
product was sequenced from both the ends. The sequencing result showed that U4417 carries an 
IS1 associated deletion from bglG gene to yieI gene (Fig. 8Z). Strains E10090, E10077, U3372 
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carry the intact bgl operon with no structural alterations, indicating that a point mutation(s) might 
have resulted in the non-utilization of β-glucosides in these three strains (Fig. 8A and 8Q).  
     Furthermore, Southern hybridization was performed with 6 different genomic digests of strain 
i484 along with MG1655 genomic digests as control (Fig. 13A & Fig.41XVIII, XIX). The 
genomic digests were probed with two probes: Probe K that maps in the bglH gene and Probe L 
that map in the yieIHG genes. The results revealed that i484 have bgl region like CFT073 that 
lacks yieJ gene (Fig.8L, 13A and Fig.41XVIII, XIX, Appendix).  
 
Figure 13: Southern analysis to fine map the insertions or deletions in the bgl region.  Restriction sites are 
indicated as black lines. The regions used as probes are shown as black bars: probe K (ScaI-SapI), L (BglII-SalI), M 
(Eco01091-EcoRI),G (EcoRI-SalI). Sizes expected for MG1655 genomic DNA digests are shown at the top of 
horizontal arrows and the variation in the signal size is shown at the bottom A) Strain i484 genomic digests are 
shown, signals were seen as expected in CFT073. B) Strain U2366 genomic digests probed with M showed increased 
signal of ~1.4kb C) Strain E291 genomic DNA was digested in 3 different sets and probed with G. An increase of 
~1.5kb size was seen. Gel images are shown in Fig. 41 (Appendix). Letters corresponds to the structures shown in 
Fig. 8. 
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Strain E291 showed an increase in size (~1.4 kb) with probe H, indicating an insertion in the 
bglHIK-yieJ region (Fig.12H and Fig.41X, Appendix). Further fine mapping (Fig. 13C & 
Fig.41XVI), PCR and nucleotide sequencing revealed that E291 carries IS629 insertion in yieJ 
gene (Fig. 13C and Fig. 8H). The increased in size corresponds to the insertion element shown in 
Figure 8H. Insertion in yieJ gene cannot explain why the strain cannot utilize β-glucoside, as the 
first three genes are necessary and sufficient for the utilization of β-glucosides. It is possible that 
in strain E291 a point mutation (s) in the structural genes might have resulted in the non-
utilization of β-glucosides. Strain U2366 showed an increase in size (~1.5 kb) with probe A. D, F 
indicating a possible insertion within the first four genes of the bgl operon (Fig. 12K and 
Fig.41II, VI, VIII). Further mapping of the insertion by using probe M and three different 
genomic digests showed insertion in bglB (Fig.13B & Fig.41XVII). The insertion size 
corresponds to the insertion element shown in Figure 8K. PCR and nucleotide sequencing 
revealed that U2366 carry IS186 insertion in bglB (Fig. 8K). The ability to utilize β-glucosides in 
strain U2366 might have been lost due to the inactivation of bglB by IS186 insertion. 
 
1.7 Long PCR analysis to analyze the alterations within the bgl/Z5211-Z5214 locus 
      Results from the Southern hybridization and nucleotide sequencing analysis revealed that 
strains show alterations within the bgl/Z5211-Z5214 locus by deletions and insertions. In order to 
analyze the genomic alterations within the bgl/Z5211-Z5214 locus in the strains that were not 
analyzed by Southern hybridization (Table 6, Appendix), a long PCR strategy was employed. 
This strategy involves the use of Elongase enzyme (Invitrogen) that can amplify DNA up to 30 
kb. In order to analyze for the presence of intact bgl operon or Z5211-Z5214, long PCR’s were 
carried out with the primers that map in the upstream region (phoU) and in the downstream 
region (yieH) and the PCR products were compared to the MG1655 and i484 (like CFT073) sizes 
(controls). Strains that have intact bgl region like MG1655 gave expected band size like MG1655 
and strains that have CFT073 like bgl region gave expected band size like i484 (like CFT073). 
Strains of O157 bgl/Z type gave expected PCR product size as expected in O157. The strains that 
gave expected sizes like MG1655, CFT073 and O157 were further analyzed by PCR’s with 
primers specific for bgl or Z5211-Z5214 (Table 6a and 6b, Appendix).  Furthermore, out of 21 
strains that showed differences in the PCR product sizes in comparison to the expected sizes of 
MG1655, CFT073 and O157, 19 strains (remaining 2 strains were analyzed in Southern analysis, 
see section 1.6, Results) were analyzed by several internal PCR’s to map the possible insertion 
and/or deletion points within the bgl/Z5211-Z5214 region (Fig. 14 and Table 6a and 6b, 
Appendix). A principle strategy of such an analysis is shown in Figure 14. 
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Figure 14: Schematic representation of PCR analysis to map the insertions or deletions within bgl/Z5211-
Z5214 region. Strain names are shown as in Table 6 (Appendix) and oligos are shown as in Table 4 (Appendix). The 
MG1655 bgl region is shown as open black arrows. Oligos are shown with vertical lines above the genes.  Horizontal 
arrows represent the PCR reactions performed with the respective oligos. A: S309/S413, B: S309/S32, C: S253/S460, 
D: S346/S460, E: S536/S460, F: S429/S348, G: S537/S413, H: S560/S561, I: S309/S561, J: S562/S564. + indicates 
expected size seen as in MG1655, (+) indicates increased size seen in comparison to MG1655. Refer Table 6 for the 
strain names and the mutations they carry in the bgl/Z5211-Z5214 locus. Out of 21 strains that show insertions or 
deletions, 19 strains were mapped using long PCR strategy. The 19 strains (letters) that corresponds to the structures 
shown in Fig. 8 are : E167 (D), W9887 (R), ECOR12 (E), ECOR20 (S), ECOR21 (S), U3633 and E10096 (B), 
U4418 (C), E345 (F), U5107 (G),  E292 (I), E164 (J), E422 (M), F911 (N), ECOR18 (T), ECOR9 (U), ECOR17 (V), 
U4417 (Z) and W7716 (P). 
 
     In the analysis shown above initial long PCR was carried out with oligos S309 and S413. The 
results showed that all the strains shown in Figure 14 (Table 6, Appendix) showed an increase in 
the PCR product size in comparison to MG1655. To further fine map the insertion points, several 
internal PCR’s were carried out (Fig. 14).The relative PCR product was later sequenced from 
both the ends for e.g. the PCR product (S560/S561) of strain E167 was sequenced with oligos 
S560 and S561. The nucleotide sequencing results revealed that strains E167 and ECOR12 carry 
IS2 insertions in the bglH gene (Fig. 8D and 8E, respectively), strain W9887 carries IS1 insertion 
in bglH gene (Fig. 8R). Strains ECOR20 and ECOR21 carry IS1 insertions at the same position in 
bglB (Fig. 8S). Both these strains do not papillate on BTB salicin indicator plates. Since, bglB is 
essential for β-glucoside utilization the insertion of IS1 in the bglB may perhaps explain the no 
papillae phenotype seen in these two strains. To map the deletion points in the strains W7716 and 
E10083 (detected by Southern hybridization) PCR was carried out using a primer that maps in the 
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upstream region (phoU gene) and the primer that map in the downstream gene (yieH). The 
obtained PCR product was sequenced from both the ends. PCR and nucleotide sequencing results 
showed that strain W7716 carries an IS1 associated deletion from Z5212 to Z5214 (Fig. 8P) and 
strain E10083 carries complete deletion of Z5211-Z5214 region (Fig. 8AD).  
     From the PCR and sequencing analysis an insertion associated fragment encoded by ISEc8 
was mapped in strains U3633, E10096 and U4418 (Fig. 8B and C). It was observed that ISEc8 
generates 6 bp target site duplication at its insertion site. The insertion element ISEc8 belongs to 
IS66 family and carries a 22bp imperfect terminal inverted repeats. It shows 51.1% identity at the 
nucleotide level to the insertion element ISRm14 from Sinorihizobium meliloti (Schneiker, 1999). 
The mechanism of ISEc8 transposition is currently not understood. 
 
1.8 A refined PCR strategy to analyze the downstream region and the presence of hybrid 
yieI gene  
      Nucleotide sequencing data of the upstream and downstream bgl and Z5211-Z5214 islands 
revealed the existence of E.coli strains that carry a hybrid yieI gene. This hybrid yieI gene is 
identical to the yieI gene of K12-MG1655 with a patch of sequence within its 5’ end that is 
identical to the sequence of the yieI gene in CFT073. In addition some strains have a mixed 
structure (section 1.4 and 1.5). In order to analyze whether strains which according to PCR 
analysis have a downstream structure as K12-MG1655, i.e. carry the yieJ gene, or which lack yieJ 
as strain CFT073 carry a hybrid yieI gene or another mixed sequence structure a refined PCR 
strategy was designed. This strategy involves a two step PCR reactions using two sets of three 
primers (Fig. 15). Both sets of primers include a MG1655 specific bglK primer (S588) and a 
CFT073 specific bglK primer (S589).These two primers match at different positions and thus a 
PCR product generated with the MG1655 specific primer has a different size than a PCR product 
generated with the CFT073 specific primer.  The reverse primer in the first set matches to the 5’ 
end of the CFT073 type yieI gene (S587), while in the 2nd set it matches to the 5’ end of the 
MG1655 type yieI (S586) (Fig. 15). In brief, by the first PCR reaction strains carrying a yieI gene 
with the 5’ end of the CFT073 type can be characterized (see Figure 15B, C, D and F). Those 
strains that showed no PCR product in this first PCR were analyzed using the second set of three 
primers. This allowed to characterize strains in which the 5’ end of the yieI gene is identical to 
MG1655 (see Fig. 15A and E). To distinguish whether strains carry a hybrid yieI gene or not, the 
PCR fragments of some strains were sequenced (Fig. 15B, C, E and F). All together, the data of 
the current study shows that out of 135 isolates that have yieI gene 43% have a hybrid yieI gene. 
The significance of the presence of the hybrid yieI gene is yet to be understood.      
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Figure 15: Schematic presentation of a PCR strategy used for typing E.coli strains at the downstream region 
of the bgl operon. Structures of bglK-yieH region are shown. Open black arrows and blocks represent MG1655 
sequence, closed arrows and blocks represents CFT073 sequence. Structures seen in the current analysis at the 
downstream region are shown in A to F. Primer mapping positions are shown beneath each structure by arrow heads. 
This strategy involves two PCR reactions. The first PCR is carried out with the primer combination S588/S89/S587. 
This PCR results in the size of one of the PCR products that corresponds to the structures shown in B, C, D, F. 
Strains that showed no PCR product in the first PCR were analyzed with a second PCR using primers 
S588/S589/S586. All strains of which no PCR product was obtained with the first set of primers yielded a PCR 
product in the second PCR corresponding to the structures shown in A, E. The expected size of the PCR product for 
each structure is shown in base pairs. – indicates no PCR product.  
 
1.9 Correlations of bgl/Z5211-Z5214 on β-glucoside utilization phenotypes. 
      A strong correlation was seen for the presence of bgl/Z5211-Z5214 and the β-glucoside 
utilization phenotypes of the strains. Out of 57 strains that show no papillae or late papillae, 58% 
of them are of O157 bgl/Z type with no bgl genes (Fig. 8O, P and AD) (Table 1a, b, and c), 14% 
have functional inactivation of bgl genes either by insertions or deletions (Fig. 8K, N, S, T, U, V, 
Z) within the bgl operon. The remaining 28% of the strains have no structural alterations in the 
bgl genes (Fig. 8A, H, L, Q, W and X). These 28% of the strains may possess point mutations 
inactivating β-glucoside utilization. Our analysis indicates that the bgl operon is a primary β-
glucoside utilization system in E.coli present in approximately 70% of the isolates, and in all of 
the strains in which it is present, its silent state is conserved. 
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Table 1a: bgl/Z5211-Z5214 locus and β-glucoside utilization phenotypes in 171 E.coli isolates  
Phenotypes on BTB salicin plates at 37°CC                                 171 strainsa 
human com-81 
animal com-32 
uro-32 
sep-25 
ABU-1 
K-12- 60 (35%)
human com-31 (38%) 
animal com-12 (37%) 
uro-10 (31%) 
sep-6 (24%) 
ABU-1 (100%) 
more papillae-27 (16%)
human com-11 (13%) 
animal com-4 (12%) 
uro-6 (19%) 
sep-6 (24%) 
ABU- 
relaxed-26(15%)
human com-10 (13%) 
animal com-5 (16%) 
uro-6 (19%) 
sep-5 (20%) 
ABU- 
no papillae-57 (33%)
human com-28 (34%) 
animal com-11 (34%) 
uro-10 (31%) 
sep-8 (32%) 
ABU- 
weak Sal+-1(1%) 
human com-1 (1%) 
animal com- 
uro- 
sep- 
ABU- 
 
MG1655 bgl-88 (51%) 
human com-36 (44%) 
animal com-22 (69%) 
 uro-15 (47%) 
sep-14 (56%) 
ABU-1 (100%) 
44 (26%)
20 (25%)d 
11 (34%) 
6 (19%) 
  6 (24%)e 
1 (100%) 
22 (13%)
8 (10%) f 
4 (12%) 
5 (16%)g 
5 (20%)h 
- 
- 22 (13%)
8 (10%) i 
7 (22%)j 
4  (12%)k 
3 (12%)o 
- 
- 
 
 
 
 
 
 
CFT073 bgl-49 (29%) 
human com-25 (31%) 
animal com- 6 (19%) 
uro-11 (34%) 
sep-7 (28%) 
ABU- 
16 (9%)
11 (13%)l 
 1 (3%) 
4 (12%) 
- 
- 
5 (3%)
3 (4%) 
- 
1 (3%) 
1 (4%) 
- 
26 (15%)
10 (13%) 
5 (16%) 
6 (19%) 
5 (20%) 
- 
2 (1%)
1 (1%) 
- 
 
1 (4%)m 
- 
- 
 
 
 
 
 
 
b
g
l
/
Z
5
2
1
1
-
Z
5
2
1
4
 
l
o
c
u
s
 
b
 
Z5211-Z5214-34 (20%) 
human com-20 (25%) 
animal com-4 (12%) 
uro-6 (19%) 
sep-4 (16%) 
ABU- 
- - - 33 (19%)
19 (23%)n 
4 (12%)p 
6 (19%) 
4 (16%) 
- 
1 (1%) 
1 (1%) 
- 
- 
- 
- 
 
a: Total number of strains analyzed, human com-commensal strains from stool samples of healthy humans, animal com-commensals from animals, uro-uropathogenic 
strains, sep-septicemic isolates, ABU-asymptomatic bacteriuria causing strain b: bgl/Z5211-Z5214 locus was analyzed by PCR, sequencing, and southern hybridization. 
Numbers of strains are indicated, percentages are within brackets and the total numbers of strains in each category are also shown c: phenotypes on BTB salicin plates at 
37°C. MG1655: papillates like MG1655, more papillae: papillates more frequently than MG1655, relaxed-weak Bgl+ on day3 of incubation, none-no papillation or late 
papilallation, weak Sal+-weakly salicin positive phenotype (day2) d: Strain E167 (bglH::IS2), E10096 (yieJ::ISEc8),E345 ∆(bglH-bglI)::IS629, yieI::IS629, E292 ∆(yieJ-
yieI)::IS629   e: W9763 t1 +102ga    f: ECOR12 (bglH::IS2), E164 ∆(bglI-yieH)::IS1   g: U3633 yieJ::ISEc8, U4418 yieJ::IS1, yieJ::ISEc8, U5107 ∆(bglK-yieJ)::IS629    
h: F1215 t1 +105ta, W8987 t1 +102 ga, W9887 (bglH::IS1)    i: E291 yieJ::IS629, ECOR9 ∆(bglB-bglH)::IS1. Strains E10077 and ECOR24 show late papillation     j: 
ECOR17 ∆(bglt1-bglK), ECOR20 bglB::IS1, ECOR21 bglB::IS1, ECOR18 ∆ (Pbgl-bglF)::IS1. Strains ECOR16, ECOR29 show late papillation     k: U4417 ∆bglG-yieI, 
U2366 bglB::IS186 and strain U3372 show late papillation,    l: E422 bglK-::IS1397-yieJ,    m: F911 ∆(bglF-yieI)::IS1294    n: E10083 ∆Z5211-Z5214. Strains ECOR35, 
ECOR36, ECOR41, ECOR42, E10100, E10084, E472, E424 show late papillation    o: F569, V9343 late papillation    p: ECOR46 show late papillation 
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Table1b: bgl/Z5211-Z5214 locus and β-glucoside utilization phenotypes of 99 E.coli strains 
Phenotypes on BTB salicin plates at 37°Cc 99 strainsa 
human com-52 
uro-22 
sep-25 
K-12-37(37%) 
human com-25 (48%) 
uro-6 (27%) 
sep-6 (24%) 
more papillae-17(17%) 
human com-5 (10%) 
uro-6 (27%) 
sep-6 (24%) 
relaxed-15(15%) 
human com-6 (11%) 
uro-4 (18%) 
sep-5 (20%) 
no papillae-30 (30%) 
human com-15 (29%) 
uro-6 (27%) 
sep-8 (32%) 
MG1655 bgl-48 (48%) 
human com-22 (42%) 
uro-12 (54%) 
sep-14 (56%) 
26 (26%) 
16 (36%)d 
4 (41%) 
  6(44%)e 
13 (13%) 
3 (6%)f 
5 (23%)g 
5 (20%)h 
- 9 (9%) 
3 (6%) i 
3 (14%)k 
3 (12%)o 
 
CFT073 bgl-32 (32%) 
human com-18 (35%) 
uro-7 (32%) 
sep-7 (28%) 
11 (15%) 
9 (21%)l 
2 (14%) 
- 
4 (4%) 
2 (4%) 
1 (4%) 
1 (4%) 
15 (15%) 
6 (11%) 
4 (18%) 
5 (20%) 
2 (2%) 
1 (2%) 
- 
1 (4%)m 
 
b
g
l
/
Z
5
2
1
1
-
Z
5
2
1
4
 
l
o
c
u
s
 
b
 
Z5211-Z5214-19 (19%) 
human com-12 (23%) 
uro-3 (14%) 
sep-4 (16%) 
- - - 19 (19%) 
12 (23%)n 
3 (14%) 
4 (16%) 
 
 
a to p as in  Table 1a 
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Table 1c: bgl/Z5211-Z5214 locus and β-glucoside utilization phenotypes of 72 ECOR strains 
Phenotypes on BTB salicin plates at 37°CC 72 strainsa 
human com-29 
animal com-32 
uro-10 
ABU-1 
K-12 -23 (32%) 
human com-6 (21%) 
animal com-12 (37%) 
uro-4 (40%) 
ABU-1(100%) 
more papillae-10(14%) 
human com-6 (21%) 
animal com-4 (12%) 
uro - 
ABU- 
relaxed-11 (15%) 
human com-4 (14%) 
animal com-5 (16%) 
uro -2 (20%) 
ABU- 
no papilale-27 (37%) 
human com-12 (41%) 
animal com-11 (34%) 
uro -4 (40%) 
ABU- 
Weak Sal+-1 (1%) 
human com-1 (3%) 
animal com- 
uro - 
ABU- 
MG1655 bgl-40 (55%) 
human com-14 (65%) 
animal com-22 (68%) 
uro -3 (30%) 
ABU-1 (100%) 
18 (25%) 
 4 (14%) 
11 (34%) 
2 (20%) 
1 (100% ) 
9 (13%) 
                           5 (17%) f 
 4 (12%) 
- 
- 
- 13 (18%) 
5 (17%)i 
7 (29%)j 
1 (10%) 
- 
- 
CFT073 bgl-17 (24%) 
human com-7 (24%) 
animal com-6 (19%) 
uro -4 (40%) 
ABU- 
5 (7%) 
2 (7%) 
1 (3%) 
2 (30%) 
- 
1 (1%) 
1 (3%) 
- 
- 
- 
11(15%) 
4 (14%) 
5 (16%) 
2 (20%) 
- 
- - 
b
g
l
/
Z
5
2
1
1
-
Z
5
2
1
4
 
l
o
c
u
s
b
 
Z5211-Z5214-15 (21%) 
human com-8 (27%) 
animal com-4 (12%) 
uro -3 (30%) 
ABU- 
- - - 14 (19%) 
7 (24%)n 
4 (12%)p 
3 (30%) 
- 
1 (1%) 
1 (3%) 
- 
- 
- 
 
 
     a to p as in  Table 1a 
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     A second significant correlation was seen for the presence of the CFT073 type bgl operon to 
the relaxed phenotype.  All the strains that showed a relaxed phenotype carry CFT073 bgl (Fig. 
8L, AC, Table 1a, b and c), indicating that CFT073 bgl is important for the strains to show 
relaxed phenotype and not vice versa. 
 
1.10 Correlations of the bgl/Z5211-Z5214 typing with phylogenetic distribution of ECOR 
strains.  
     The 72 ECOR strains are phylogenetically classified into 5 different groups: A, B1, B2, D, 
and E based on the genetic distance matrix on electrophoretically detected allelic variation at 38 
enzyme-encoding loci (Herzer et al., 1990 and references therein; Whittam et al., 1983).  It was 
reported that Group A is a distinct lineage comprising of K-12 and K-12-like strains isolated for 
the most part from humans. B1 group is predominant with the strains isolated from non-primate 
mammals, whereas the group B2 strains are mostly from humans and other primates. The group 
D is a heterogeneous group that consists of strains from humans, non-primate mammals and other 
primates and group E is a variant group from the other four with the strains isolated from humans 
and non-primate mammals (Herzer et al., 1990).  
     Comparison of the E.coli types seen at the bgl/Z5211-Z5214 locus in the present study to the 
phylogenetic distribution of ECOR strains revealed significant correlations. 14 out of 15 ECOR 
strains that belong to group B2 are of CFT073 bgl/Z type (Table 2). All the MG1655 bgl/Z type 
strains belong to group A. Likewise; all the strains that belong to group D are of O157 bgl/Z type 
(Table 2). Strains in the fourth bgl/Z type are distributed in group A and B1. Fifth bgl/Z type 
strains are distributed in A, B1 and E and mixed bgl/Z type strain is distributed in group B2. 
 
Table 2: bgl/Z5211-Z5214 type with ECOR phylogeny 
Phylogenetic groupsc  72 strainsa 
 A B1 B2 D E 
MG1655 type-11 (15%)d 11(15%) - - - - 
O157 type-15 (21%) - - - 12 (17%) 3 (4%) 
CFT073 type-16 (22%) 1 (1%) 1 (1%) 14 (20%) - - 
Fourth type-17 (24%) 7 (10%) 10 (14%) - - - 
bg
l/Z
52
11
-Z
52
14
b 
Fifth type-12 (16%) 6 (8%) 5 (7%) - - 1 (1%) 
 Mixed type - - 1 (1%) - - 
 
a: 72 ECOR strains used in the study  
b: types based on the bgl/Z5211-Z5214 region analysis 
c: phylogenetic groups are based on Herzer et al., 1990 
d: number of strains are shown and percentages are calculated to the total number of ECOR strains analyzed in the 
study. 
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1.11 Spontaneous activation of the bgl operon in natural E.coli isolates. 
      In E.coli K-12 95-98% of the mutations that activate bgl operon are found in the vicinity of 
the promoter that includes integration of mobile DNA elements, point mutation within the 
binding site of the catabolite gene activator protein (CAP) and deletions encompassing an 
upstream AT-rich sequence element (Reynolds et al., 1981; Reynolds et al., 1986; Schnetz and 
Rak, 1988).  Only 2-5% of the activating mutations are unlinked, involving loci such as hns, gyr, 
bglJ and leuO (Defez and de Felice, 1981; DiNardo et al., 1982; Giel et al., 1996; Ueguchi et al., 
1998). To know whether the pattern of activation is identical in the strains that show different 
papillation phenotypes on BTB salicin plates at 37°C, the spontaneous mutants of a selection of 
strains that show the MG1655 like phenotype, the more papillae phenotype or relaxed phenotype 
or those that papillate late (after day 5) were analyzed (described in materials and methods). 
Expect from the strains that show the relaxed phenotype all the spontaneous mutants were 
isolated at 37°C. Spontaneous mutants from the strains that show relaxed phenotype were 
isolated at 28°C.  
      The seven Bgl+ mutants of the uropathogenic strain U3454 (MG1655 like phenotype) and two 
mutants of U3372 (late papillae) show activation of the bgl operon by insertions in the upstream 
AT-rich silencer sequences (Fig. 16). Out of seven spontaneous mutants of the septicemic isolate 
i484 (relaxed phenotype) one has a deletion of 47 bp, one mutant has a point mutation in CRP 
binding site and the other five mutants do not carry any sequence change in the bgl promoter 
vicinity (Fig. 16). Similarly, out of 6 spontaneous mutants of a septicemic isolate W7483 (relaxed 
phenotype), 2 of them have a deletion of 72 bp in the promoter vicinity and the remaining 4 
mutants do not have any sequence change. Of two commensal strains E10091 (relaxed 
phenotype) and E176 (more papillae), all of the 3 Bgl+ mutants of E10091 and 1 mutant of E176 
do not have sequence change in the promoter vicinity. The Bgl+ mutants that do not have any 
change in the promoter vicinity may carry mutations elsewhere in the genome which is yet to be 
determined.  The pattern of activation of the bgl operon seen in the analyzed strains resemble to 
that of the activation seen in E.coli K-12. However, it varies from strain to strain and may depend 
on its cellular pleiotropic control of the bgl operon or of transposition. 
 strain 
name 
type typing at bgl/Z5211-
Z5214  
phenotype number of 
mutants 
analyzed 
number of 
mutants in cis 
L U3454 uro CFT073 MG1655 7 7 
L i484 sep CFT073 relaxed 7 2 
L W7483 sep CFT073 relaxed 6 2 
L E10091 com CFT073 relaxed 3 0 
L E176 com CFT073 more papillae 1 0 
Q U3372 uro Fourth late papillae 2 2 
A 
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Figure 16: Spontaneous activation of the bgl operon. A) Strain names are shown as listed in Table 6. Uro 
indicates uropathogenic, sep-septicemic, com-commensal. Letters corresponds to the structures shown in Fig. 8. 
Typing at the bgl/Z5211-Z5214 locus is shown. Phenotypes are on BTB salicin plates at 37°C. No. of mutants 
analyzed are shown. B) DNA sequence of CFT073 bgl promoter region is shown. Sequenced Bgl+ alleles with 
insertions of IS1, IS629 and deletions in the promoter region are indicated. Positions of the IS elements are 
represented by straight lines with the arrowhead ends showing the relative orientations according to their defined left 
and right ends. The proximal deletion endpoints are indicated by right angled arrows marked with ∆. Numbering is 
relative to the transcription start of the bgl operon. The CAP binding site is underlined and base exchange within the 
CAP site is given above the sequence. Promoter Pbgl is marked by a brace and the transcriptional start site is 
indicated.  Horizontal arrows above the sequence represent the inverted repeats.  Two uropathogenic strains (U3454 
and U3372) were analyzed for the spontaneous activation of the bgl operon. Out of seven spontaneous mutants of 
U3454, 6 of them carry IS1 insertion and one carry IS629.  Two of the U3372 Bgl+ mutants that arise after day 7 
incubation at 37°C carry IS1 insertions. Two septicemic isolates (i484 and W7483) were analyzed. Out of Seven 
Bgl+ mutants of i484, 1 had a deletion of 47 bp, and other had a mutation from C to T in CAP binding site, the rest 5 
mutants have no changes in the bgl promoter region. Deletion of 72 bp is seen in 2 out of 6 W7483 Bgl+ mutants. 
Two commensal strains (E10091 and E176) were analyzed. All the 3 mutants of E10091 and 1 mutant of E176 did 
not have any changes in the bgl promoter region. Bgl+ mutants from relaxed phenotype strains were isolated at 28°C. 
 
1.12 Deduced amino-acid sequence alignment of BglG 
     Of some strains (7 MG1655 bgl/Z type, 8 fourth bgl/Z type and 12 CFT073 bgl/Z type, Table 
6, Appendix) in addition to the bgl promoter-leader region, the first gene bglG was sequenced 
and the deduced amino acid sequences of BglG were aligned with the deduced amino acid 
sequences of MG1655 BglG and CFT073 BglG (Fig. 17). The alignment results showed that the 
strains of MG1655 bgl/Z type do not have sequence variations.  Some of the strains of the fourth 
bgl/Z type (phoU sequence like O157 and bgl sequence like MG1655, Table 6 Appendix) and all 
of the CFT073 bgl/Z type carry few variations in comparison to MG1655 (Fig. 17).   
      The antiterminator BglG, belongs to SacY/BglG family of related proteins (Stulke et al., 
1998). The proteins belonging to this family have an N-terminal RNA-binding domain which is 
involved in the anti-termination activity (Manival et al., 1997) and two conserved PRD (PTS 
B 
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regulatory domain) domains which are targets for both positive and negative control by 
phosphorylation.  In each PRD domain there are one to two conserved histidines which are the 
target residues for phosphorylations (Stulke et al., 1998).  
 
Figure 17: Deduced amino acid sequence alignment of BglG. Deduced amino acid sequences of the 27 strains (7 
MG1655 type, 8 fourth types and 12 CFT073 type) were aligned and compared with the deduced amino acid 
sequences of MG1655 and CFT073 BglG. Amino acid changes in comparison to MG1655 BglG are shown. 
Conserved amino acids in comparison to MG1655 BglG are represented as dots. Typing of the strains based on the 
nucleotide sequence alignment is shown at the left. Representative strains in each type along with the strains that 
have specific amino acid changes are shown. Strains of MG1655 type do not have any change. Two strains of fourth 
type have no sequence variations are like MG1655; remaining 5 strains have few amino acid changes. CFT073 bgl 
type strains carry 2 to 3 amino acid changes. Inverted arrows represent the conserved amino acid residues in the 
SacY/BglG family of proteins. Open bar represents RNA binding domain, Closed black bar represents PRD-1 
domain and hatched bar represents PRD-2 domain. 
 
In the alignment of the deduced amino acid sequences, strains of the fourth bgl/Z type and 
CFT073 bgl/Z type have amino acid changes in the RNA binding domain as well as in the PRD 
domains. With the exception of septicemic isolate i484, all the CFT073 bgl/Z type strains carry 
A37P.  However, this may not affect BglG activity since in the antiterminator ArbG (from the 
gram negative bacterium Erwinia chrysanthemi) also carries a proline residue in place of alanine 
at this position (el Hassouni et al., 1992).   In addition, the structure of SacY (another member of 
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the SacY/BglG family) RNA binding domain (Manival et al., 1997) indicates that this residue is 
located in the loop region and thus may not have a role in the function of BglG.  Strain E10077 (a 
fourth bgl/Z type strain) carries a K48E change in BglG. This could affect the BglG activity, 
since Lysine is a conserved residue in the SacY/BglG group of anti-terminators (Declerck et al., 
2002).  The conserved histidine residues in the PRD-domains of BglG was found to be unaffected 
in all the strains which were analyzed (Fig. 17). 
 
1.13 Do the sequence variations in the CFT073 bgl type strains influence bgl expression? 
      Khan and Isaacson (1998) have reported that the expression of the bgl operon occurs in 
infected mouse liver and suggested a unique role for this operon in vivo. The septicemic isolate 
i484 which was used in their studies was also sequenced at the bgl region in our present work. 
Strain i484 have 12 bp sequence variations in the bgl promoter region like CFT073 in 
comparison to MG1655. However, it has BglG-P37A (number refers to the translational start) in 
the deduced amino acid sequence which is in contrast to CFT073. To analyze whether the 
sequence variations seen at the bgl regulatory region (includes bgl promoter, t1 and the first gene 
bglG) in the CFT073 bgl/Z type strains have any influence on the bgl expression, plasmidic 
construct that carry lacZ gene fused at the end of bgl promoter, terminator t1 and the first gene 
bglG was used (Fig. 18). The Pbgl-t1-bglG fragment of the strains shown in Figure 18 was 
isolated by PCR with oligos S145 and S201 and fused to the lacZ gene in the plasmid vector 
pKES15 that contains pACYC origin (refer Table 4 and Table 8 for primer position and plasmid 
construction, respectively). The expression of these constructs were determined in K-12 ∆bgl, 
∆lacZ background from cultures grown to the exponential phase (OD 600 of 0.5) in M9 medium 
with Casamino acids, Vitamin B1, 1% glycerol and antibiotics (see materials and methods). 
     No significant difference was seen in the β-galactosidase activity in the constructs carrying 
fourth bgl/Z type (phoU sequence like O157 and bgl sequence like MG1655) or CFT073 bgl/Z 
type sequence in comparison to MG1655. However, constructs that carry specific mutations as 
seen in the case of U5107 (t1 +103tg) show a ~2 fold increase in the β-galactosidase activity 
compared to MG1655 (1090 and 550 U, respectively Fig. 18C and A). Strain E10077 (a fourth 
bgl/Z type) that carries a K48E change in BglG (from the deduced amino acid sequence) showed 
~ 2 fold lesser activity (275 U, Fig. 18F) than that of MG1655.  The Lysine residue in the RNA 
binding domain of BglG is a conserved residue among the BglG-SacY group of anti-terminators 
(Declerck et al., 2002). Thus, change from Lysine to Glutamine might have a role in the function 
of BglG in strain E10077.  
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Figure 18: β-galactosidase activity of the Pbgl reporter constructs directed in K-12.  Shown are the results of 
plasmidic construct Pbgl-t1-bglG-lacZ whose expression is directed in K-12.  Strain names and specific base pair 
changes are shown. Nucleotide sequence changes in comparison to MG1655 bgl sequence are shown as non-capitals 
and the numbering indicated is relative to the transcription start of the bgl operon. Amino acid changes in 
comparison to MG1655-BglG are shown as capitals and numbering is relative to the translational start of BglG. 
Plasmids were transformed into S541 and β-galactosidase activity at OD600=0.5 was determined. β-galactosidase 
activity is expressed in miller units (Miller, 1972). Shown are the average results from at least 3 independent 
experiments and from at least two independent tranformants. Standard deviations errors are less than 10%.Bars 
represent the β-galactosidase activity. The Pbgl-t1-bglG-lacZ readings for each plasmidic constructs (units) are as 
follows: A) pKES83 (550U) B) pKEGN1 (460U) C) pKEGN2 (1090U) D) pKEGN3 (505U) E) pKEGN5 (580) F) 
pKEGN4 (275) G) pKEGN6 (560) H) pKEGN33 (775) I) pKEGN9 (705) J) pKEGN7 (695) K) pKEGN8 (805) L) 
pKEGN84 (1040) M) pKEGN34 (1640) N) pKEGN35 (785) O) pKEGN36 (850) P) pKEGN37 (815) Q) pKEGN39 
(850) R) pKEGN38 (725). 
 
     The variants of CFT073 bgl/Z type shows ~ 1.5 to 2 fold enhancement in the β-galactosidase 
activity in comparison to the MG1655 construct (Fig. 18I to R). Strain F911 (CFT073 bgl/Z type) 
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that does not have -25ct change (position relative to transcription start of bgl operon) carries an 
additional base pair change in the leader region (+26ca), shows 3 fold higher activity (1640 U) 
than MG1655. Taken together the results demonstrate that with the exceptions of the specific 
sequence variants (Fig. 18B, C, F, G, H, J to R), the sequence variations seen in the fourth bgl/Z 
type and CFT073 bgl/Z type at the bgl promoter and in the first gene bglG do not influence the 
bgl expression in K-12 background. However, at this stage, it cannot be ruled out that the 
sequence variations seen in the CFT073 bgl/Z type may have an impact on the bgl expression in 
an untested background (could be a different strain background or in an environment inside the 
host). 
 
1.14 Sequence variations in the CFT073 bgl type strains do not have significant influence 
on  the bgl promoter activity 
 
     To analyze whether the sequence variations seen at the vicinity of the bgl promoter in the 
CFT073 bgl/Z type strains have any influence on the bgl promoter activity, strains (same as in 
Fig. 18) representing unique sequence variations as compared to MG1655 bgl sequence were 
selected for constructing reporter constructs that carry bgl promoter +25bp (numbering relative to 
transcription start of bgl operon) fused to lacZ (Fig 19).   
 
Figure 19: β-galactosidase activity of the Pbgl +25-lacZ reporter constructs in wt (S541) and in rpoS- 
background.  Shown are the results of plasmidic constructed of Pbgl+25-lacZ whose expressions are directed in K-
12.  Strain names and typing at the bgl/Z5211-Z5214 locus is shown as in Table 6 (Appendix).  Bars represents the 
β-galactosidase activity expressed in miller units (Miller, 1972). Shown are the average results from at least 3 
independent experiments and from at least two independent tranformants. Standard deviation errors are less than 
10%. The plasmidic constructs (units in wt, rpos) are as follows: A) pKEKB30 (1775, 5080) B) pKEGN10 (2080, 
5455) C) pKEGN40 (1895, not determined) D) pKEGN15 (1535, 3505) E) pKEGN17 (1290, 2935) F) pKEGN16 
(1565, 3325) G) pKEGN14 (1590, 3415) H) pKEGN12 (920, 1740) I) pKEGN11 (1680, 3750) J) pKEGN13 (1190, 
2325). 
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RpoS is the alternative sigma factor of E.coli RNA polymerase and is required for transcription 
of many genes expressed during the onset of stationary growth phase (Loewen and Hengge-
Aronis, 1994). And also, RpoS was reported to be necessary for silencing of the bgl operon. 
Hence, the expression levels of the constructs carrying various sequence variations were analyzed 
in both wt (S541) and in rpoS (S887) background in the exponential growth phase of the cells 
(Fig. 19).  
     Constructs carrying fragments from strains i484 and E7370 showed a decreased activity when 
compared to the MG1655 construct.  In addition, construct carrying fragment from E475 showed 
∼ 2 fold decreased in the promoter activity in comparison to MG1655 construct (920U to 1775U, 
Fig. 19A and 19H). Strain E475 carries specific sequence variations (no -25ct) in comparison to 
CFT073 sequence. Thus, the decreased in promoter activity could be due to specific sequence 
changes seen in E475 construct. The strain E7370 (mixed bgl/Z type) have upstream and bgl 
sequence like CFT073 followed by downstream sequence like CFT073 with exception of 5’ end 
of yieI gene like MG1655. With the exceptions of the constructs carrying fragments from i484, 
E475 and E7370, the activity of all the other Pbgl+25-lacZ constructs was more or less similar to 
the MG1655 construct.   
      In order to analyze whether the sequence variations has any role in the RpoS mediated bgl 
regulation, activity of all the Pbgl+25-lacZ constructs were analyzed in rpoS background. The 
results showed a two fold increase in the rpoS background in all the constructs similar to that of 
MG1655 construct, suggesting that the sequence variations seen in the CFT073 bgl/Z type does 
not influence the RpoS mediated bgl regulation.  
     Furthermore, the decreased in the promoter activity seen in the constructs of i484 and E475 (in 
comparison to MG1655 construct) at the exponential growth phase of the cells in both wt and 
rpoS initiated further studies in analyzing the expression levels of the constructs following the 
growth curve (Fig. 20). The growth curve of the cultures was determined measuring the OD600 at 
different time points along with MG1655 construct.  Bacterial cells were harvested at the onset 
and early stationary phase (OD600=1, 1.5, 2) and the expressed LacZ activity was determined 
(Fig. 20). All three constructs (i484, E475, MG1655) were repressed to two fold at the onset of 
the stationary phase.  The expression levels of the i484 and E475 constructs decreased further 
while the expression directed by the MG1655 constructs was constant. 
 
 
 
Results 39
.                   
Figure 20: β-galactosidase activity of the Pbgl+25-lacZ reporter constructs in wt (S541) and in rpoS background 
following the growth curve of the strains.  Shown are the results of plasmidic construct of Pbgl+25-lacZ whose 
expression is directed in K-12.  Strain names and typing at the bgl/Z5211-Z5214 locus is shown.  Bars represents the 
β-galactosidase activity expressed in miller units (Miller, 1972). Shown are the average results from at least 3 
independent experiments and from at least two independent tranformants. Standard deviation errors are less than 
10%. β-galactosidase assay results of the three constructs repressed two fold at the onset of the stationary phase. The 
expression of the MG1655 construct decreased further while the expression of i484 and E475 construct was constant. 
The plasmidic constructs (units in wt, rpos) at OD600=1 are as follows: MG1655 construct pKEKB30 (900, 5080), 
i484 construct pKEGN17 (535, 1715) and E475 construct pKEGN12 (600, 1345). OD600=1.5 readings in wt, rpos are 
as follows: pKEKB30 (590, 2175), pKEGN17 (435, 1305), pKEGN12 (510, 1080). OD600=2 readings in wt and rpos 
are as follows: pKEKB30 (570, 1920), pKEGN17 (355, 1055), pKEGN12 (400, 920).   
 
1.15 A mutagenesis screen to identify factors that are involved in the relaxed phenotype 
in E.coli 
In E.coli K-12 the wt-bgl operon is silent in the laboratory conditions i.e. it is not expressed in all 
tested laboratory conditions. However, it was observed that 15% of the natural isolates do exhibit 
a weak Bgl+ phenotype (relaxed phenotype) on BTB salicin plates at 37°C (on day 3, Fig. 9). 
This made us to speculate that in these 15% of the strains there could be additional factors which 
are important for the strains to show relaxed phenotype. Hence, in order to identify those factors 
we chose one strain i484 and a transposon mutagenesis screen were carried out using a repts 
plasmid that carries miniTn10-cmR cassette (pKESK18, see materials and methods). In brief, wt 
i484 was mutagenised with pKESK18 and the mutants that show a phenotype like MG1655, 
more papillae or no papillae were screened (Fig. 21A). In total, the screen yielded 16 mutants that 
met the above criterion. Of these mutants, 5 showed a MG1655 like phenotype, 8 mutants 
showed more papillae and 3 mutants showed no papillation. In addition to these 16 mutants, one 
mutant was isolated that showed a strong Bgl+ phenotype (Fig. 21A). In order to eliminate the 
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mutants that carry mTn10- cmR insertions in the bgl operon, two long PCR’s were performed for 
all 17 mutants with oligos: a) S157 (maps upstream to bgl promoter) and S312 (maps in bglB) b) 
S309 (maps in bglB) and S348 (maps in yieI). Those mTn10-mutants that yielded larger PCR 
products (expected sizes with miniTn10-cmR insertions) were eliminated from further analysis.   
 
 
 
Figure 21: Mutagenesis screen to identify the factors that are essential for relaxed phenotype.  A) Schematic 
representation of the mTn10-cat mutagenesis strategy is shown. The starting strain i484 has the natural bgl operon. 
This strain is mutagenised with pKESK18 and mutants were screened on BTB salicin plates at 37°C. Wild type i484 
strains show relaxed phenotype on day 3 incubation. In this screen mutants were selected that papillate like MG1655, 
more papillae or no papillae. Mutant numbers and the mutated genes/system is shown. B) This strategy yielded 
mutants carrying transposon insertions in cysN, cysH, cysJ, purL, ybdM, and purC genes. The insertions are shown 
with respect to the published E.coli CFT073 chromosome. The arrowhead indicates the direction of cat gene. The 
positions of mTn10 insertions are as follows: Ec225 (AE016765: 141948), Ec226 (AE016765: 135774), Ec227 
(AE016764: 146222), Ec230 (AE016762: 215048), Ec232 (AE016765: 139681), Ec233 (AE016765: 139499), 
Ec235 (AE016764: 235798), Ec238 (AE016765: 139673). The encoded gene products are shown beneath the 
respective genes. 
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The mutant that showed the strong Bgl+ phenotype carried miniTn10-cmR insertion upstream of 
bglF. The Bgl+ phenotype in this mutant could be attributed to the constitutive expression of bglF 
and bglB genes. Those mutants that gave PCR products like wt-i484 were further processed with 
ST-PCR to identify the miniTn10-cmR insertions (see materials and methods). From the obtained 
ST-PCR products nucleotide sequencing was determined. Blast searches were carried out with 
the obtained sequence information. To this end, the screen yielded the following mutants that 
have insertions in the following genes: cysN (mutant #Ec226), cysH (#Ec233, Ec238, Ec232), 
cysJ (#Ec225), purL (#Ec235), ybdM (#Ec230), purC (#Ec227) (Fig. 21B). The genes cysN, cysH 
and cysJ are involved in the sulfate assimilation pathway. This pathway is involved in the 
conversion of sulfate to sulfide, in preparation for incorporation into cysteine and methionine. 
Mutations in cysN, cysH and cysJ may lead to the alterations in the sulfate assimilation which 
may in-turn affect the amino acid synthesis. On the other-hand the gene cysH is involved in 
conversion of PAPS (phosphoadenosine phosphosulfate) to adenosine 3’, 5’-phosphate which in-
turn is required for the synthesis of phosphate that can be ultilized for the synthesis of 
phosphoenol pyruvate. Thus, mutation in cysH may have direct or indirect effects on the PTS 
system, which may consecutively, affect the transport of β-glucosides. However, this hypothesis 
remains to be thoroughly explored. The genes purL and purC are involved in the de novo 
biosynthesis of purine nucleotides. The mutations in these genes could be attributed for the 
alterations in the purine nucleotide pool which may affect the cellular physiology of the strain.  
     The gene product of ybdM is not known at present. However, homology searches with the 
deduced amino acid sequence showed significant identities that matches with the complete 
coding sequences of the following proteins: Z1644 (E.coli O157-ParB like nuclease, 
AAQ19140)-91%, IbrB (E.coli ECOR9-DNA binding, arginine biosynthesis, AF460182)-88%, 
YbdM (S. typhimurium-putative transcriptional regulator, AE008724)-60%, BF2122 (B. fragilis-
putative transcriptional regulator, AP006841)-46%, EF0120 (E. faecalis-ParB like nuclease, 
AF454824)-45%. Most of the matches seen were with the hypothetical proteins from other 
bacterial species. To this end, the effect of the mutation in ybdM gene on β-glucoside utilization 
is not understood. 
 
1.16 A mutagenesis screen in the mixed Sal+ mutants isolated from strains that show 
relaxed phenotype at 37°C. 
     In order to know whether the relaxed phenotype is caused by the mutations or is due to the 
leaky expression of the bgl operon, strains i484 and E7370 (both show relaxed phenotype at 
37°C) were selected for the analysis. Wild type strains of i484 and E7370 were streaked on BTB 
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salicin plates and incubated at 37°C. After 3 days of incubation both the strains showed relaxed 
phenotype. The Sal+ part of the streak was purified to isolate independent mutants. However, the 
subsequent purification steps resulted in a mixture of colonies, where some of the colonies 
showed weak Sal+ phenotype and some colonies showed Sal- phenotypes. Re-streaking of the 
Sal+ or Sal- colonies also resulted in the colonies with mixture of phenotypes. Thus, in the current 
study we were unable to purify complete Sal+ mutants from the strains that show relaxed 
phenotype at 37°C. Two of such mutants from each strain that show mixed phenotype were 
selected for further analysis (Fig. 22A).   
     A miniTn10-cmR mutagenesis strategy is shown in Figure 22A.  The two mixed mutants of 
i484 (Ec240 and Ec241) and two mixed mutants of strain E7370 (Ec254 and Ec255) were 
mutagenised with plasmid pKESK18 and the mutants that show Sal– were screened. The screen 
yielded 3 mutants from Ec240 (i484 mixed Sal+ #1), 9 mutants from Ec241 (i484 mixed Sal+ #2), 
5 mutants from Ec254 (E7370 mixed Sal+ #1) and 8 mutants from Ec255 (E7370 mixed Sal+ #2) 
(Fig. 22A). The screen yielded mutations in bgl operon, pgi, cysG, serC, ybdM, carB and rfaC.  
Mutations in the bgl genes hinder the β glucoside utilization which explains the Sal- phenotype in 
those mutants. The pgi gene codes for the enzyme phosphoglucoisomerase of the glycolysis 
pathway. It was shown that in a pgi mutant glycolysis is blocked and this accelerates RNaseE 
mediated degradation of the ptsG gene transcript.  The ptsG gene codes for a transport protein for 
Glucose uptake and is a part of the PTS transport system (Kimata et al., 2001). In addition, the 
work from Dole et al., (2004) has reported that mutation in pgi results in a decreased expression 
of the bgl operon. The gene cysG codes for seroheme synthase that act as a co-factor for sulfite 
reductases (gene product from cysJ, see Fig. 21B). Mutations in serC may have an effect on 
serine biosynthesis. The gene carB codes for carbamoylphosphate synthase that is involved in the 
de novo synthesis of pyrimidine ribonucleotides and arginine biosynthesis. The gene rfaC codes 
for product that is involved in lipopolysaccharide core biosynthesis. Lipopolysaccharide is a 
major component of outer membrane of gram-negative bacteria, such as E.coli. Mutations in rfaC 
may have pleiotropic effect within the cell (Chen and Coleman, 1993; Bauer and Welch, 1997). 
In addition to the above mentioned mutations, the screen also yielded a mutant that carries 
miniTn10-cmR insertion in ybdM gene (which was obtained from the earlier screen as well, Fig. 
22B). Taken together, the results from the miniTn10-cmR mutagenesis of the wt-i484 and the 
screen performed with the two mixed mutants of relaxed phenotype strains primarily picked up 
mutations in the genes that are required for nucleotide and/or amino acid biosynthesis (Fig. 21 
and 22). The effect of the mutation in these genes may lead to the alterations in the nucleotide 
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pool and/or amino acid pool of the bacterial cell which in-turn may have pleiotropic effect on the 
expression of various genes (that may include regulators of bgl operon silencing such as H-NS). 
Thus, the alterations in the nucleotide or amino acid pool may have direct or indirect effect on H-
NS activity which in turn may affect the β-glucoside utilization. The other possibility is that it 
could be a direct effect on the repression of bgl by H-NS.    
 
 
Figure 22: Mutagenesis screen to identify the factors that are essential for relaxed phenotype.  A) Schematic 
representation of the mTn10-cat mutagenesis strategy is shown. The starting strain i484 and E7370 has the natural 
bgl operon. Both strains were streaked on BTB salicin plates at 37°C and mixed Sal+ mutants were isolated. Two 
such mutants from each strain were mutagenised with pKESK18 and Sal- mutants were screened on BTB salicin 
plates at 37°C. B) This strategy yielded mutants carrying transposon insertions in pgi, ybdM, cysG, serC, carB, rfaC 
and in bgl operon. The insertions are shown with respect to the published E.coli CFT073 chromosome. The 
arrowhead indicates the direction of cat gene. The positions of mTn10 insertion with respect to the Genbank primary 
accession numbers are as follows: Ec246 (AE016770: 235679), Ec249 (AE016770: 236173), Ec242 (AE016762: 
215064), Ec256 (AE016767: 299877), Ec260 (AE016758: 108192), Ec266 (AE016755: 35300), Ec 264 (AE016768: 
298893). The encoded gene products are shown beneath the respective genes. * indicates papillation seen after day 7. 
# indicates Sal+ 
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2. Identification and analysis of an additional β-glucoside system in E.coli 
     (This section, in part, is in preparation for a publication) 
 
2.1 Strain i484 ∆bgl and O157 type (at bgl/Z5211-Z5214 locus) strains papillates on BTB 
salicin plates 
      In the bgl/Z5211-Z5214 analysis it was observed that out of 33 O157 bgl/Z type strains, 9 
strains papillate late on BTB salicin plates at 37°C (Table 6, Appendix). This suggested an 
existence of an additional system required for the β-glucoside utilization which can be activated.  
     In addition, the spontaneous Bgl+ mutant of i484 (Ec2, ∆47 Bgl+) that was isolated at 28°C 
was transformed with plasmid pFMAC11 (repts-TetR, ∆bgl in bgl region) and the bgl operon was 
deleted as described in materials and methods (also see Fig. 23A). The resultant strain i484 ∆bgl 
(Ec93) was tested for its phenotype on BTB Salicin plates at 37°C and at 28°C. At both the 
temperatures i484 ∆bgl showed Sal- phenotype. Phenotypes were also determined for the 
utilization of three other β-glucosides (Arbutin, Cellobiose and Esculin). The results revealed that 
i484 ∆bgl showed Arb- Cel- and Esc- phenotypes at both 37°C and at 28°C.  Interestingly, it was 
observed that after 5 days of incubation at 28°C, i484 ∆bgl showed papillation on BTB salicin 
plates. This observation supported the earlier speculation from the 9 O157 bgl/Z type strains that 
in E.coli additional β glucoside system (s) may exist and can be activated.  Hence, to identify the 
system that is responsible for the papillation phenotype in the absence of bgl genes the strain i484 
∆bgl was selected for further studies. 
     Four of the Sal+ spontaneous mutants from i484 ∆bgl were purified at 28°C as mentioned in 
materials and methods (also see Fig. 23A). All the four mutants (Ec131, Ec132, Ec133, and 
Ec134) showed Sal+ Arb+ Cel+ and Esc+ phenotypes on respective indicators plates at 28°C and 
were Sal- Arb- Cel- and Esc- at 37°C (Fig. 23A). Phenotypes on Salicin and Esculin plates at 28°C 
were stronger compared to the other two sugars.  
 
2.2 A miniTn10-cmR mutagenesis screen to identify the additional β-glucoside system   
     In an approach to identify the system that is involved in the utilization of the β-glucosides, a 
miniTn10-cmR mutagenesis was performed. The four Sal+ mutants isolated from i484 ∆bgl  at 
28°C (Ec131, Ec132, Ec133, Ec134) were mutagenised with plasmid pKESK18 (as described in 
the previous sections, Fig. 21 and 22) and the mutants that show Sal- phenotypes at 28°C and 
37°C were screened (Fig. 23). 
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Figure 23: Summary of the identification of additional β-glucoside system in E.coli. A)  Summary of the 
identification of additional β glucoside system. In brief, spontaneous Bgl+ mutant of wt-i484 was isolated at 28°C 
and bgl operon was deleted using plasmid pFMAC11. The resulting strain Ec93 (i484 ∆bgl) papillae’s at 28°C. Four 
such spontaneous mutants were purified and mutagenised using plasmid pKESK18. The mTn10-insertion mutants 
that showed Sal- phenotype at 28°C were screened. Shown are the respective strain numbers used in the strategy. The 
obtained mTn10-insertion mutants were later analyzed by ST-PCR and the obtained PCR products were sequenced 
from both ends. § indicates that strain papillates after day 10 at 37°C. * indicates weak Sal+ phenotype at 28°C. 
Phenotypes at 28°C and at 37°C are also shown. Mutants-mutated genes are indicated. nd indicates not determined. 
B) Based on the homology searches from the obtained nucleotide sequence information, the mTn10-insertions were 
mapped. This strategy yielded mutants carrying transposon insertions in c1956-c1960 locus, dksA region and in pyrD 
region. The insertions are shown with respect to the published E.coli CFT073 chromosome. The arrowhead indicates 
the direction of cat gene. The positions of mTn10 insertion with 9bp target site duplications are relative to the 
Genbank primary accession numbers: Ec135 (AE016760: 291472-291480), Ec136 and Ec137 (AE016760: 291646-
291654), Ec139 (AE016760: 291205-291213), Ec140 (AE016758: 147545-147553), Ec143 (AE016760: 288797-
288805), Ec144 (AE016760: 290312-290320), Ec147 (AE016760: 292417-292425), Ec148 (AE016755: 171175-
171183). The mutants Ec138, Ec141, Ec142, Ec145, Ec146, Ec149, and Ec150 were not analyzed further. The 
encoded gene products are shown beneath the respective genes. * indicates as in A. 
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     In total the screen yielded 16 miniTn10-cmR mutants with four mutants from each starting 
strain (Fig. 23A).  The miniTn10-cmR insertion mutants Ec135 to Ec139, Ec141, and Ec143 to 
Ec147 showed Sal- phenotype at both 28°C and 37°C. However, mutants Ec140, Ec142, Ec148, 
Ec149 and Ec150 showed weak Sal+ phenotype at 28°C. ST-PCR and nucleotide sequencing 
were carried out to map the insertion site in the chromosome (materials and methods).  
 
     Out of nine mutants that were analyzed by nucleotide sequencing, 7 mutants carried 
miniTn10-cmR insertions in the c1955-c1960 region of the sequenced strain CFT073 (Fig. 23).  
The c1955-c1960 region comprises of six putative ORF’s: c1955 to c1960. Five ORF’s c1955 to 
c1959 reads in the same orientation, whereas c1960 reads in the opposite orientation. All the 7 
mutants that carry miniTn10-cmR insertions in c1955-c1960 showed Sal- phenotype at both 28°C 
and 37°C, indicating a possible second locus in E.coli for β-glucoside utilization. Furthermore, 
comparative genomic analysis of the c1955-c1960 region with the other three sequenced strains 
indicated that this locus is uniquely present in CFT073 and is absent in MG1655 and two variants 
of O157 (EDL933 and Sakai). Thus, this locus comprises of putative genes that are encoded in a 
genomic island.   
 
     In addition to the mutants with insertions in c1955-c1960 region, the screen also yielded two 
mutants that carried miniTn10-cmR in two other loci. Both the mutants showed weak Sal+ 
phenotype at 28°C (Fig. 23). Mutant Ec148 carried miniTn10-cmR insertion close to the gene 
dksA (Fig. 23). DksA was originally identified in E. coli as a multi-copy suppressor of the 
temperature sensitivity of dnaKJ mutant (Kang and Craig, 1990). Deletion and/or over-
expression of dksA have been shown to have pleiotropic effects that includes defects in the 
chaperonin function, gene expression, cell division, amino acid biosynthesis, quorum sensing, 
and virulence (Kang and Craig 1990; Bass et al., 1996; Turner et al., 1998; Webb et al., 1999; 
Ishii et al., 2000; Branny et al., 2001; Hirsch and Elliott, 2002 and Brown et al., 2002).  In 
addition, recent report has shown that DksA is absolutely required for rRNA regulation (Paul, et 
al., 2004).  
 
     Mutant Ec140 carried miniTn10-cmR insertion in the gene pyrD (Fig. 23). The gene pyrD 
encodes for dihydroorotate dehydrogenase enzyme that is involved in pyrimidine ribonuclotide 
biosynthesis. Mutations in dskA and pyrD might have pleiotropic effects in the cell which 
consecutively may affect the β-glucoside utilization. However, both these mutants were not 
analyzed in more detail in this study.  
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2.3 Homology searches for the deduced amino acid sequences of c1955-c1960 genes 
     The c1955-c1960 region carries six open reading frames and is thought to encode putative 
proteins (Welch et al., 2002). Based upon analysis of the deduced amino acid sequences, five of 
these proteins have similarity with proteins associated with the utilization of β-glucosides as 
carbon sources in E.coli and other bacteria (Fig. 24). 
c1955: The last ORF spans 1446 nucleotides and potentially encodes a deduced protein of 482 
amino acids. The deduced protein from this ORF displayed homology with the complete coding 
sequences of 6-phospho-β-glucosidases (BglA) from Enterobacteriaceae members such as 
E.coli, Yersinia, Shigella, Salmonella, Erwinia and Klebsiella. In addition, C1955 also showed 
significant similarity to 6-phospho-β-glucosidases from Gram-positive bacteria (Fig. 24). With 
the high degree of similarity to the phospho-β-glucosidases it suggests that c1955 may encode a 
putative phospho-β-glucosidase enzyme for the utilization of β-glucosides. 
c1956: The fifth ORF spans 1674 nucleotides and could encode a protein of 558 amino acids.  
The deduced protein from this ORF displayed similarity to the complete coding sequences of 
YieC precursors (BglH) from E.coli (68%), Shigella (67%) (Fig. 24). BglH is a product of the bgl 
operon and encodes for putative membrane protein (porin) specific for β-glucosides (Andersen et 
al., 1999). Sequence similarities were also seen with LamB proteins from Aeromonas, Yersinia, 
Erwinia, Shigella and Klebsiella. LamB proteins are known to act as substrate-specific porins 
which is involved in the guided diffusion of maltose and maltodextrins into the E.coli cells (Boos 
and Shuman, 1998).  
c1957: The fourth ORF spans 315 nucleotides and could encode a protein of 105 amino acids. 
The deduced protein from this ORF displayed high percentage similarities with the complete 
coding sequences of β-glucoside specific PTS IIA domains from Erwinia and Photorhabdus (Fig. 
24). It also showed significant similarities with Listeria, E.coli, Shigella, Salmonella, Bacillus β-
glucoside specific PTS IIA domains. Therefore, this ORF may possibly encode the enzyme IIA 
domain of PTS system for transport of sugars like β-glucosides. 
c1958:  The third ORF spans 1362 nucleotides and could encode a protein of 454 amino acids. 
The deduced protein from this ORF displayed similarity to several GenBank entries that showed 
homology with the complete coding sequences of enzyme IIC domain of PTS system specific for 
β-glucoside transport. L.monocytogenes CelB, B.lichenformis Blo1162 and L.plantaurum PtsBC 
showed a very high similarity followed by PTS IIC domains from Enterobacteriaceae members 
(Fig. 24). Thus, this ORF may encode the enzyme IIC domain of PTS system and may be 
involved in the transport of β-glucosides. 
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c1959: The second ORF spans 312 nucleotides and could encode a protein of 104 amino acids. 
The deduced protein shows greater similarities to the complete coding sequences of enzyme IIB 
domains of L.monocytogenes B.lichenformis followed by Streptococcus, Pseudomonas and 
Enterococcus. E.coli ChbB proteins show 41% identities and 56% similarities to C1959 (Fig. 24). 
Therefore, c1959 may encode a putative PTS IIC domain for the transport of β-glucosides in the 
c1955-c1960 system in E.coli. 
 
c1960: The first ORF spans 699 nucleotides and would encode deduced protein of 233 amino 
acids. This ORF reads in the opposite orientation in comparison to the other five ORF’s. The 
deduced protein from this ORF displayed similarity to several GenBank entries that show 
homology to Bacillus GntR family of transcriptional regulators. Highest similarity was seen with 
Erwinia ECA1849 (putative transcriptional regulator, GntR family), E.coli and Shigella YidP 
(putative transcriptional regulator) (Fig. 25). Similarities were also seen with DNA binding 
protein IolR from Bacillus, Fatty acyl transcriptional regulator FuxR from E.coli, GntR family 
proteins from Bacillus, Erwinia, Listeria, Lactobacillus and Corynebacterium. In addition, weak 
similarities were seen with hypothetical proteins YegW from CFT073 and YydK from Bacillus 
subtilis. From the blast searches it suggested that c1960 could possibly act as a regulator in the 
c1955-c1960 system. The role of C1960 in the c1955-c1960 system is discussed later in the next 
sections. 
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Figure 24: Identities and similarities of deduced proteins from the c1955-c1959 region of E.coli CFT073.  
Identities and similarities are shown are percentages. The homology searches using the deduced amino acid 
sequences were carried out in NCBI BLAST and in EMBL BLAST. Shown are the identities and similarities relative 
to the complete amino acid sequence match. P indicates phospho. 
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            CFT073-C1960          ----------------------VIFQKIARLLKSEINGNSWHVGDLLPSEAELAVRYNVSRNTLRKALSLLEGEGIIHRKHGSGTYIQK----------- 
       Erwinia-YP_049946 35%, 62% -----------MASDRGKGGLKVIYKFIAEQIRSRINSAEFRVGEVLPAEKHLAKEFSVSRMTVRKALEMLVAEGLLDRRHGSGTYILQ----------- 
             MG1655-YidP 35%, 60% ----------------------MIYKSIAERLRIRLNSADFTLNSLLPGEKKLAEEFAVSRMTIRKAIDLLVAWGLVVRRHGSGTYLVR----------- 
             EDL933-YidP 35%, 60% ----------------------MIYKSIAERLRIRLNSADFTLNSLLPGEKKLAEEFAVSRMTIRKAIDLLVAWGLVVRRHGSGTYLVR----------- 
           Sakai-Ecs4624 35%, 60% ----------------------MIYKSIAERLRIRLNSADFTLNSLLPGEKKLAEEFAVSRMTIRKAIDLLVAWGLVVRRHGSGTYLVR----------- 
         S.flexneri-YidP 33%, 58% ----------------------MIYKSIAERLRIRLNSADFTLNSLLPGEKKLAEEFAVSRMTIRKAIDLLVAWGLVVRRHGSGTYLVR----------- 
         B.subtilis-IolR 32%, 49% -----------------------------MKLMRIQEMEEYILSHGTVSLDELCQVFNVSKNTVRRDINKLTEKGAIEKVYGGVTSIEKTALVPFENRTI 
         B.cereus Bc4053 29%, 49% -----------MLMNIDKYSPFPIYYQIQEWVKQLIEDGEWKPGDKIPSENELCDKFEVSRMTIRQAINNLVEQGYLYRKRGIGTFVQL----------- 
        B.anthracis-GntR 29%, 49% -------------MNIDKYSPFPIYYQIQEWVKQLIEDGEWKPGDKIPSENELCDKFEVSRMTIRQAINNLVEQGYLYRKRGIGTFVQL----------- 
             MG1655-FarR 32%, 54% ------------------MGHKPLYRQIADRIREQIARGELKPGDALPTESALQTEFGVSRVTVRQALRQLVEQQILESIQGSGTYVKE----------- 
     E.chrysanthemi-ExuR 29%, 45% ---------------MALTESRRLYQQLAAELKQRIENGVYPVGDKLPAERNISEEMNVSRTVVREAIIMLEVEGYVEVRKGSGIHVIS----------- 
             CFT073-YegW 27%, 45% MEQAHTQLIAQLNERILAADNTPLYIKFAETVKNAVRSGVLEHGNILPGERDLSQLTGVSRITVRKAMQALEEEGVVTRSRGYGTQINN----------- 
         B.subtilis-YydK 28%, 46% ---------------------MLKYQQIATEIETYIEEHQLQQGDKLPVLETLMAQFEVSKSTITKSLELLEQKGAIFQVRGSGIFVRKHK--------- 
L.monocytogenes-LMO00575 27%, 55% -----------------MAQNQTKYSFIAEEIRKRIMNHAYPLNQPIPDEITLAKEFDCSRMTMKKALEVLVLEGLLYRKRGHGTFIIKSALD------- 
           L.lactis-RgrB 27%, 51% ----------------MARKSVPNYVKIHDALKDEVEKGIWKIGQRLPSERDLAERFTVSRMTARQAVTALVDEGILDRRVGSGTYVAS----------- 
 
            CFT073-C1960          -------KNFVAHIDHMNSFSEIAHKSGKEAGSQIMKFEVQDASPTIATELNLVTGEQVYYIKRLRFIED-------------NAAQLEETWMSVARFPD 
       Erwinia-YP_049946 35%, 62% -------KDVQHESHALNSFAEHMRLIGRTTTNDVVDFRIIPAPPAIARQLRLRTDEKIYFARRIRYVDG-------------KSCMLEDSYLPVAPFPE 
             MG1655-YidP 35%, 60% -------KDVLHQTASLTGLVEVLKRQGKTVTSQVLIFEIMPAPPAIASQLRIQINEQIYFSRRVRFVEG-------------KPLMLEDSYMPVKLFRN 
             EDL933-YidP 35%, 60% -------KDVLHQTASLTGLVEVLKRQGKTVTSQVLIFEIMPAPPAIASQLRIQINEQIYFSRRVRFVEG-------------KPLMLEDSYMPVKLFRN 
           Sakai-Ecs4624 35%, 60% -------KDVLHQTASLTGLVEVLKRQGKTVTSQVLIFEIMPAPPAIASQLRIQINEQIYFSRRVRFVEG-------------KPLMLEDSYMPVKLFRN 
         S.flexneri-YidP 33%, 58% -------KDVLHQTASLTGLVEVLKRQGKTVTSQVLIFEIMPAPPAIASQLRIQINEQIYFSRRVRFVEG-------------KPLMLEDSYMPVKLFRN 
         B.subtilis-IolR 32%, 49% QHQDEKTKIAHYASRFIEDHDLVFIDSGTTTKSILDTLDPAKNVTILTNSLDIINAASALKNINLIIIGN-------------NYKRKTRSFVGMDDPAM 
         B.cereus Bc4053 29%, 49% -------PKVEQKLQGMTGFTEDMISRGMNPSSQLLSFRLVPATAKIADRLRIQEGESVYEVRRIRLADD-------------EPIAFETTYLSPALVKD 
        B.anthracis-GntR 29%, 49% -------PKVEQKLQGMTGFTEDMISRGMNPSSQLLSFRLVPATAKIADRLRIQEGESVYEVRRIRLADD-------------EPIAFETTYLSPALVKD 
             MG1655-FarR 32%, 54% -------ERVNYDIFQLTSFDEKLSDRHVDTHSEVLIFEVIPADDFLQQQLQITPQDRVWHVKRVRYRKQ-------------KPMALEETWMPLALFPD 
     E.chrysanthemi-ExuR 29%, 45% --------NQQRHLLAANGSDADFLTAGPFELLQARQLIESNIAEFAATQVTRQDIIQLMEIQENARQEDRFRDSEWDLKFHVQVALATQNSAMATIVEK 
             CFT073-YegW 27%, 45% --------IFEYSLKEARGFSQQVVLRGKKPDTLWVNKRVVKCPEEVAQQLAVEAGSDVFLLKRIRYVDE-------------EAVSIEESWVPAHLIHD 
         B.subtilis-YydK 28%, 46% -------RKGYISLLSNQGFKKDLED--FNVTSKVIELDVRKPTPEAAENLNIGMDEDIYYVKRVRYING-------------QTLCYEESYYTKSIVTY 
L.monocytogenes-LMO00575 27%, 55% ------ADRLQIHNQEVNGFTKLLN--GKKVISKVIEFKVIFPTEEIAERLHIEMETPIYDILRVRLVKD-------------EPYVLEHTYMPVGVIPG 
           L.lactis-RgrB 27%, 51% -------RRVREKMRGTTSFTEIISSQGKVPSTEVLSYIRTAPNEVECEKLNITKKDSIIRMERIRYADN-------------VPICYEVASIPFKLVKS 
 
            CFT073-C1960          LTVSHMQKSKFSYIENECGIKIIG-----TFETFSPTFPTPEIASILRISPRDPILKIQTQAVDSNSIPLDYSLLYSNIFEFQVKYFFPR------ 
       Erwinia-YP_049946 35%, 62% LSVKHLQGSKFAYIEDEKHIEIAG-----CYEVFSPILADVSVARLLSVSEGAPLLQMTSLSQSVEGAYLDFSIMIYNVHDYQVSFYMQRNKLSL- 
             MG1655-YidP 35%, 60% LSLQHLEGSKFEYIEQECGILIGG-----NYESLTPVLADRLLARQMKVAEHTPLLRITSLSYSESGEFLNYSVMFRNASEYQVEYHLRRLHPEKS 
             EDL933-YidP 35%, 60% LSLQHLEGSKFEYIEQECGILIGG-----NYESLTPVLADRLLARQMKVAEHTPLLRITSLSYSESGEFLNYSVMFRNASEYQVEYHLRRLHPDKS 
           Sakai-Ecs4624 35%, 60% LSLQHLEGSKFEYIEQECGILIGG-----NYESLTPVLADRLLARQMKVAEHTPLLRITSLSYSESGEFLNYSVMFRNASEYQVEYHLRRLHPDKS 
         S.flexneri-YidP 33%, 58% LSLQHLEGSKFEYIEQECGILIGG-----NYESLMPVLADRLLARQMKVAEHTPLLRITSLSYSESGEFLNYSVMFRNASEY-------------- 
         B.subtilis-IolR 32%, 49% LDKYNINKAFMSATGTTLTHGLTN---SDLLEYEIKKRISEKAKEVYLLADHSKFGKSTLLTYAPFDRLHCIVTSQPLDDEYTQYCNEHQIGIHLA 
         B.cereus Bc4053 29%, 49% INEEILQQSLYEHLEKKLGFKLVS-----ATQSIEASVATENEAEHLHIPKKAPVLVMRQWSYSEGEIPLEYVKCIYRGDRYKFITNIARNK---- 
        B.anthracis-GntR 29%, 49% INEEILQQSLYEHLEKKLGFKLVS-----ATQSIEASIATDNEAEHLHIPKKAPVLVMRQWSYSEGEVPLEYVKCIYRGDRYKFITNIARNK---- 
             MG1655-FarR 32%, 54% LTWQVMENSKYHFIEEVKKMVIDR-----SEQEIIPLMPTEEMSRLLNISQTKPILEKVSRGYLVDGRVFEYSRNAFNTDDYKFTLIAQRKSSR-- 
     E.chrysanthemi-ExuR 29%, 45% MWSQRIHNPYWRKLHEHIDDKSIESWCEDHDQILKALIRKDPYAAKLAMWQHLENTKQMLFRATTDDFEFNVDRYMFAENPVVHLDHITNGKL--- 
             CFT073-YegW 27%, 45% VDAIGIS--LYDYFRSQHIYPQR------TRSRVSARMPDAEFQSHIQLDSKIPVLVIKQVALDQQQRPIEYSISHCRSDLYVFVCEE-------- 
         B.subtilis-YydK 28%, 46% LNNEIVSHSIFHYIREGLGLKIGF-----SDLFLHVGQLNEEEAEYLGLEAGLPKLYIESIFHLTNGQPFDYSKISYNYEQSQFVVQANSFLL--- 
L.monocytogenes-LMO00575 27%, 55% INQQILEGSIYSYIQDDLNLKIAS-----SYKQIRADKATLLDQQYLDCASDDPVVEVEQTVYLNNGLAFEFSRSRHRYDKFVFTTVNIARR---- 
           L.lactis-RgrB 27%, 51% FDKKEITSNFFKTLESHGHVIGR------SEQIVSAKRVSTEVSEYLKTRVGAAILGLTQVSYLTDGTAFEYVLSQYVGDRFEFYLER-------- 
 
Figure 25: Deduced amino acid sequence alignment of c1960. Identical residues are blocked in black boxes. Similar residues are blocked in grey boxes. Residues that are weakly similar are 
shown in bold letters and residues that are non-similar are shown in grey. Percentages of – (Identities, similarities)- of C1960 with the follwing proteins are as follows: Erwinia carotovara 
ECA1840 (35%, 62%, GenBank accession number YP_049946), MG1655 YidP (35%, 60%, Blattner et a., 1997), EDL933 YidP (35%, 60%, Perna et al., 2001), Sakai Ecs4624 (35%, 60%, 
Hayashi et al., 2001), S.flexneri  YidP (33%, 58%, Wei et al., 2003) B.subtilis IolR (32%, 49%, Yoshida et al., 1995), B.cereus Bc4053 (29%, 49%, Ivanova et al., 2003), B.anthracis GntR 
(29%, 49%, Read et al., 2002), MG1655 FarR (32%, 54%, Blattner et a., 1997), E.chrysanthemi ExuR (29%, 45%, GenBank Q9X930), CFT073 YegW (27%, 45%, Welch et al., 2002), 
B.subtilis YydK (28%, 46%, Kunst et al., 1997), L.monocytogenes GntR (27%, 55%, Nelson et al., 2004), L.lactis RgrB (27%, 51%, Bolotin et al., 2001),. Percentages are relative to full 
length protein. 
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2.4 Analysis of additional β-glucoside system locus in 171 E.coli isolates. 
 
     Comparative genomic analysis of the c1955-c1960 region (additional β-glucoside system) of 
E.coli CFT073 with the other three sequenced strains indicate that this locus is uniquely present 
in CFT073 and is absent in MG1655 and two variants of O157 (EDL933 and Sakai). Thus, this 
locus comprises of genomic island encoded region in E.coli (Fig. 26). The genes upstream to 
c1955-c1960 region comprise of marR, marA and marB encodes gene products for multiple 
antibiotic resistances and the genes in the downstream region of c1955-c1960 region comprises 
of ydeD and ydeF encodes for proteins of unknown function (hypothetical proteins).  
     To analyze whether the natural population of E.coli carries c1955-c1960 system, all the 171 
isolates were analyzed by PCR with c1955-c1960 region specific primers. The primers were 
designed based on the published nucleotide sequence of strain CFT073 (Welch et al., 2002). All 
the strains were analyzed by long PCR with a primer mapping in marB gene (S401) and the other 
in ydeD gene (S402) (Table 6a and b, Appendix). Those strains that gave expected PCR products 
like that of CFT073 (in the current study wt-i484 strain was used as control because it carries 
intact c1955-c1960 system) were further analyzed with specific primers that maps in the internal 
regions of c1955-c1960 genes and the PCR product sizes were compared to the expected PCR 
product sizes of CFT073 c1955-c1960 region (see Table 4 and Table 6a and b, Appendix). 
Strains that do not carry c1955-c1960 system gave expected PCR product size as in MG1655 
(used as control) with primers S401 and S402 (Table 4, Appendix). In addition, PCR with 
primers that maps specifically in the internal regions of c1955-c1960 genes resulted in no PCR 
products in this group of strains. Thus, confirming the absence of c1955-c1960 region.   
     Furthermore, it was observed that out of 171 strains, 7 of them resulted in PCR products of 
unexpected size with primers S401 and S402 (due to insertions or deletions) in comparison to the 
expected sizes of CFT073.  This group of strains was further analyzed with primers that map in 
the internal region of c1955-1960 and the PCR products that correspond to the possible insertion 
or deletion point was sequenced from both the ends (Fig. 26). The detailed analysis is shown in 
Figure 26. The analysis revealed that out of 171 strains: 74 strains do not have c1955-c1960 
region and are like MG1655 or O157 (Fig. 26A), 90 strains have c1955-c1960 region intact (Fig. 
27B), 3 strains carry IS1 insertions within the c1955-c1960 system (Fig. 26C and D), 1 strain 
carry IS1 associated deletion from c1957 to c1956 (Fig. 26E) and 3 strains show alterations 
within the c1955-c1960 region by deletions (Fig. 26F to H).  
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Figure 26: c1955-c1960 region in 171 E.coli isolates. Strains were analyzed by PCR. PCR was performed with the 
primers mapping in marB and ydeD genes. The c1955-c1960 region is shown in grey and upstream and downstream 
regions are in black. Out of 171 strains: A) 74 strains gave expected products like MG1655 indicating the absence of 
c1955-c1960 region. B) 90 strains gave expected products like CFT073 indicating the presence of intact c1955-
c1960 region.  C) Strain F645 carries IS1 insertion in c1956 with 8 bp target site duplication (AE016760: 289424-
298431) D) 2 strains E464 and E466 carries IS insertion in c1955 with 9bp target site duplication (AE016760: 
288391-288399). E) Strain ECOR17 carries IS1 associated deletion from AE016760: 288646 to 290509. F) Strain 
St4723 carries deletion from c1955 to c1956 (AE016760: 287503-290170) G) Strain U2873 carries deletion from 
c1956 to c1960 (AE016760: 288957 to 292879) H) Strain ECOR63 carries deletion from c1958 to c1959 
(AE016760: 290809 to 292442). The positions mentioned are relative to the Genebank primary accession number of 
E.coli CFT073 genome. Text direction in the insertion elements represents the relative orientations of the insertion 
elements according to their defined left and right ends. Typing at bgl/Z5211-Z5214 locus is also shown and numbers 
in each type are also shown. Primer mapping positions are shown. 
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The strains E464 and E466 carry IS1 insertion in c1955 at the same insertion point suggesting 
that the strains could be derivatives of each other (Fig. 26D). Taken together, the analysis at the 
c1955-c1960 region also revealed evidence that in nature deletions and insertions are common 
features of bacterial genome evolution. 
  
2.5 Correlations of c1955-c1960 analysis with the phylogenetic distribution of ECOR strains 
      Analysis of c1955-c1960 region in the 72 ECOR strains significantly correlated to its 
phylogenetic distribution (Table 3).  19 out of 25 strains that belong to Group A do not carry 
c1955-c1960 system (like MG1655). In contrast, 13 out of 16 strains that belong to Group B1 and 
14 out of 15 strains that belong to Group B2 carry c1955-c1960 system (like CFT073). 8 out of 
12 strains that belong to Group D carry c1955-c1960 system and none of the Group E strains 
carry c1955-c1960 system. Overall, the data shows that the presence of c1955-c1960 system is 
predominant in the strains that belong to Group B2 and B1. 
 
Table 3: c1955-c1960 system and ECOR phylogeny 
c1955-c1960 systemb 
 
72 strainsa
+ - 
A-25 (35%)d 6 (8%) 19 (27%) 
B1-16 (22%) 13 (18%) 3 (4%) 
B2-15 (21%) 14 (20%) 1 (1%) 
D-12 (17%) 8 (12%) 4 (5%) 
Ph
yl
og
en
et
ic
 ty
pe
sc
 
E-4 (5%) 0 4 (5%) 
 
a: 72 ECOR strains used in the study  
b: Presence (+) or absence (-) of c1955-c1960 system 
c: phylogenetic groups are based on Herzer et al., 1990 
d: number of strains are shown and percentages are calculated to the total number of ECOR strains    
    analyzed in the study. 
 
2.6 The four spontaneous mutants carry identical point mutation in the putative regulatory 
     region 
     In order to characterize the spontaneous activation of the c1955-c1960 system, the putative 
regulatory region between c1959 (β-glucoside specific PTS IIB domain) and c1960 (putative 
regulator) was sequenced from the starter strain i484 ∆bgl (Ec93) and from the four spontaneous 
mutants (Ec131 to Ec134). Nucleotide sequence alignment of the i484 ∆bgl and the four mutants 
with published sequence of CFT073 revealed that strain i484 ∆bgl has identical sequence as in 
CFT073. While the four spontaneous mutant carry an identical point mutation from G to A at 
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position AE016760- 292542 (position relative to GenBank accession number) (Figure 27). The 
sequence around the mutation matches with the consensus sequence of CAP binding site. In 
addition, the mutation was seen to be in the non-conserved nucleotide of the putative CAP-
binding site. Thus, the sequence in this region looks like a typical Class II CAP dependent 
promoter region. In case of Class II CAP dependent promoters the CAP binding site is centered 
at the -41.5 nucleotide position (with respect to the transcription start) and the -35 box is replaced 
with CAP binding site. To this end, the c1955-c1960 system may possess a putative Class II CAP 
dependent promoter which needs to be further substantiated.  
 
Figure 27: Nucleotide sequence of the putative regulatory region of the c1955-c1960 system.  
The c1955-c1960 system is shown in inverted orientation with respect to Fig. 19. Nucleotide sequence is shown from 
AE016760: 292694 to 292455 of the E.coli CFT073 genome. The nucleotide sequence of Ec93 (i484 ∆bgl) is 
identical to CFT073 with no sequence changes. The four spontaneous mutants (Ec131 to Ec134) carry identical point 
mutations from G to A. The nucleotide change is shown at the top of the sequence. Putative CAP binding site is 
underlined. Putative Class II CAP dependent promoter is shown by a brace and putative -10 regions are shown by 
horizontal line below the sequence.  Deduced amino acid sequences of c1959 and c1960 are shown at the top of the 
nucleotide sequence.  
 
 
2.7 c1955-c1960 system encodes genes for β-glucoside utilization 
 
      In order to test whether the constitutive expression of the c1955-c1960 system allows 
utilization of β-glucosides, the putative promoter of the c1955-c1960 system was replaced with 
tac promoter under the control of lacI. The expression of these constructs can be regulated with 
IPTG. The putative structural genes c1955 to c1959 from i484 ∆bgl and from two spontaneous 
mutants Ec132 and Ec134 were cloned and the phenotypes of the resulting plasmids in Ec93 
(i484 ∆bgl) and S541 (K-12 ∆bgl) were determined on BTB indicator plates in the presence of 
four β-glucosides (Salicin, Cellobiose, Arbutin and Esculin, Fig. 28). The results revealed that in 
i484 ∆bgl background, wt-construct (that carries c1955-c1959 genes from i484 ∆bgl) is sufficient 
for the utilization of β-glucosides (Salicin, Cellobiose, and Arbutin). The results are also similar 
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with other two constructs carrying activated fragments (pKEGN53 and 54). However, in K-12 
∆bgl background the wt-construct did not complemented for the β-glucoside utilization at both 
28°C and 37°C. In the two constructs carrying activated fragments, construct pKEGN53 was able 
to complement whereas, the other construct did not complemented. Complementation in K-12 
∆bgl for the β-glucoside utilization with one of the activated derivative (pKEGN53) could be due 
to PCR generated errors in the structural genes. Interestingly, it was observed that an Arbutin 
positive (Arb+) phenotype was seen with both wt-constructs and activated constructs in i484 ∆bgl 
and in K-12 ∆bgl at both 28°C and 37°C (Fig. 28). This is possibly due to the presence of the 
gene bglA. The gene bglA is conserved in all the four sequenced E.coli strains, encodes an 
enzyme phospho β-glucosidase that is necessary for the hydrolysis of β-glucosides like Arbutin. 
The enzyme BglA can cleave β-glucosides only when the sugars are transported into the cell 
(Prasad et al., 1973). Thus, the constitutive expression of c1955 to c1959 (putative transporters) 
in the constructs analyzed could function for the transport of arbutin and the Arb+ phenotype seen 
in the i484 ∆bgl and K-12 ∆bgl transformants could be attributed to the BglA activity. Taken 
together, the data suggests that c1955-c1960 system encodes genes necessary for β-glucoside 
utilization system.  
 
2.8 c1955-c1960 system is ON in septicemic isolate background but OFF in K-12 
background  
 
     The constitutive expression of the structural genes (c1955-c1959) showed that c1955-c1960 
system encodes genes for β-glucoside utilization. In order to analyze whether the c1955-c1960 
system allows for the utilization of β-glucosides in i484 ∆bgl and K-12 ∆bgl background, the 
genes c1955 to c1960 from i484 ∆bgl and from the four spontaneous mutants were cloned into a 
plasmid vector containing pACYC origin. The plasmids were transformed into i484 ∆bgl 
background (Ec93) and in K-12 ∆bgl (S541) background. The phenotypes of the tranformants 
were determined on BTB indicator plates in the presence of four β-glucosides (Fig. 28). The 
results revealed that Ec93 tranformants with the plasmids carrying fragments from spontaneous 
mutants (pKEGN42 to 45) showed Sal+ Cel+ Arb+ Esc- phenotype at 28°C. However, at 37°C 
only Arb+ phenotype was seen. This suggested that the enzyme activity of the phospho β-
glucosidase (encoded by c1959) is temperature sensitive. In the K-12 ∆bgl transformants the 
results revealed that the plasmids carrying fragments from spontaneous mutants (pKEN42 to 45) 
did not allow for the utilization of Salicin, Cellobiose and Esculin at 28°C and 37°C. However, a 
strong Arb+ phenotype was seen at both the temperatures (Fig. 28). As mentioned earlier (in 
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section 2.7) the Arb+ phenotype is possible due to the presence of bglA gene. At an outlook, it 
also suggests that additional factors might be necessary for the expression of c1955-c1960 system 
and these factors might be absent in K-12.  
 
 
Figure 28: Phenotypes of the c1955-c1960 system constructs in i484 ∆bgl (Ec93) and K-12 ∆bgl (S541). Shown 
are the phenotypes on BTB indicator plates with 0.5% Sal-Salicin, Arb-Arbutin, Cel-Cellobiose, Esc-Esculin at 28°C 
and 37°C. The structures of the two plasmidic constructs used in the complementation analysis are also shown.  
Strain Ec93 carries wt-c1955-c1960 system and strain Ec131 to Ec134 carries activated derivatives of c1955-c1960 
system. The phenotypes of the un-transformed strains are also shown at the top panel. Followed by phenotypes of the 
Ec93 transformants complemented with plasmids (pKEGN41 to 45). Plasmids and strains from which the fragments 
are taken are shown as follows: pKEGN41 (Ec93), pKEGN42 (Ec131), pKEGN43 (Ec132), pKEGN44 (Ec133), 
pKEGN45 (Ec134).  Constructs pKEGN42 to 45 can complement the utilization of β-glucosides in Ec93 (at 28°C) 
but not in S541. The constructs pKEGN53 to 55 carry fragments from Ec132, Ec133 and Ec93 respectively and the 
complementation was seen only in Ec93 background and not in S541. Phenotypes of the transformants with plasmids 
pKEGN53 to 55 were determined in the presence of 1mM IPTG. Phenotypes were determined from two independent 
experiments and from two independent plasmidic clones. The results are reproducible in each case. +++ Sal+, ++ 
medium Sal+, + weak Sal+, - Sal-, –p Sal- but papillates and –R relaxed phenotype. 
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2.9 The promoter of c1955-c1960 system  is CAP dependent and is catabolically repressed 
in the presence of glucose 
 
 
     To test whether the point mutation seen in the CAP-binding site has influence on the promoter 
activity, two different lacZ fusions were made from wt (i484 ∆bgl) and from the activated 
derivative that carry point mutation in the CAP-binding site of c1955-c1960 system (Ec134). The 
first construct comprises of the promoter (Pc1955-c1960) fused to lacZ and the second construct with 
the gene c1960 with Pc1955-c1960 fused to the lacZ (Fig. 29). The plasmidic constructs were 
integrated into S541 (K-12 ∆bgl ∆lacZ) chromosomal attB site (see materials and methods). The 
expression of the integrated derivates were determined from cultures grown to the exponential 
phase (OD 600 of 0.5) in M9 medium with Casamino acids, Vitamin B1, 0.5% glycerol and 
antibiotics. It was seen that in the wt construct, the promoter activity was reduced 2 fold in the 
presence of putative regulator c1960 (200 to 100U, Fig. 29I A and B) suggesting c1960 as a 
putative repressor in the c1955-c1960 system. The promoter activity in the constructs carrying 
activated promoter, activity was increased to ~10 fold in comparison to the wt-Pc1955-c1960-lacZ 
construct (200 to 1905U, Fig.29I A and C). In addition, the repression of the promoter activity 
was not affected by c1960 in the activated derivatives suggesting that the point mutation might 
have hindered the binding of putative repressor in the promoter region (Fig. 29).  
 
     In order to test whether the Pc1955-c1960 activity is catabolically repressed in the presence of 
glucose, expression of the constructs were determined in the presence of 0.5% glucose. A 2 to 3 
fold decrease in the promoter activity was seen in all the constructs suggesting that the promoter 
activity is catabolically repressed in the presence of Glucose. To test whether the additional β-
glucoside system promoter is CAP dependent, cyaA gene that codes for the adenylate cyclase 
enzyme catalyzing production of cyclic AMP (cAMP) was deleted resulting in K-12 ∆bgl ∆lacZ 
∆cyaA (strains S2272 to S2279).  Due to a lack of cAMP in these strains the active CAP-cAMP 
complex cannot form and bind to the CAP binding site of the c1955-c1960 promoter region 
thereby expected to cause low or no expression. The results revealed that the promoter activity 
was very low in all the four reporter constructs in the absence of cAMP (see –cAMP values, Fig. 
29). However, in the presence of 1mM cAMP the activity of the constructs with activated 
promoter showed ~10 fold increase in comparison to the wt-constructs (Fig. 29I compare values 
in +cAMP of A, B to C, D). To further support that the promoter is CAP dependent, expression 
of the plasmidic constructs were determined in crp background (this strain lacks CAP protein) 
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and the results revealed that activity in all the constructs were drastically reduced (Fig. 29II, see 
crp readings). Expression of the plasmidic constructs in wt in the presence of Glucose or 
Glycerol (Fig. 29II) supported the data with the chromosomal constructs (Fig. 29I), where it was 
seen that promoter activity of the constructs that carry activated derivates was enhanced to ~ 20 
fold in comparison to the wild type constructs (Fig. 29II compare A, B to C, D).  
 
 
 
 
Figure 29: β-galactosidase acitivity of Pc1955-c1960-lacZ reporter constructs. β-galactosidase activity is expressed in 
miller units (Miller, 1972). Bars represent the β-galactosidase activity. Shown are the average results from atleast 3 
independent experiments and from at least two independent clones. I) Assays of the wt (S541) cultures were carried 
out in M9 medium with either Glycerol or Glucose as carbon source (materials and methods) and assays for cyaA 
were carried out in LB medium with or without 1mMcAMP. Plasmids used for chromosomal integrations are as 
follows: A) pKEGN46 B) pKEGN51 C) pKEGN48 D) pKEGN52. Strains carrying the reporter constructs in attB 
(units in M9-Gly, M9-Glu, cyaA –cAMP and cyaA +cAMP) are as follows: A) S2180/81 (200, 70, 55, 90) B) 
S2184/5 (100, 40, 30, 35) C) S2182/3 (1905, 565, 40, 535) D) S2186/7 (1840, 520, 30, 420). Standard deviation 
errors are less than 10%. The strains with ∆cyaA carrying identical reporter constructs are as follows: A) S2272/3 B) 
S2276/7 C) S2274/5D) S2278/9. * indicates mutation in CAP binding site II) Plasmidic assays of the reporter 
constructs are shown. Plasmids used for the assays are shown as in I. Assays in wt (S541) in M9 and LB medium are 
indicated. Assays of crp (S996) and hns (S614) were carried out in LB medium. Units in Wt-M9-Glu, M9-Gly, LB, 
crp and hns are as follows: A) 2995, 1020, 2465, 380, 3200 B) 2875, 1150, 2250, 195, 3760 C) 24245, 8720, 22738, 
318, 25840 D) 28605, 10960, 28858, 390, 36050. 
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It’s been known that the histone like protein (H-NS) is involved in the silencing of the bgl operon 
(Dole et. al., 2004). To test whether H-NS has any role in the regulation of the c1955-c1960 
system, the expression of the plasmidic Pc1955-c1960-lacZ reporter fusions were determined in hns 
background. The results showed that no significant difference was observed in the hns in 
comparison to the wt (Fig. 29II, compare values of wt (LB) and hns). Taken together, the data 
suggest that the promoter of the c1955-c1960 system is CAP dependent and is catabolically 
repressed in the presence of glucose. In addition, it also suggests that H-NS has no role on the 
promoter activity. 
 
2.10 Expression of Pc1955-c1960-lacZ reporter constructs are induced by salicin in septicemic 
isolate background (i484 ∆bgl) that carries activated c1955-c1960 system. 
 
      To test whether the expression of the Pc1955-c1960-lacZ reporter constructs can be induced with 
the β-glucosides (like salicin, cellobiose). The strain i484 ∆bgl and two mutants that carry 
activated derivatives of c1955-c1960 system (Ec132 and Ec134) were transformed with 
plasmidic constructs carrying wt-Pc1955-c1960-lacZ (pKEGN46), wt-c1960-Pc1955-c1960-lacZ 
(pKEGN52) and respective Pc1955-c1960 reporter constructs carrying fragments with point mutation 
(activated derivatives, pKEGN48, 52) and the expression was determined in exponential growth 
phase of the cells grown at 28°C and 37°C (Fig. 30). 
 
     In strain i484 ∆bgl no difference was seen in all the four constructs in the presence of Salicin 
or cellobiose at both temperatures. However, in the c1955-c1960 spontaneous mutants (Ec132 
and Ec134), the wt-c1960-Pc1955-c1960-lacZ construct (pKEGN51) showed ~5 to 8 fold increase in 
the activity in the presence of Salicin in comparison to the absence (8220U, 7800U in comparison 
to 920U at 28°C and 14615U, 14140U in comparison to 2905U at 37°C, Fig. 30B). The construct 
that carried activated c1960-Pc1955-c1960-lacZ fragment (pKEGN52) showed a ~1.5 fold 
enhancement in the promoter activity in the presence of Salicin at 28°C (13575U and 12200U in 
comparison to 8310U, Fig. 30D). No effect of Salicin was seen in the constructs carrying just the 
promoter alone fused to the lacZ gene (Fig. 30A and C). In addition, no induction with cellobiose 
was seen at both temperatures in all the four constructs. To this end, the data suggests that upon 
transport of the β-glucosides into the cell the putative regulator c1960 can also act as an activator 
of the c1955-c1960 system.  
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Figure 30: β-galactosidase acitivity of Pc1955-c1960-lacZ reporter constructs in i484 ∆bgl and two spontaneous 
mutants of c1955-c1960 system (Ec132 and Ec134). β-galactosidase activity is expressed in miller units (Miller, 
1972). Bars represent the β-galactosidase activity. Shown are the average results from at-least 3 independent 
experiments and from at least two independent clones. All assays were carried out in M9 medium with 0.5% 
glycerol, vitamin B1, casa amino acids, antibiotics and with or without β-glucosides like salicin, cellobiose. – 
indicates no β-glucosides in the medium, +sal indicates-with 0.2% salicin, +cel-0.2% cellobiose. Plasmids used in 
the analysis are A) pKEGN46 B) pKEGN51 C) pKEGN48 D) pKEGN52. Strain name, units (-sal, +sal, +cel) are as 
follows: A) i484 ∆bgl (885, 850, 800 at 28°C) (3400, 3210, 2780 at 37°C). Ec132 (1090, 1060, 1075 at 28°C) (2940, 
2660, 2965 at 37°C), Ec134 (885, 1320, 945 at 28°C) (2810, 3246, 3050 at 37°C). B) i484 ∆bgl (895, 920, 915 at 
28°C) (2900, 2905, 2780 at 37°C). Ec132 (935, 8220, 1210 at 28°C) (2880, 14615, 3980 at 37°C). Ec134 (960, 7800, 
1060 at 28°C) (2765, 14140, 3360 at 37°C). C) i484 ∆bgl (7360, 6995, 8180). Ec132 (6700, 8520, 7950). Ec134 
(6920, 9020, 7160). D) i484 ∆bgl (7870, 8310, 8475).Ec132 (6775, 13575, 9370). Ec134 (6585, 12200, 8270). * 
indicates mutation in the CAP binding site. 
 
2.11 The β-glucosides salicin, cellobiose, chitobiose, arbutin and esculin are not inducers 
of c1955-c1960 in K-12 background. 
      The phenotypes of the S541 (K-12 ∆bgl ∆lacZ) complemented with two different types of 
constructs carrying c1955-c1960 system revealed that c1955-c1960 system cannot complement 
for the utilization of β-glucosides in K-12 (Fig. 28). In addition, the induction of wt-c1960-Pc1955-
c1960-lacZ activity with β-glucoside (Salicin) in the septicemic isolate background (i484 ∆bgl) 
(Fig.30) initiated further studies to carry out in K-12 ∆bgl ∆lacZ background. Thus, to test 
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whether the c1955-c1960 promoter activity is induced with any of the β-glucoside in K-12 
background, the expression of the chromosomal constructs carrying wt-Pc1955-c1960 was 
determined in the presence of two different constructs provided in trans (Fig. 31). One construct 
carries structural genes (c1955-c1959) from the activated derivatives driven by inducible tac 
promoter (pKEGN53) and the other construct carries activated c1955-c1960 system driven by its 
own promoter (Pc1955-c1960) (pKEGN43). 
Figure 31: β-galactosidase acitivity Pc1955-c1960-lacZ reporter constructs in K-12 ∆bgl. β-galactosidase activity is 
expressed in miller units (Miller, 1972). Shown are the average results from at-least 3 independent experiments and 
from at least two independent clones. * indicates activated c1955-c1960 system. Bars represent the β-galactosidase 
activity. Strains carrying the chromosomal constructs are listed as in Fig. 29. Shown are the values with two 
constructs provided in trans: pKEGN53-carries structural genes of c1955-c1959 (from the activated derivative) 
driven by inducible tac promoter, pKEGN43-carries the intact c1955-c1960 system (from the activated derivative). 
Identical results were seen with two other respective independent clone pKEGN52 and pKEGN44.  Assays with 
pKEGN53 in trans were performed at both 28°C and 37°C in the presence or absence of β-glucosides like salicin 
(sal), cellobiose (cel), chitobiose (chb), arbutin (arb) and esculin (esc) with or without 1mM IPTG. Assays with 
pKEGN43 in trans were performed with or without salicin at 37°C. All assays were carried out in M9 medium with 
0.5% glycerol, vitamin B1, casa amino acids and with relevant antibiotics. – indicates no β-glucosides. β-
galactosidase activity in units with pKEGN53 in trans are as follows: at 28°C absence of β-glucosides, +IPTG, +Sal, 
+Cel, +Chb, +Arb, +Esc (construct A: 70, 70, 60, 60, 30, 50, 60; construct B: 30, 35, 35, 25, 15, 22, 35) at 37°C 
absence of β-glucosides , +IPTG, +Sal (A: 185, 150, 150 B: 85, 60, 55). β-galactosidase activity in units with 
pKEGN54 in trans: absence of β-glucosides, +Sal (A: 195, 180 B: 85, 90). 
 
The promoter activity was determined from exponential growth phase of the cells (Fig. 31). The 
results revealed that in the strains that carry construct with the structural genes (c1955-c1959) 
under the control of inducible tac promoter, none of the tested β-glucosides (salicin, cellobiose, 
chitobiose, arbutin and esculin) induced the Pc1955-c1960 activity. Also, no effect of Salicin was 
seen on the Pc1955-c1960 activity in the presence of intact c1955-c1960 system. Taken together, 
these results demonstrate that the tested β-glucosides are not inducers of c1955-c1960 system in 
K-12 background. 
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2.12 Expression of Pc1955-c1960-lacZ reporter construct is induced by salicin and arbutin in 
K-12 background that carries activated copy of bgl operon. 
 
     The expression of Pc1955-c1960-lacZ constructs in septicemic isolate background carrying 
activated copy of c1955-c1960 system suggested that upon transport of the β-glucosides into the 
cell c1955-c1960 system is induced. To test this idea in the K-12 background, constructs carrying 
wt-Pc1955-c1960-lacZ reporter systems were analyzed in wt (S49), K-12 ∆bgl (S162) and 
spontaneous mutant of bgl operon that carry bglR::IS1 (S157) (Fig. 32).  
      In the wt strain and in K-12 ∆bgl no difference was seen in the presence or absence of Salicin 
at both temperatures. However, in the strains that carries activated copy of the bgl operon 
promoter activity was significantly enhanced in the presence of salicin at 37°C. In the 
spontaneous mutant that carry bglR::IS1 the promoter activity of the wt-c1960-Pc1955-c1960-lacZ 
construct was enhanced to 4 fold at 37°C in the presence of salicin and arbutin in comparison to 
the absence (compare 14370U and 11320U to 3505U Fig. 32B). However, no such difference 
was seen at 28°C.  
 
Figure 32: β-galactosidase and β-glucosidase activity of the wt-Pc1955-c1960-lacZ reporter constructs in K-12 
background. β-galactosidase activity is expressed in miller units (Miller, 1972). Shown are the average results from 
at-least 3 independent experiments and from at least two independent clones. Plasmids used in the analysis are A) 
pKEGN46 B) pKEGN51. Plasmids were transformed in to strains wt (S49), K-12 ∆bgl, and Bgl+ mutant bglR::IS1 
(S157). All assays were carried out in M9 medium with 0.5% glycerol, vitamin B1, casa amino acids, and antibiotics 
and with or without β-glucosides like Salicin (Sal) Arbutin (Arb), and Esculin (Esc). β-glucosidase activity was 
determined for strains S49, S162, S157, S432 to quantitate the level of β-glucosidase expression (see materials and 
methods). β-galactosidase activity in Units at 37°C (no β-glucosides, +Sal, +Arb, +Esc): Construct A wt (4315, 
4890, nd, nd) K-12 ∆bgl (4392, 3905, 4635, 4520), Bgl+ (4690, 4155, 4665, 4200) Construct B wt (3360, 3680, nd, 
nd) K-12 ∆bgl (3905, 4505, 3670, 4990), Bgl+ (3505, 14370, 11320, 5900). At 28°C construct A Bgl+ (2055, 2135, 
nd, nd) construct B (1680, 2120). β-glucosidase activity in units (-Sal, +Sal): construct A wt (1, 2), K-12 ∆bgl (1, 2), 
Bgl+ (3, 135) construct B wt (1, 2), K-12 ∆bgl (1, 2), Bgl+ (3, 135). 
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     In order to analyze the level of bgl operon expression in the spontaneous mutant of bgl operon 
carrying bglR::IS1 (S157), β-glucosidase assays were performed (materials and methods). The 
results revealed that the mutant with bglR::IS1 showed ~70 fold enhancement in the β-
glucosidase activity in comparison to the wt (135U to 2U, see β-glucosidase activity results Fig. 
32). This suggests that in the spontaneous mutant of the bgl operon that carry bglR::IS1, due to 
the high expression of bgl genes the intake of phosphorylated sugars might have resulted in 
higher promoter activity of the wt-Pc1955-c1960-c1960-lacZ reporter construct. To this end, the 
results suggest that the amount of phosphorylated β-glucosides transported into the cells may 
influence the promoter activity of c1955-c1960 system in K-12 background. However, whether 
the intake of phosphorylated β-glucosides or the degradation products of β-glucosides is 
responsible for this activation remains to be answered. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 64
3. Correlations of the genome variations at bgl/Z5211-Z5214 locus to the other   
carbohydrate utilization systems 
 
     (This section, in part, is in collaboration with Prof. Diethard Tautz, Institute for Genetics,     
     University of Cologne, Germany) 
 
3.1 Correlations of bgl/Z5211-Z5214 locus typing with c1955-c1960 locus analysis and 
lactose utilization phenotypes     
     Comparison of the typing at the bgl/Z5211-Z5214 genomic island to that of the presence of 
c1955-c1960 genomic island revealed interesting correlations. Out of 46 strains that have 
CFT073 type bgl region, 45 strains carry c1955-c1960 system. None of the strains that are 
MG1655 bgl/Z type carry the c1955-c1960 island. In the remaining 4 types, 17 out of 33 O157 
bgl/Z type, 21 out of 34 fourth bgl/Z type strains, 12 out of 20 fifth bgl/Z type strains and 2 out of 
5 mixed bgl/Z type strains have c1955-c1960 system (Fig. 33).  The predominance of c1955-
c1960 system in the strains that have CFT073 type bgl region is statistically significant.  
 
 
Figure 33: Comparison of bgl/Z5211-Z5214 typing with c1955-c1960 locus analysis and lactose utilization 
phenotypes. Bars represent number of strains in each category. Open bars represent number of strains that are 
MG1655 type at bgl/Z5211-Z5214 locus, closed black bar-CFT073 type, hatched bar-O157 type, cross hatched-
fourth type bricked bar-fifth type and squared bar-mixed type. No. of strains that have c1955-c1960 region are 
represented as light grey bars. The c1955-c1960 region is predominant in CFT073 type, and none of the MG1655 
type strains carry c1955-c1960. Out of 171 strains, 99 strains were analyzed for lactose utilization phenotypes. 
Shown are the numbers of Lac- strains in each type represented by dark grey bars. Out of nine Lac- strains, six of 
them belong to O157 type. The correlations for the predominance of c1955-c1960 region in CFT073 type and 
predominance of Lac- in O157 type are found to be statistically significant. 
 
Furthermore, in order to analyze whether the typing of the E.coli isolates at the bgl/Z5211-Z5214 
locus has any correlations with the utilization of other carbohydrates, the Lac phenotype of all the 
E.coli isolates and the lac locus of Lac negative strains were analyzed. Statistically significant 
correlation was seen in the comparison of lac operon analysis with the bgl/Z5211-Z5214 typing. 
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Out of nine strains that showed Lac- phenotype, 6 of them have functional LacI and LacZ and are 
LacY negative. All these six strains are of O175 bgl/Z type (Fig. 33).  
 
3.2 Analysis of lac operon in 171 E.coli isolates 
     The E.coli lac operon encodes the gene products that are required for the utilization of lactose. 
The products of lac operon are beta-galactosidase LacZ, permease LacY and galactosidase 
acetyl-transferase LacA. The lacI gene that is not the part of lac operon encodes for a repressor. 
The comparative genomics of the four sequenced E.coli strains revealed that the lac operon is 
conserved in all the four strains (Fig. 34). However, variations were seen around the lac operon 
region as shown in Figure 34.  
 
     All the isolates were analyzed for their phenotype on MacConkey lactose indicator plates at 
37°C. The analysis revealed that out of 171 strains analyzed, 162 of them are Lac positive 
indicating that these strains have intact lac operon (Fig. 34A to C). The remaining nine strains 
that showed Lac- phenotype were analyzed by PCR with various primers specific for lac operon 
region. Strain W8987 did not gave any PCR product with various primer combinations, 
indicating the lack of lac operon in this strain (Fig. 34H). Strain ECOR6 gave expected PCR 
products with S435/S546 and no PCR product were seen with S545/S436, S95/S434 and 
S545/S434 indicating a possible deletion within the lacZ gene (Fig. 34G).  
 
     The remaining seven strains gave expected PCR products like that of MG1655 indicating the 
presence of intact lac operon. However, strain E10084 gave an increased PCR product with 
primers S95/S165 (see Table 4, materials and methods) and the obtained PCR product was 
sequenced from both the ends. It was seen that E10084 carries IS1 insertion in lacY gene (Fig. 
34E). This could explain why the strain cannot utilize lactose. Due to the functional inactivation 
of the lacY gene, lactose cannot be transported into the cell. To analyze whether LacI and LacZ 
are functional in these seven strains, β-galactosidase assays in the presence or absence of IPTG 
were performed. Induction of the β-galactosidase acitivity was seen in the presence of IPTG in 
strains F645, U4409, E179 E173 and ECOR43 indicating that both LacI and LacZ are functional 
and the Lac- phenotypes of these strains could be due to the mutations in the lacY gene (Fig. 34D 
and E). However, in case of strain E10085 β-galactosidase activity was not induced in the 
presence of IPTG. In an approach to address why the strain E10085 is Lac negative, the lacI and 
lacZ genes from E10085 were PCR amplified and cloned into a low copy vector resulting in 
plasmid pKEGN50. The pKEGN50 was transformed into S527 (MG1655, lac+) and phenotypes 
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were determined. The results revealed that S527 transformed with pKEGN50 showed Lac+ 
phenotype. This answers that E10085 LacI does not carry mutation that is dominant negative. 
Furthermore, to see if the promoter of the E10085 lac operon is affected, nucleotide sequencing 
was performed from the PCR product that contain promoter region. The nucleotide sequencing 
revealed that the promoter region of E10085 is unaffected.  
 
 
Figure 34: lac operon in E.coli isolates. The structures of the lac operon region in A) MG1655 B) CFT073 C) 
O157-EDL933 and Sakai are shown. Arrow head represents direction of the oligos. Strain CFT073 lacks a ~9.7kb 
region at the upstream and a ~3.8kb region at the downstream of the lac operon (shown by dotted lines in A). Strain 
O157 carries an additional 1.8Kb fragment with two open reading frames Z0443 and Z0442 at the upstream region of 
lac operon. However, the downstream region is like MG1655. Phenotypes on MacConkey lactose plates are shown. 
+ indicates Lac+ and – indicates Lac-Results of β-galactosidase assay are shown. + indicates induction of β-
galactosidase acitivity in the presence of IPTG and –indicates no induction. D) five strains F645, U4409, E179, E173 
and ECOR93 show Lac- phenotype and show induction in β-galactosidase assay. E) Strain E10084 carries IS1 
insertion in lacY with target site duplication of 9bp from +3367 to +3375 (positions with respect to transcription start 
of lac operon) shows Lac- phenotype. F) Strain E10085 and ECOR6 shows Lac- phenotype and no induction in β-
galactosidase assay. G) Strain ECOR6 did not gave PCR product with S435/S434, S545/S436, S545/S434, 
S95/S434, however it gave expected PCR product size as in MG1655 with S435/S546, S545/S546 and S151/S118. 
H) Strain W8987 did not result PCR product with S154/S100, S123/S165, S95/S165 and S123/S9 (refer Table 4, 
materials and methods for primer positions). 
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3.3 Nucleotide polymorphisms at the lac promoter region  
     The nucleotide sequence alignment of the lac promoter region from the four published 
sequenced strains shows that each strain differs from each other with sequence variations. The 
Nucleotide sequence alignment of the four sequenced strains is shown in Figure 35.  
           
Figure 35: Nucleotide sequence alignment of the lac promoter region in the four published sequenced strains. 
Shown is the nucleotide sequence alignment of MG1655, CFT073, O157-EDL933 and Sakai. Nucleotide sequence 
changes in comparison to MG1655 are indicated. Conserved nucleotides are shown as dots. Deduced amino acid 
sequence of MG1655 and CFT073 are shown at the top and O157 variants EDL933 and Sakai are shown at the 
bottom of the alignments. Amino acid changes in CFT073 are shown as subscripts. lac operators are indicated by 
horizontal lines above the sequence. lac promoter is shown by brace and -10 and -35 regions are shown by horizontal 
lines. CAP binding site is underlined. 
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Strain CFT073 carries around 16bp sequence variations in comparison to MG1655 sequence. It 
carries an additional base pair in the promoter region in comparison to MG1655 and O157.  
Strain O157 EDL933 carries around 15bp variations and strain Sakai carries around 19bp 
sequence variations in comparison to MG1655. No sequence changes were seen in the -10 and -
35 box (Fig. 35). In order to analyze whether the polymorphism seen in the four sequenced 
strains are also present in the natural isolates of E.coli, the nucleotide sequencing of the lac 
promoter region (shown in Fig. 35) in all the  isolates is currently under progress (the sequencing 
part of the work is in collaboration with Prof. Diethard Tautz). 
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IV. Discussion 
     Strains of Escherichia coli differ significantly in their genome sizes. Considerable insight has 
been gained into the role of ‘pathogenicity islands’ and ‘genomic islands’ for these differences. In 
this study, the DNA polymorphisms at two of the regions that show variations between the four 
sequenced E.coli strains have been assessed in 171 commensal and pathogenic E.coli isolates: 
bgl/Z5211-Z5214 region and c1955-c1960 region. The bgl/Z5211-Z5214 region and c1955-
c1960 region are genomic islands in E.coli. In addition to the analysis of the two loci, lactose 
utilization phenotypes were assessed in all the isolates and the lac locus of the Lac negative 
strains were analyzed. Based on the observations at the bgl/Z5211-Z5214 region strains were 
typed into five main types and one sub type. It was observed that the typing of the E.coli strains 
at the bgl/Z5211-Z5214 locus correlated as well with the analysis of the other two loci. Taken 
together, this study addresses a possible method of typing E.coli strains at bgl/Z5211-Z5214 
locus. 
 
1.  Genome variations at three loci in E.coli isolates 
      In the present work correlations for the five following features were observed: bgl/Z5211-
Z5214 typing, c1955-c1960 system analysis, lac operon analysis, β-glucoside utilization 
phenotypes and phylogenetic distribution of ECOR strains (Fig. 36).  
     Out of 171 strains analyzed 33 strains have MG1655 bgl/Z locus, lac operon and none of them 
have c1955-c1960 system. All of the ECOR strains that have this structure belong to 
phylogenetic group A. 45 of the strains have CFT073 bgl/Z locus, c1955-c1960 system and lac 
operon. 8 out of 11 ECOR strains that show relaxed phenotype have this structure and are 
predominant in phylogenetic group B2.   
     Strains that have O157 bgl/Z locus are predominant in group D. Six out of 9 strains that are 
Lac- have O157 bgl/Z locus and all of them lack c1955-c1960 system indicating a high rate of 
genetic variability at the region of carbohydrate utilization systems in this group of strains. 
Strains that have fourth bgl/Z locus are predominant in group B1, where 21 of them have both lac 
operon and c1955-c1960 system and 13 have lac operon but lacks c1955-c1960 system. Out of 
20 strains that have fifth bgl/Z locus, 12 of them have both lac operon and c1955-c1960 system 
and 8 of them lacks c1955-c1960 system. Out of 5 strains that have mixed bgl/Z locus, 2 strains 
have both lac operon and c1955-c1960 system and 3 strains have lac operon but lacks c1955-
c1960 system. The occurrence of the mixed bgl/Z type strains in the natural population of E.coli 
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may provide an insight in understanding the bacterial genome dynamics. In addition, it provides 
an evidence for the role of horizontal gene transfer in shaping the bacterial genome evolution.   
                          
 
Figure 36: Schematic representation of the three loci analyzed in 171 strains. Horizontal lines represent the 
linear chromosomes of the 171 strains analyzed in this study. Positions of the three loci are shown not to scale. 
Typing at the bgl/Z5211-Z5214 locus (MG1655 bgl/Z, CFT073 bgl/Z, O157 bgl/Z, Fourth bgl/Z, Fifth bgl/Z and 
Mixed bgl/Z) is indicated. c1955-c1960 indicates c1955-c1960 system. Total numbers of strains in each type are 
shown. Number of ECOR strains and its phylogenetic grouping (Herzer et al., 1990) are indicated. Numbers of 
ECOR strains that show relaxed phenotype on BTB salicin plates at 37°C are also shown.  
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2. Structure of the bgl/Z5211-Z5214 locus in E.coli 
     The bgl/Z5211-Z5214 region may represent a good model to study the process of genomic 
island evolution in E.coli (Fig. 4, see introduction). The results from the current analysis reveal 
that five main and one sub bgl/Z types of E.coli strains may exists in the natural population. It 
was observed that, out of 171 strains approximately 20% of the strains have bgl locus like 
MG1655, 26% have bgl locus like CFT073, 20% of the strains have Z5211-Z5214 locus like 
O157, 20% have upstream sequence like O157 followed by the bgl and downstream like 
MG1655, 11% have upstream, bgl and downstream like MG1655 with hybrid yieI gene.  In 
addition, 3% of the strains have a mixture of sequences from MG1655, CFT073 and O157 in 
bgl/Z5211-Z5214 locus which is assigned as mixed type in the current study (Fig. 8, Results). 
The grouping of the E.coli strains in the current study supports the evolutionary model proposed 
by Herbelin and co-workers (2000) and reflects the hypothesis that in the natural population four 
to five types of E.coli strains may exist. However, existence of the variants from these types 
cannot be ruled out (for e.g., mixed type strains in the current study). Furthermore, the random 
mutagenesis screen in a septicemic strain i484 that has CFT073 type bgl revealed that strain i484 
is similar to CFT073 in the other loci as well, supporting the hypothesis in considering 
bgl/Z5211-Z5214 locus as a possible marker for typing E.coli isolates. 
    It was observed that the upstream phoU gene is conserved in all the isolates analyzed. 
However, the downstream region is variable as seen in the four sequenced E.coli strains (Fig. 8, 
Results). phoU is an essential gene in E.coli and mutations in phoU results in severe growth 
defects and alterations in phosphate levels (Steed & Wanner, 1993). The current study also 
revealed that in the natural population of E.coli approximately 43% of the strains carry hybrid 
yieI gene. The implication of this observation is yet to be understood. Furthermore, the alterations 
seen within the bgl/Z5211-Z5214 locus by insertions and deletions provides a model for how 
genes are lost from a genome once they no longer provide any selective advantage. In addition, it 
was observed that all of the CFT073 bgl/Z type strains and some strains in fourth bgl/Z type and 
mixed bgl/Z type do not carry yieJ gene. The absence of yieJ gene may possibly suggest the 
formation of “black holes” i.e., deletions of genes that may enable commensal bacteria to evolve 
toward a pathogenic life style. The gene product of the yieJ gene is currently unknown. The 
formation of “black holes” is observed in the deletion of cadA gene that encodes for Lysine 
decarboxylase that catalyzes the reaction for the formation of cadaverine which acts as an 
inhibitor of Shigella enterotoxin activity (Maurelli et al., 1998). Thus, it suggests that the creation 
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of black holes is a pathway that complements gene acquisition in the evolution of bacterial 
pathogens. 
     The sequence analysis and PCR-based studies used in this study could be further explored in 
designing an optimal PCR based strategy that would lead to a more convenient and easy 
approach to type E.coli at bgl/Z5211-Z5214 locus. The availability of genome sequences of four 
E.coli strains has provided wealth of information in designing strain specific primers for the 
optimal PCR strategies. Which could be further explored in analyzing the variations at other loci 
that might give an insight into a novel PCR based strategy for typing E.coli.   
 
3. Silencing of the bgl operon is conserved 
     The current analysis has provided extensive evidence for the β-glucoside utilization 
phenotypes of the natural E.coli isolates from diverse sources. The observations revealed that 
silencing of the bgl operon is conserved in E.coli. Three different kinds of papillation phenotypes 
were seen, where majority of the strains papillated like MG1655 or more frequently than 
MG1655. However, around 15% of the strains showed a weak Bgl+ phenotype (relaxed) (Fig. 9). 
Strains that showed relaxed phenotype can papillate only at 28°C, suggesting a temperature 
sensitive regulation of β-glucoside utilization in this group of strains. 
      Furthermore, the pattern of activation of the bgl operon seen in the representative strains of 
MG1655 like phenotype, more papillae phenotype and relaxed phenotype demonstrated that the 
bgl operon is spontaneously activated in the natural E.coli isolates as in MG1655 (Fig. 16, 
Results). However, difference in the activation varies from strain to strain. The basis for these 
differences between the strains is not known at this stage; it could be speculated that this could be 
because of the strain to strain background and may depend on the cellular pleiotropic control of 
the bgl operon or of transposition. 
 
4. Sequence variations in the bgl operon have no significant influence on the bgl expression 
in K-12 background 
     The observation of the weak Bgl+ phenotype (relaxed phenotype) in 15% of the strains in the 
laboratory condition suggests that the basal expression of the bgl operon could be high in this 
group of strains. In addition, it was observed that all the strains that showed relaxed phenotype 
carried CFT073 type bgl (Table 1, Results). The analysis of the expression levels of Pbgl-lacZ and 
Pbgl-t1-bglG-lacZ fusions in K-12 background showed that the sequence variations in the bgl 
promoter region seen in CFT073 bgl/Z type do not have significant influence on the promoter 
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activity. However, constructs carrying fragments with additional base pair changes show 
significant differences in comparison to MG1655 indicating the importance of the sequence 
change(s) on bgl expression (Fig. 18 and 19, Results). At this stage, it cannot be concluded that 
the sequence variations seen in the CFT073 bgl type may not have an impact on the bgl 
expression. It might be possible that in an environment inside the host or in an untested strain 
background the sequence variations might play a role in the bgl expression. 
 
5. Positive regulatory factors necessary for relaxed phenotype 
     To ensure whether the relaxed phenotype is not due to the multiple papillation, we tried 
purifying the papillae from day 3 incubated BTB salicin plates at 37°C. However, all the attempts 
in purifying complete Bgl+ mutants were unsuccessful. A mTn10 mutagenesis screen to unravel 
the factors that are essential for relaxed phenotype in wt-i484 yielded mutations in bgl operon, 
cysN, cysH, cysJ, purL, purC and ybdM (Fig. 21). Mutations in bgl operon hinder the utilization 
of β-glucosides. Mutations in cysN, cysH, and cysJ affect sulfate assimilation and consecutively 
affect the biosynthesis of cysteine and methionine. Mutations in purC and purL affect the de novo 
biosynthesis of purine nucleotides. The second round of mTn10 mutagenesis yielded mutations in 
5 new genes: pgi, cysG, serC, carB and rfaC (Fig. 22). It was shown that bgl operon could be 
specifically downregulated by pgi mutation (Dole et al., 2004). Mutations in cysG, serC, carB 
and rfaC have general response on the cellular metabolism by affecting the sulfate assimilation, 
amino acid biosynthesis, ribonucleotides synthesis and lipopolysaccharide biosynthesis 
respectively.  
     The two rounds of screen basically yielded mutations in the genes that are involved in amino 
acid biosynthesis or nucleotide biosynthesis. Mutations in these genes may lead to the alterations 
in the nucleotide pool and/or amino acid pool of the bacterial cell. This could have a potential 
influence on the expression of various genes that may include regulators of the bgl operon 
silencing such as H-NS.  Thus, the pleiotropic response during these events may have effect 
(through H-NS) on the β-glucoside utilization. The direct effect on the repression of bgl by H-NS 
also cannot be ruled out. The precise mechanism to the effect of mutations in these genes on the 
β-glucoside utilization remains to be determined.    
     On the other-hand, in both the independent miniTn10-mutagenesis screen mentioned above, 
mutation in the gene ybdM was obtained. The effect of the mutation in the hypothetical gene 
ybdM on β-glucoside utilization cannot be speculated at this stage. However, homology searches 
revealed that the ybdM may encode protein that is homologous to putative transcriptional 
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regulators from E.coli, Salmonella, Bacillus, and Enterococcus (see results section 1.15). To this 
end, it would be interesting to further characterize the role of hypothetical protein YbdM in the β-
glucoside utilization.   
 
6. c1955-c1960 locus in E.coli 
     The studies on natural isolates of E.coli have revealed that E.coli K-12 may possess additional 
systems for the utilization of β-glucoside sugars (Hall, 1988; Parker and Hall, 1988). Due to the 
remarkable ecotype diversity of E.coli, the presence of various β-glucoside systems may play a 
potential role that permits its adaptation to a novel environment in which β-glucosides are the 
sole carbon source. In this study, the isolation and characterization of an additional β-glucoside 
specific locus from E.coli is reported.  
      Some of the strains that carry Z5211-Z5214 locus in place of bgl showed late papillation on 
BTB salicin plates at 37°C. This papillation phenotype suggested an existence of additional β-
system which is activated upon prolonged incubation in the presence of β-glucosides. A 
miniTn10-cmR mutagenesis screen to unravel the presence of additional β glucoside-system 
primarily yielded mutations in c1955-c1960 locus of the published genome sequence of E.coli 
CFT073 (Fig. 23). 
     The c1955-c1960 represents an island encoded system that is present uniquely in the CFT073 
genome and absent in the other three sequenced E.coli strains. The analysis revealed that 57% of 
the strains have c1955-c1960 region like CFT073 and the remaining 43% do not carry this locus 
(Fig. 26). The data also showed that c1955-c1960 system is predominant in the strains that have 
CFT073 type bgl region. None of the MG1655 bgl/Z type strains carried c1955-c1960 system 
(Fig. 26). Furthermore, the nucleotide sequence alignment of the upstream (marB) and 
downstream (ydeD) regions of c1955-c1960 in the four sequenced E.coli strains showed sequence 
variations between the strains (data not shown). Typing of E.coli isolates at c1955-c1960 locus 
might give correlations with the typing at bgl/Z5211-Z5214 locus which may lead in elucidating 
novel typing methods for E.coli strains. 
 
7. c1955-c1960 system encodes genes for β-glucosides utilization 
      Homology searches of the deduced amino acid sequences of the genes in the c1955-c1959 
region showed significant similarity to the proteins that are involved in the β-glucoside utilization 
in diverse bacteria (Fig. 24, Results). The deduced amino acid sequences of c1960 showed 
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significant similarity with GntR family of transcriptional regulators from Bacillus, Listeria, 
Erwinia and E.coli.  
      In an attempt to analyze the potential functions of the proteins encoded by this locus, 
phenotypes were determined in the presence of various β-glucosides. The analysis revealed that 
the c1955-c1960 encode genes that can hydrolyze four β-glucosides (Salicin, Arbutin, Cellobiose 
and Esculin) at 28°C, supporting the assignment of the putative gene products traced from the 
blast searches (Fig. 24). The results were further strengthened by the complementation of the 
c1955-c1960 region in i484 ∆bgl background (Fig. 28). Moreover, the constitutive expression of 
the putative structural genes (c1955-c1960) from wt-strain (i484 ∆bgl) complemented the 
utilization of three of the tested sugars. Furthermore, it was observed that c1955-c1960 genes 
cannot complement in K-12 background. This data suggested that in addition to c1955-c1960, 
additional factors that are absent in K-12 are required for the utilization of β-glucosides.  
 
8. Regulation of c1955-c1960 system 
 
     Nucleotide sequencing of the putative promoter region in between the genes c1959-c1960 
revealed that all the four spontaneous mutants carried identical point mutations (Fig. 27).  The 
mutation was seen to be in the non-conserved nucleotide of a putative CAP binding site. Along 
with, a putative -10 box that consists of conserved nucleotides essential for RNA polymerase 
binding was mapped. Thus, this region looks like a typical Class II CAP dependent promoter, 
where the -35 box is replaced with a CAP-binding site.   
 
     Expression of Pc1955-c1960-lacZ fusions showed that the mutation seems to be involved in the 
activation of c1955-c1960 system (Fig. 29). The two fold repression in the promoter activity 
noticed in the wt-construct suggested a repressor activity for c1960. This repression was 
abolished in the constructs that carry mutation in the putative CAP binding site. The promoter 
activity was two to three fold repressed in the presence of glucose, suggesting a carbon catabolite 
repression by primary sugars. In addition, the results from ∆cyaA and crp backgrounds reveal that 
the promoter acitivity is CAP dependent. The protein H-NS is involved in the silencing of E.coli 
bgl operon at multiple levels (Dole et al., 2002; Dole et al., 2004) however, no such influence of 
H-NS was seen in the tested c1955-c1960 constructs. To this end, the data suggests that the 
mutation in the putative regulatory region might be responsible for the activation of the c1955-
c1960 system. 
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     Furthermore, it was observed that salicin, cellobiose, arbutin and esculin are not inducers of 
c1955-c1960 system in the wt-K-12 background (Fig. 31).  However, it was observed that the 
promoter activity of the wt-construct carrying c1960 was induced with salicin in K-12 
background that carry activated copy of the bgl operon (Fig. 32). Similar observations were seen 
from i484 ∆bgl background that carry activated copy of c1955-c1960 system (Fig. 30). Taken 
together, the data implies that transport and/or phosphorylation of β-glucosides is necessary for 
induction of c1955-c1960 system. It also suggests that upon transport of the β-glucosides c1960 
could possibly act as an activator of the c1955-c1960 system. However, whether the intake of 
phosphorylated β-glucosides or the degradation products of the β-glucosides is responsible for 
this activation remains to be answered. 
9. Correlations of bgl/Z5211-Z5214 typing with other carbohydrate utilizing systems 
     Most studies on the utilization of carbon sources by E.coli date back before the unraveling of 
its complex ecotype diversity. A reassessment of some characteristics within the updated 
genomic context appeared warranted.  Lactose is abundantly found in nature and assimilation of 
lactose is an important feature of enteric bacteria. E.coli and Klebsiella pneumoniae can utilize 
lactose as a carbon source. Where as, the other enteric bacteria like Shigella, Salmonella, Serratia 
and Yersinia cannot utilize lactose. Thus, lactose utilization can be attributed as a phenotypic 
characteristic that distinguishes E.coli and Klebsiella from other enteric bacteria (Ochman et al., 
2000). Lawrence and Ochman (1998) have pointed out that the species specific traits such as 
lactose utilization are derived from the functions encoded by horizontally transferred genes. To 
test whether the heterogeneity seen at the bgl/Z5211-Z5214 locus and c1955-c1960 locus have 
correlations with the other carbon utilizing systems, studies on lac operon were performed. The 
data showed that 162 out of 171 strains can utilize lactose. The higher percentage of Lac+ strains 
in the natural population of E.coli suggests that lac operon is highly conserved in its functional 
state (Fig. 34).  
     Furthermore, a strong correlation of the lactose utilization phenotypes with the bgl/Z5211-
Z5214 typing was observed. Out of nine strains that are Lac-, six of them possibly carry 
mutations in lacY gene that result in functional inactivation of the permease (Fig. 34). Moreover, 
all these six strains belong to O157 type (at bgl/Z5211-Z5214 locus). This suggests that O157 
type (at bgl/Z5211-Z5214) strains might be with a high level of genetic variability that is required 
for the higher probability of its survival in a constantly changing environment.  
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10. Outlook 
       The current analysis might give an insight in answering the rapid bacterial evolution which is 
concerned with some of the relevant issues of current studies. Firstly, what types and how many 
types of E.coli strains are present in the natural population? Secondly, is there any correlation for 
the presence of different loci in the genome of E.coli to its habitat? Thirdly, where do the 
genomic islands come from and by what mechanisms are they transferred? Finally, how is it 
possible to identify cases of horizontal gene transfer?  
     The report from Kilic and coworkers (2004) suggested a unique role for β-glucoside 
utilization systems in the maintenance of pathogenic life style of a bacterium. Further studies on 
c1955-c1960 system or bgl on these aspects would give an insight in understanding whether the 
β-glucoside utilization systems such as bgl or c1955-c1960 system contributes to the virulence of 
E.coli.  
     In summary, the present study highlights the genetic diversity at the bgl/Z5211-Z5214 region 
and c1955-c1960 region among pathogenic and commensal E.coli isolates. The correlations seen 
with the bgl/Z5211-Z5214 locus typing, c1955-c1960 system analysis, lac operon analysis, β-
glucoside utilization phenotypes and phylogenetic distribution of ECOR strains might implicate 
bgl/Z5211-Z5214 locus as a possible marker for typing E.coli strains. In addition, the study 
supports the hypothesis that in nature five main types of E.coli strains may exist. Furthermore, 
the genetic variations seen at the three loci provide evidence for frequent acquisition of foreign 
DNA through horizontal gene transfer events, as well as for the deletions within the genomes 
during the course of bacterial evolution. 
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V   Materials and Methods 
 
1.  Chemicals, enzymes and other materials 
     Chemicals and enzymes were purchased from commercial sources. Oligonuleotides were 
purchased from Invitrogen life technologies (Karlsruhe, Germany) or Eurogentec.  
 
2.  Media and agar plates 
 
LB medium (1 l) 10g Bacto Tryptone (Difco) 
   5g Yeast-extract (Difco) 
 5g NaCl 
 (for plates 15g Bacto Agar, Difco) 
  
NB medium (1 l) 8g Bacto NB broth, dehydrated (Difco) 
 (3g Bacto Beef extract, 5g Bacto peptone) 
  
SOC medium (1 l)                                    prepare SOB in 970ml H2O: 
 prepare SOB in 970ml H2O 
 20g Bacto Tryptone (Difco) 
 5g Yeast-extract (Difco) 
 0.5g NaCl 
 1.25ml 2M KCl 
 adjust pH 7.0 with NaOH 
 autoclave, add 10ml 1M MgCl2 
 for SOC add 19.8ml 20% glucose 
  
MacConkey lactose  
indicator plates (1 l) 50g
 
MacConkey agar with lactose (Difco) 
  
BTB indicator plates 
(Schaefler, 1967) 15g
 
Bacto Agar (Difco) 
 1g Yeast-extract (Difco) 
 1g Tryptone (Difco) 
 5g NaCl 
 add 900ml H2O, autoclave 
 add sterile: 
 1ml 1M MgSO4 
 1ml 0.1M CaCl2 
 1ml Vitamin B1 (stock solution 1mg/ml, filter 
sterilized) 
 0.5ml 1mM FeCl3 
 20ml 10% (w/v) Casaminoacids 
 50ml 10% (w/v) (Salicin or Cellobiose or Arbutin or 
Esculin, filter sterilized) 
 10ml Bromthymol blue stock solution (2% BTB in 
50% ethanol, 0.1N NaOH) 
 adjust colour with NaOH 
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M9 Medium  
(Miller, 1972)                                       prepare 20X M9 (stock solution): 
 140g Na2HPO4 x 2 H2O 
 60g KH2PO4 
 20g NH4Cl 
 H2O to 1 l 
  
                                                             M9 medium (prepare from sterile solutions): 
 50ml 20x M9 
 1ml 0.1M CaCl2 
 1ml 1M MgSO4 
 0.5ml 1mM FeCl3 
 1ml Vitamin B1 (stock solution 1mg/ml) 
 66ml 10% Casamino acids 
                                                             carbon source 0.5% final concentration: 
 25ml 20% Glucose 
 or 6.25ml 80% Glycerol 
 H2O to 1 l 
      
3.  Antibiotics  
 
Antibiotics stock storage final conc. 
Ampicillin 50mg/ml in 50% ethanol -20°C 50µg/ml 
Chloramphenicol 30mg/ml in ethanol -20°C 15µg/ml 
Kanamycin 10mg/ml in H2O +4°C 25µg/ml 
Spectinomycin 50mg/ml in 30% ethanol  -20°C 50µg/ml 
Tetracyclin 5mg/ml in 70% ethanol -20°C 12µg/ml 
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4.  General Methods 
 
      The molecular biology methods like restriction enzyme digestions, ligations and other 
enzyme reactions, PCR, plasmid DNA purification, auto-radiography were performed as 
described (Sambrook et al., 2001; Sambrook et al., 1989) or according to the manufacturer 
instructions, unless otherwise stated.  Large scale preparations of plasmid DNA were performed 
using the plasmid maxi kit (Qiagen or Promega) according to manufacturer instructions. 
 
5.  E.coli isolates and growth conditions 
 
     The E.coli K-12 strains used in this study are listed in Table 5 (Appendix). 98 clinical E.coli 
isolates comprising of 52 commensals, 22 uropathogenic and 24 septicemic were obtained from 
Dr. Georg Plum, Institute for Medical Microbiology, University of Cologne, Germany (Table 6a, 
Appendix). All these 98 isolates are isolated from human sources and were obtained from the 
local hospitals. Septicemic strains are isolates from the blood of the patients with septicemia. 
Uropathogenic strains are isolates from urine samples of patients with urinary tract infections and 
commensal strains are isolates from the stool samples of healthy individuals. The septicemic 
strain E.coli i484 was a kind gift from Dr. Richard E. Isaacson, Department of Veterinary 
Pathobiology, University of Illinois, Urbana, Illinois, USA (Table 6a, Appendix). The 72 ECOR 
(E.coli reference collection) strains that comprises of 29 commensals from humans, 32 
commensals from animals (Zoo and domesticated), 10 uropathogenic and 1 asysmptomatic 
bacteriuria strain were obtained from STEC (Shiga Toxin-producing Escherichia coli) Center, 
Michigan State University, MI, USA (Table 6b, Appendix). Strains were grown in Luria-Bertani 
(LB) liquid/agar medium (Miller, 1972) and preserved as DMSO stocks (1.5ml of overnight 
grown culture in LB medium + 50µl DMSO) at -80°C. Where necessary, antibiotics were added 
to final concentrations as mentioned (see materials and methods 3). 
 
6.  PCR analysis of the bgl/Z5211-Z5214 locus in E.coli isolates 
 
     Oligonucleotides used in this study are listed in Table 4 (Appendix).  To analyze the genetic 
diversity of the E.coli isolates at the bgl/Z5211-Z5214 locus, a PCR strategy was designed based 
upon the use of the published MG1655, CFT073, O157-EDL933 and Sakai genome sequences. 
The mapping positions of the PCR primers used in the bgl/Z5211-Z5214 locus analysis are 
schematically shown in Figure 37. PCR reactions were performed either with single colony 
suspension or with the plasmid constructs of the respective strains as templates (Table 8, 
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Appendix). The strains were analyzed by PCR with various bgl specific primers to see whether 
they carry the bgl operon. In the strains that carry the bgl operon the sequence of the upstream 
region (phoU gene), bgl promoter region and the downstream region (yieJIH) was determined.  
To analyze whether the strains carry an intact bgl operon long PCR (using Elongase, Invitrogen, 
Germany) with oligos mapping in the phoU and yieH genes was performed (Table 4, Appendix). 
PCR products were analyzed in comparison to the expected PCR product sizes in MG1655 and 
i484 (like CFT073). Strains that do not carry the bgl operon were analyzed by PCR with Z5211-
Z5214 specific primers (strains in Table 6b, Appendix) or with ST-PCR (strains in Table 6a, 
Appendix). ST-PCR products were sequenced. The presence of intact Z5211-Z5214 region in all 
the strains was analyzed by long PCR. 
     The strains that showed differences in the long PCRs in comparison to the expected PCR 
product sizes of MG1655, CFT073 and O157 were analyzed further with several internal PCRs to 
map the possible deletion or insertion points. An example of such an analysis is shown in Figure 
14 (Results).  The relative PCR products (e.g., as described in Fig. 14, Results) were sequenced 
from both the ends. Details of the PCR analysis are shown in Table 6 (Appendix). 
 
 
Figure 37:  Schematic presentation of the oligos mapping positions in MG1655, CFT073 bgl region and in 
O157 Z5211-Z5214 region. Oligos are shown with black arrows and arrowhead indicates the direction of the oligo 
from 5’ to 3’. MG1655, CFT073 and O157 bgl/Z5211-Z5214 region is shown as in Figure 4 (Introduction). 
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7. ST-PCR (Semi-Random PCR) 
 
     ST-PCR is a semi-random two step PCR method that involves two successive PCR reactions 
and two pairs of PCR primers. This method is simple and very specific to identify the novel DNA 
sequences next to previously known sequences (Chun et al., 1997). Chun and co-workers (1997) 
have used ST-PCR to identify genes that are mutated in miniTn3 mutagenesis. In brief, in the 
first reaction, one primer anneals to the end of the transposable element, while the other contains 
a specific 20-nucleotide sequence followed by ten bases of degenerate sequence and a specific 
five-nucleotide sequence. A subset of these degenerate primers anneals to an unknown DNA 
sequence near the transposable element and allows initial amplification. The second pair of 
primers anneals to specific DNA sequences, one from the transposable element and the other 
from the 20-nucleotide sequence in the semi-random primer resulting in the amplification of a 
specific PCR product.  
     In the current study ST-PCR was employed for two reasons: a) to identify the genes that are 
mutated in the miniTn10-cmR mutagenesis (also see 8, materials and methods) and b) to identify 
the presence of Z5214-Z5211 in the bgl/Z5214-Z5211 locus. Oligos used for ST-PCR are listed 
in Table 4 (Appendix). The ST-PCR approach to map the miniTn10-cmR insertions is 
schematically shown in Figure 38. In brief, the first round of PCR reaction (PCR1) was 
performed in a 20µl reaction volume with a combination of degenerate primer S360 composed of 
20 bases of defined sequence, followed by ten random bases, followed by the bases GATC (four-
nucleotide sequence GATC was used because of its higher frequency in the E.coli genome) 
(modified from (Chun et al., 1997) and with primer S357 (or S358) that maps in the miniTn10-
cmR cassette. PCR1 reaction mix was then diluted to 1:5 times with water to 100µl. 1µl from the 
diluted mix was used as template in the second round of PCR reaction (PCR2) performed in a 
20µl reaction volume with S361 (anneals to the complement of the 20 bases of defined sequence 
at the 5’ end of primer S360) and S359 (nested primer in the miniTn10-cmR cassette). The 
obtained PCR products were later sequenced with S359.  
 
Figure 38: Summary of ST-PCR (modified from Chun et al., 1997). The miniTn10-cmR insertions in the 
chromosome can be screened by ST-PCR. Briefly, PCR 1 is performed with S357/S360 or S358/S360 followed by 
PCR2 reaction with S359/S361. The obtained PCR products were sequenced with S359. 
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The PCR conditions for PCR1 and PCR2 are as described in (Chun et al., 1997). To identify the 
presence of Z5211-Z5214 region, briefly, the first round of PCR reaction (PCR1) was performed 
with a combination of degenerate primer S360 and the specific primer that map in phoU (S145) 
or yieH (S412) gene. The second round of PCR reaction (PCR2) was performed with S361 and 
nested primers in phoU (S373) or yieH (S413). The obtained PCR products were later sequenced 
with primers mapping in phoU or yieH gene. 
 
8.  miniTn10-cmR mutagenesis  
 
     The miniTn10-cmR mutagenesis was performed with plasmid pKESK18 (pSC101 derivative). 
Plasmid pKESK18 is repts, carries a miniTn10-cmR transposon, and the Tn10 transposase gene 
driven by the phage λ pR promoter (Fig. 39). The transposase expression is repressed at 28°C by 
the temperature sensitive cI-857. However, at 42°C the cI-857 repressor is inactive.  Hence, at 
42°C the transposase is expressed, leading to the transposition of the miniTn10-cmR transposon. 
Concomitantly, the plasmid is lost as it does not replicate owing to the Repts protein. 
day 1: 
* transform the strain (to be mutagenised) with the plasmid pKESK18, select transformants at 
28°C on LB kanamycin + chloramphenicol plates 
day 2: 
* pick single colony from the transformants and inoculate into 3ml LB with kanamycin and 
chloramphenicol. Grow overnight at 28°C 
day 3: 
* prepare 10-4, 10-6 and 10-7 dilutions of the overnight culture to a final volume of 2 ml in 
sterile Mg-saline  
* from 10-4 dilution, plate 100µl of the diluted cells on  LB-chloramphenicol plates and incubate 
at 42°C (plates are pre warmed to 42°C before plating the cells). In parallel, for determining 
the cell titer, plate 200µl from 10-6 and 10-7 dilutions on LB kanamycin + chloramphenicol 
plates and incubate at 28°C 
* replica plate the colonies on BTB Salicin-chloramphenicol plates and in parallel check for 
kans 
* characterize the miniTn10-cmR insertions by ST-PCR (Fig. 38, see materials and methods 7) 
 
 
            
Figure 39: Schematic presentation of 
plasmid pKESK18. Refer to text for more 
details. Primers used in ST-PCR are shown 
as listed in Table 4 (Appendix). 
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9.  DNA sequencing and sequence data analysis 
 
     DNA sequencing was performed with the Big dye terminator cycle sequencing kit (version 1.0 
or 3.0, ABI Prism) according to the manufacturer’s instructions and using an automated DNA 
sequencer. The details of the sequence information’s are documented in the lab records. 
Homologues searches were performed with BLASTN (National Center for Biotechnology 
Information) and with Fasta3 (European Molecular Biology Laboratory). Nucleotide Sequence 
alignments and amino acid sequence alignments were performed using Vector NTI programme.  
 
10.  Statistical tests 
 
     Statistical correlations were calculated by Chi square tests and Fishers Exact test using the 
online resources available at http://www.georgetown.edu/faculty/ballc/webtools/web_chi.html 
and  http://www.unc.edu/~preacher/fisher/fisher.htm  respectively. 
 
11. Preparation of competent cells and transformation (CaCl2 method) 
 
TEN buffer: 20mM Tris-HCl pH 7.5, 1mM EDTA, 50mM NaCl 
* grow cells in 25ml LB medium till OD600=0.3 
* centrifuge at 3000rpm and re-suspend the cell pellet in 12.5 ml ice cold 0.1M CaCl2 
* incubate on ice for 20 minutes 
* centrifuge again and re-suspend pellet in 1ml ice cold 0.1M CaCl2 
* use 100µl of these cells for transformation 
* add 1-10ng of the plasmid or 10µl (=1/2) of the ligation mix to be transformed into the pre-
cooled eppendorf tube and make up the volume to 50µl with TEN buffer. Cool the mix on 
ice. 
* add 100µl of competent cells and incubate on ice for 20 minutes 
* heat-shock at 42°C for exactly 2 minutes 
* incubate on ice for 10 minutes 
* add 1ml LB medium and shake at 37°C for 1 hour 
* plate 100µl on suitable selective plates 
 
 
12. Preparation of electrocompetent cells and electroporation 
 
* inoculate 3ml LB with a single (fresh O/N) colony. Shake at 37°C overnight 
* from overnight grown culture inoculate 200µl to 50ml fresh LB medium in 250ml conical 
flask 
* grow cells (37°C in a shaker) to an OD600 of 0.6-0.7 
* place the flask with the culture on ice for 1hr 
* transfer culture to sterile, prechilled centrifuge tubes (50ml Blue capped tubes) 
* centrifuge the cells at 3000rpm for 15 minutes at 4°C. Decant the supernatant. 
* re-suspend the pellet in approximately 50ml of cold (0-4°C) sterile water 
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* centrifuge cells at 3000rpm for 15min at 4°C and decant the water carefully without 
disturbing the pellet. Place tubes back on ice 
* re-suspend the pellet in approximately 25ml of cold (0-4°C) sterile water 
* centrifuge cells at 3000rpm at 4°C 15min. Decant the water and place tubes back on ice. 
* using glass pipette re-suspend cells in 2ml cold sterile 10% glycerol. 
* centrifuge cells at 6000rpm for 15min at 0-4°C. Decant the supernatant and place tubes back 
on ice. 
* re-suspend pellet in 200µl cold sterile 10%glycerol. 
* take 40µl from this for single transformation, alternatively cells can be frozen and stored at -
80°C (see below) 
* incubate cells for at least 1 additional hour on ice 
* make aliquots: 40µl in ice-cold eppendorf tubes 
* freeze in liquid N2, store at -80°C 
 
Electroporation: 
* prechill the electrocuvettes on ice 
* if case of frozen electrocompetent cells: thaw cells slowly on ice 
* prepare Eppendorf-tube on ice with plasmid DNA (free from salts) 
* add 40µl of competent cells  
* incubate for 10minutes 
* transfer the mixture (DNA + Competent cells) into the prechilled Electrocuvettes near 
Electroporator 
* electroshock at 1.8kv for 3seconds 
* remove the Electrocuvette immediately and add 1ml of SOC medium as quickly as possible 
into the cuvette 
* transfer the medium from the cuvette into the test tube and incubate for 1hr at 37°C 
* plate 100µl on suitable selective plates 
 
13. Plasmids and DNA fragments 
 
      A brief description of plasmid constructions can be found in Table 8 (Appendix). Details of 
plasmid constructions are documented in the lab records and sequences compiled in Vector NTi. 
     A series of plasmids starting with pKEGN1 were constructed which have a pACYC (p15A) 
replication origin (Fig.40). The starting material was a similar plasmid with MG1655 bgl 
(pKES15). They have λ phage attachment site (attP) cloned into them that allows the λ integrase 
mediated recombinational insertion into the chromosomal attB site of E.coli (Diederich et al., 
1992). These plasmids also have a Ω cassette which contains the Spectinomycin resistance gene, 
aadA and strong transcriptional terminators at its 3’end. As seen in Figure 40, plasmid pKEGN1 
has convenient restriction enzyme sites which could be used to replace the bgl construct with a 
different construct.  For integrations into the chromosomal attB site, these plasmids were cut with 
BamHI (in some cases BglII) and the originless fragment containing the Spectinomycin resistance 
gene and the gene(s) of interest was used for insertion into the attB site as described (see 
materials and methods, 14).   
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14.  Integration of plasmids in the attB site of E.coli chromosome (Diederich et al., 1992; 
Dole et al., 2002) 
 
* transform the recipient strain with helper plasmid pLDR8 and select on LB Kanamycin plates 
at 28°C 
* inoculate 3-4ml LB Kanamycin medium in glass tubes from a fresh single colony of the 
strain/pLDR8-plates 
* shake culture over night at 28°C 
* inoculate 25ml LB Kanamycin medium in 100ml Erlenmeyer flask with 1.25ml (1:20 
dilution) of the fresh over night culture 
* shake culture at 37°C for 90 minutes 
* prepare competent cells using the CaCl2 method 
* cut 5µg of the plasmid containing the construct to be integrated with BamHI or BglII (10U 
per 100µl) incubate overnight at 37°C 
* run on agarose gel and extract the originless fragment using Qiagen gel extraction kit 
* use 10ng BamHI (or BglII) fragment for re-ligation in 20µl total volume 
* transform the competent cells prepared as above using 10µl (=1/2) of BamHI (or BglII) re-
ligation reaction 
* plate: 2 x 0.2ml on LB Spectinomycin plates and if appropriate 1x 0.2ml on MacConkey 
lactose Spectinomycin plates 
* incubate plates at 42°C over night 
testing of clones via PCR: 
* pick a colony and resuspend the cells in 100µl H2O 
* use the PCR-primer: S93/S164: to test the attB/P`-side 
                                        S95/S96: to test the attP/B`-side 
                                        S95/S164: to see integrations of dimers 
                                        suitable primers to the test the cloned fragment 
 
15.  β-galactosidase assay (Miller, 1972) 
 
Z-buffer 60mM Na2HPO4, 40mM NaH2PO4, 10mM KCl, 1mM MgSO4, 100µg/ml 
Chloramphenicol, pH 7.0 
Figure 40: Schematic representation 
of plasmid pKEGN1.  The starting 
material for this plasmid was a similar 
plasmid with MG1655 bgl. This plasmid 
and later plasmids based on the same 
principle carry a λ phage attachment site 
attP for integration into the E.coli 
genome. Resistance markers for 
Spectinomycin (aadA) and Kanamycin
(neo) are shown.  Plasmid pKEGN1 has 
E10085-Pbgl-t1-bglG-lacZ construct. 
This plasmid can be conveniently 
replaced with a different constructs to 
generate a series of plasmids used in the 
study.  Restriction sites used for cloning 
(SalI-XbaI) are indicated. 
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Na2CO3 1M 
ONPG 4 mg/ml  in 0.1M phosphate buffer pH 7.0 
SDS 0,1 % (w/v) 
chloroform  
 
day 1:  
* prepare overnight cultures (3-4 ml) in minimal media M9 with necessary supplements as 
required e.g. glycerol or other carbon sources, casamino acids, thiamine, antibiotics etc. or LB 
medium with necessary supplements as required 
day2: 
* measure the OD600 of the overnight cultures diluted 1:5 
* inoculate 8 ml cultures to an OD600 of 0.1 in 100 ml conical flasks 
* in case of induction add 1mM IPTG and/or 0.2% (w/v) Salicin (or Cellobiose or Arbutin or 
Esculin) 
* grow cultures to OD600=0.5 at 37°C  
* harvest the cultures on ice 
* to perform enzyme assay prepare appropriate 1ml dilutions from the cooled cultures in ice 
cold Z-buffer (at least 3 dilutions in duplicates were prepared) 
* add 10µl 0.1% (w/v) SDS and 20µl chloroform to all dilutions  
* set up blanks with 1 ml Z-buffer in four separate 2 ml Eppendorf-tubes 
* vortex the probes for 15 seconds and then immediately pre-incubate them for 10 minutes at 
28°C 
* start the reaction by adding 0.2 ml ONPG with multi-pipette and mix  
* stop the reaction after 30 minutes by adding 0.5 ml 1M Na2CO3 (or later, when the color turns 
to a strong yellow, note exact time) 
* centrifuge the probes for 5 to 10 minutes at room-temperature and measure the OD420 
calculate the enzyme activity in Miller units as: 
       1 unit = OD420   x dilution factor x 1000 
                           OD600   x time (minutes) 
 
16. β-glucosidase assay 
 
Z-buffer 60mM Na2HPO4, 40mM NaH2PO4, 10mM KCl, 1mM MgSO4, 100µg/ml 
Chloramphenicol, pH 7.0 
Na2CO3 1M 
PNPG 8mg/ml  in 0.1M phosphate buffer pH 7.0 
 
day 1: 
* grow bacteria in (3-4ml) in minimal media M9 medium with necessary supplements as 
required e.g.: glycerol, casamino acids, thiamine, antibiotics etc.  
day 2: 
* measure the OD600 of the overnight cultures diluted 1:5 
* inoculate 8 ml cultures to an OD600 of 0.1 in 100 ml conical flasks 
* for induction add 0.2% (w/v) Salicin 
* grow cultures to OD600=0.5 at 37°C  
* harvest the cultures on ice 
* to perform enzyme assay prepare appropriate 1ml dilutions from the cooled cultures in ice 
cold Z-buffer (at least 3 dilutions in duplicates were prepared) and set up four blanks with 1 
ml Z-buffer 
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* pre-incubate them for 5 minutes at 37°C 
* start the reaction by adding 0.2 ml PNPG (with multipipette), mix and incubate at 37°C  
* stop the reaction after 30 minutes by adding 0.5 ml Na2CO3 after 30 minutes (or earlier, when 
the color turns to a strong yellow, note exact time). 
* centrifuge the samples for 5 to 10 min at room-temperature and then measure the OD410  
* calculate the enzyme activity in as: 
       1 unit = OD410   x dilution factor x 1000 
                           OD600   x time (minutes) 
 
17. Construction of ∆cyaA strains by T4GT7-transduction 
 
* inoculate strains S2180, S2182, S2184 and S2186 into LB medium containing Spectinomycin 
* mix 100µl of a fresh overnight cultures with 10µl, 5µl and 2µl T4GT7 lysate (prepared from 
strain S632 (∆cyaA::kan), lab collection)  
* incubate for  20' at room temperature 
* plate entire mix onto LB plates containing Kanamycin for selection of the transductants 
* re-streak colonies several times to get rid of  contaminating T4GT7 phages 
* test the clones via PCR with S502/S503 (expected PCR product size: ~1.9kb). 
 
18. Isolation of Genomic DNA 
 
Mg-Saline 0.85% NaCl, 10mM MgSO4 
Solution I 50mM Glucose, 25mM Tris-Cl pH-8.0, 10mM EDTA, 
1mg/ml Lysozyme 
Lysis buffer 1M NaCl, 25mM Tris-Cl, pH 7.5, 10mM EDTA,  
4% SDS 
TE buffer 10mM Tris-Cl pH 8.0, 1mM EDTA 
 
* spin down 10 ml fresh overnight grown culture (5000 rpm; 10 min) 
* wash 1x with Mg-Saline 
* resuspend in 1 ml Solution I and add lysozyme. Incubate for 10-15min at room temperature 
* add 2ml Lysis buffer and mix by inversion and incubate for 5min at room temperature 
* add 10µl RNase and mix by inversion and incubate at 65°C for 15min 
* add 200µl Proteinase K and mix by inversion and incubate at 37°C for 15min 
* add 1 volume of Phenol/Choloroform (1:1) and mix by inversion, transfer to new tube and 
spin to separate aqueous and organic phases 
* transfer the upper phase to a fresh tube using cut off end (blunt) pipetting tips and add 2-3 
volumes of Ethanol 
* wind out DNA carefully 
* resuspend in 500µl TE  
* add 20µl RNase and incubate at 37°C for 10 min 
* add 5µl Proteinase K and incubate at 37°C for 10 min  
* extract with 1 volume of Phenol/Chloroform, spin and transfer upper phase to a fresh 
Eppendorf tube with cut off end (blunt) tips and add 2 volumes of Ethanol. 
* wind out DNA as above. 
* dry under vaccum for few minutes 
* resuspend in 250µl TE. 
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19. Southern hybridization (modified from Sambrook and Russell/Current protocols) 
 
depurination solution 0.125M HCl 
denaturation solution 1.5M NaCl, 0.5M NaOH 
neutralisation solution 1M Tris, 1.5M NaCl 
20x SSPE (1 l) 2.4M NaCl, 0.16M NaH2PO4. H2O, 16mM EDTA in 800ml of 
H2O, adjust pH to 7.4 with NaOH (~6.5 ml of a 10N solution), 
make up the final volume to 1 l with H2O, sterilize by 
autoclaving  
 
50x Denhardt’s reagent  1% (w/v) Ficoll (Type 400), 1% (w/v) polyvinylpyrrolidone, 1% 
(w/v) bovine serum albumin 
 
pre-hybridization buffer 5x Denhardt’s reagent, 5x SSPE, 0.5% (w/v) SDS, 100µg/ml  
Salmon sperm DNA (ssDNA) (100µl from 100mg/ml stock 
solution, boiled for 10min and chilled on ice for 5min before 
adding) 
 
washing solutions:         Buffer A 2x SSPE + 0.1% SDS 
                                        Buffer B 2x SSPE + 0.5% SDS 
                                        Buffer C 1x SSPE + 0.1% SDS 
                                        Buffer D 2x SSPE 
 
10µg of the genomic DNA was digested with appropriate restriction enzymes (20U) in a volume 
of 100µl. Incubate overnight at 37°C. The samples were loaded onto 0.7% agarose gel and 
electrophoresis was carried out by running the gels in low voltage (40-60volts) in TAE buffer. 
Following the electrophoresis, DNA samples in the gel were visualized in UV light along with 
the fluorescent rulers placed adjacent to the gel and photographed. The gel was then processed 
for depurination by submerging the gel in depurination solution for 10-20 min with gentle 
agitation, followed by denaturation for 15-30 min and neutralization for 15-30 min with gentle 
agitation at room temperature. The fragments were transferred to uncharged nylon membrane 
(Amersham Biosciences, Germany) by ascending capillary method in 20x SSPE transfer buffer 
(Sambrook et al., 2001). Briefly, the uncharged nylon membrane was placed on top of the gel and 
both the gel and membrane were sandwiched in between 4-5 Whatman filter papers (type 3MM). 
This setup was then placed on the wick (long Whatman filter paper) that runs on a solid support 
and in contact to the buffer 20x SSPE. A 500ml water bottle was placed above the complete 
apparatus for efficient transfer of DNA. The transfer of DNA was allowed for 8-24 hours. To fix 
the DNA, the membrane was incubated for 30 min to 2 hours at 80°C in a vaccum oven. The 
membrane was pre-hybridized with pre-hybridization solution at 68°C for 2-8hrs in hybridization 
bottles. Pre-hybridization was followed by hybridization to α32-P dCTP specific probes (prepared 
using Ready To Go DNA labeling kit, Amersham) at 68°C for 8-12hrs.  Following hybridization 
the membrane was washed in Buffer A for 3 min at room temperature, Buffer B for 15 min at 
room temperature, Buffer C for 30 min at 65°C, and Buffer D for 10 min at room temperature 
with gentle agitation. The membrane was then dried and exposed to X-ray film with an 
intensifying screen for 16-24 hours at room temperature to obtain an auto-radiographic image. 
The bgl region specific probes were generated either by PCR with MG1655 cells using bgl region 
specific primers or by restriction digestion of the plasmids pFDY52 and pFDX733 (Schnetz et 
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al., 1987). Detailed description of the positions of probes and the genomic digests used for 
Southern hybridization are shown in Figure 11 (Results). 
 
20. Construction of i484∆bgl strain (Ec93)  
 
      The strain Ec2 (i484 Bgl+ mutant) that carries an activated bgl operon with a ∆47 bp in the 
silencer-bgl promoter region was transformed with plasmid pFMAC11 (repts-tetR, ∆bgl in bgl 
region, Caramel and Schnetz, 1998). The tranformants were selected on LB plate with 
Tetracycline at 28°C. Single colony was inoculated into LB medium with Tetracycline and was 
grown overnight at 28°C. The grown culture was plated on LB plate with Tetracycline at 42°C (at 
this step the plasmidic construct is integrated into the chromosome). Single colonies from this 
plate were inoculated into LB medium and grown at 28°C over night (this step allows 
recombination event to occur). The grown culture is plated on BTB salicin plate at 37°C and 
screened for Bgl-. The obtained Bgl- colonies were tested for Tetracycline sensitivity and PCR 
with oligos S4/S32. 
 
21. Isolation of Bgl+ and/or Sal+ mutants 
 
      To isolate Bgl-positive mutants, cells carrying the wild-type bgl operon were plated on BTB-
salicin plates and incubated at 37°C or 28°C. Bgl+ papillae were picked after 2-4 days of 
incubation at 37°C or 28°C and re-streaked on BTB-salicin plates for purification.  Expect from 
the strains that show relaxed phenotype all the spontaneous mutants were isolated at 37°C. 
Spontaneous mutants from the strains that show relaxed phenotype were isolated at 28°C. To 
characterize the mutation that caused activation, the bgl promoter region was amplified by PCR 
and the fragments were sequenced.  
 
     The c1955-c1960 salicin-positive mutants (Ec131 to Ec134), the strain Ec93 (i484 ∆bgl) 
carrying wild-type c1955-c1960 system was plated on BTB-salicin plates and incubated at 28°C. 
Sal+ papillae were picked after 5 days of incubation at 28°C and re-streaked on BTB-salicin 
plates for purification. The four isolated Sal+ mutants also show Cel+ (cellobiose-positive), Arb+ 
(arbutin-positive) and Esc+ (esculin-positive) phenotype on respective BTB indicator plates at 
28°C. Schematic presentation of the isolation of c1955-c1960 mutants are shown in Figure 23 
(Results).  
 
22. Microscopy for imaging β-glucoside utilization phenotypes 
 
      For imaging the phenotypes of the E.coli strains, strains were streaked on Bromthymol blue 
(BTB) salicin (β-glucoside) indicator plates and phenotypes were documented up to 5 days of 
incubation using a Stereomicroscope Zeiss stemi 2000-C Microscope. For processing images 
Adobe photoshop and/or CorelDRAW was used. 
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Table 4: Synthetic oligonucleotides used in the present study 
namea sequenceb positionc or reference 
S4 GGATGGACATTGACGAAGC phoU: 443 to 461 
S5 GGATTGTTACTGCATTCGC bgl: +42 to +60 
S9 TGAGGGGACGACGACAGT lac: +305 to +288 
S32 CCACTGCGGCAAGCTGAG MG1655 yieJ: 549 to 566 
S34 GGATAAACTGCTGGCGGG MG1655, O157 phoU: 690 
to 707 
S54 CCTCTAGAATTCCGCGCCCCATGACGA bgl: +224 to +205 
S91 GTGATTTGCATGTTCATAGCAAGGAC bgl: +148 to +123 
S92 CAAGAGGAATATGACTTAAGAGTTCG bgl: +342 to +317 
S94 GCTTTACTAAGCTGATCCGGTGGA pKES15: 8479 to 8502 
S95 CATATGGGGATTGGTGGCGA lac: +3009 to +3028 
S100 CATCGTAACCGTGCATCTGCCA lac: +330 to +309 
S118 TGCGGGCCTCTTCGCTATTA lac: +171 to +152 
S123 TGTGGAATTGTGAGCGGATA lac: -6 to +15 
S145 CCGGTCGACGCGTTCGCGCGGATGGACATTGACGAAGC phoU: 431 to 461 
S154 pGTGAAACCAGTAACGTTATACGATGTCG lac: -1168 to -1141 
S157 CCCGTCGACTTATAACTGCGAGCATGGTCA bgl: -76 to -55 
S165 GTAACAGTGGCCCGAAGATA MG1655, O157 lac: +3462 
to +3443 
S186 ATAACCAGAGAATACTGGTGAAGTCGGGT bgl: +75 to +103 
S201 GCGTCTCTAGAAATATTTCAGTGTTCTTTGCGCACG bgl: +974 to +950 
S212 CCTCTAGATTTTTATAACGAACATCCAGGTTCG bgl: +25 to +1 
S220 GCGGATCCATGAACATGCAAATCACCAAAATTCTCA bgl: +132 to +159 
S224 GGGGATCCACCCGCAAGCATGGCAATGT bgl: +841 to +860 
S252 AGATGCTGCACGACGTGCTGG phoU: 410 to 430 
S253 GTCACGGCAAACGAAAGCGC MG1655 bgl: +5427 to 
+5446 
S257 GCTCTAGATGCCCTCTACCGCTTTGCG bgl: +1097 to +1079 
S309 CCGTCTAGACATCGATTTTTATCACCGT bgl: +3171 to +3189 
S312 TGATCCCCGCCTGCGC bgl: +3352 to +3337 
S335 CTTCAGGATCGAGCGTAATACCA MG1655 yieH: 121 to 99 
S336 CGCGGAAAATCGTCAGTAACA yieG: 394 to 374 
S346 CCACTCTGATTTCGAATCTATTCGT bgl: +5777 to +5801 
S347 GCACAATAAGCCGATCGTTCA yieH: 567 to 587 
S348 CGGGTCACAGAAACGTTATCGT MG1655, CFT073 yieI: 219 
to 240 
S349 GTAACGACATGTTGATTTCATTAAACGT MG1655 bgl: +3529 to 
+3502 
S350 GCTGCCGCAGAATTAGCACT MG1655 bgl: +8002 to 
+8021 
S351 GGATGATGCCAGCATAGAAGGT MG1655 yieJ: 222 to 243 
S352 GAGCGGCATAACCTGAATCTGA IS1: 625-646 
S357 GGCAGGGTCGTTAAATAGCCGCTTATGT miniTn10-CmR oligo: 1180 
to 1214 
S358 CGGTATCAACAGGGACACCAGGATTTATTTATTCT miniTn10-CmR oligo: 263 to 
236 
S359 GCTCTAGAGATCATATGACAAGATGTGTATCCACCTTAACT miniTn10-CmR oligo: 70 to 
38 and 1411 to 1443 
S360 GGCCACGCGTCGACTAGTACNNNNNNNNNNGATC ST-PCR oligo, modified 
from (Chun et al., 1997) 
S361 GCTCTAGAGGCCACGCGTCGACTAGTAC ST-PCR oligo, modified 
from (Chun et al., 1997) 
S367 CGGAATTCGGGCCCGCCCTATTATAATCAACACGCTATGTAGT MG1655, CFT073 marB:  
192 to 220 
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Table 4: Synthetic oligonucleotides used in the present study 
namea sequenceb positionc or reference 
S368 CCGCTCGAGCGGCCGCGTCGACGGCGTAAAGCGGTAAAGGTCA CFT073 ydeD: 893 to 913 
S373 CCGGTCGACGCTGCCAGAATATTTGTGAGTTTATCT phoU: 613 to 640 
S374 GGTCAGCAACCCTTATATCGATACA CFT073 c1955: 1020 to 
1044 
S375 GCAGGAAGTCAGATTATGAAATTTGA CFT073 c1960: 271 to 296 
S376 CACCGTTTTCATTTTTGATGTTATCA CFT073 c1956: 295 to 270 
S377 GACCGCGTTAATTAGTCAGGATGA CFT073 c1957:168 to 191 
S401 GGGCGTTGCGGAACAAAC marB: 54 to 71 
S402 GTATTTGGTTTGCGGTGGCGTAAAGCGGT ydeD: 877-905 
S406 GCGGATCCGCAAAGCGGTAGAGGGC bgl: +1078 to +1096 
S407 TGATGATAAAGGTAATCTGCTAAACCG MG1655 bgl: +1371 to 
+1397 
S408 GCCTGGTTGTGCAGCATTCTG bgl: +1771 to +1791 
S409 GATCAGCGGCGTTGACGAG MG1655 bgl: +2171 to 
+2189 
S410 CATTCACGTCGCTGATACCACG bgl: +2571 to +2592 
S411 GCGGATCCTTTTATCGTTAGCGAATGATGG bgl: +2990 to +2966 
S412 CCATGCGGCAAAAGCGATGAATGT yieH: 447 to 470 
S413 CCGATCGTTCACCCGAAAGTCACCA yieH: 557 to 601 
S429 GGCGAAAAACTTGCTGATAATTGT bgl: +7860 to +7883 
S430 GCATGATCAATCATACGTTTAACCA CFT073 c1959: 74 to 50 
S431 GTCGCAATAGTAGGAGAAGCATCCT CFT073 c1960: 326 to 302 
S432 GCTCTAGATTTTTCCTTACTGGTATATAACAGACTACATT CFT073 AE016760: 292477 
to 292508 
S433 CCGGTCGACGAATTCTTTTGCACCTTTTAAGAGCCATT CFT073 AE016760: 292673 
to 292651 
S434 CGGGATCCGCTTAAGCGACTTCATTCACCTGA lac: +4428 to +4397 
S435 CCGGTCGACGAATGGCGCAAAACCTTTC lac: -1238 to -1219 
S436 CGGGATCCCGGTTATTATTATTTTTGACACCA lac: +3124 to +3099  
S437 CGACGGTACGCTGGTCGA yieH: 33 to 50  
S460 CTTCGGTAACCGGACCTTGC MG1655 bgl: +7942 to  
+7923 
S463 AGTGCCTGACAGCTACGTGACG bgl: +7815 to +7836 
S467 CAATCCTTTACTCAGTAAGCTTAACCGAGTGCTAATTCTGC MG1655 bgl: +8033 to 
+8008 
S479 CCGTCGACCCACCAGCAAATGAGCCGTGTCGCGG bgl: +7337 to +7354 
S490 CGGAATTCGTAGTCTGTTATATACCAGTAAGGAAAAATATGA CFT073 AE016760: 292505 
to 292472 
S491 GCTCTAGACCGTTTGATTTAAATCACATGGGTA marB: 132 to 160 
S502 CCGTGGTCCATCCTAACATCCT cyaA AE000456: 7930-7951 
S503 CATTATTCCGGTGACGGATGAATC cyaA AE000456: 11315-
11292 
S536 CTGAATGCTAAAGCGGCAGATC bgl: +6848 to +6869 
S537 CAGTGGCTTGGGATGATATTTGA MG1655 yieJ: 32 to 54 
S545 CTGTTGCCCGTCTCACTGGT lac: -217 to -198 
S546 CTGTCCTGGCCGTAACCGA lac: +535 to +517 
S547 CGCTTAGTTTTTCATTATCATTAGGGA O157 Z5214: 481-455 
S548 GTCGATTGTGATGATAAAATACGTTCT O157 Z5211: 2248-2274 
S560 GCGAAGGAAGCCTCACAAGA bgl: +4304 to 4323 
S561 CCCGTTATTATCCTGATTATCTTTTTC bgl: +5477 to +5451 
S562 GTCGTTACACGCGCCATTCAC bgl: +3522 to 3542 
S563 CGGGTGAATATTGTCCGGAAC bgl: +6346 to +6326 
S564 CCGTAGCGCTTAGACATTTGTGA bgl: +4273 to 4252 
S565 GCGTTCCAGAATGCTGCACA bgl: +1797 to 1778 
S566 GCTGGTTCGGTGATACCAAACA bgl: +2213 to 2192 
Appendix                                                                                                                      93 
 
a:  name of the oligo in the lab collection 
b: sequence is shown from 5’ to 3’ end. P indicates 5’ phosphate. Restriction enzyme sites are underlined; overhangs 
are in italics. 
c: Oligo mapping positions are indicated. Numbering in bgl and lac are relative to the transcription start of the bgl 
operon and lac operon respectively. Wherever relevant, oligos mapping specifically to K-12 MG1655 sequence are 
prefixed with MG1655. Likewise oligos specific for the CFT073 sequence are prefixed with CFT073 and those 
specific for O157 sequence are prefixed with O157. Oligos that are not prefixed maps to all the four published 
sequences. Un-prefixed bgl oligos maps to both MG1655 and CFT073 bgl operon. Numbering in phoU, yieJIHG, 
c1955-c1960, marB, ydeD are relative to their respective translational start. Positions of the oligos S250, S302, S432, 
S433 and S490 are relative to the NCBI accession numbers. Numbering in IS1 is relative to the defined left and right 
ends of the insertion element (Grindley, 1978). Additional descriptions and strategies when used for cloning are 
documented in lab records.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
Table 4: Synthetic oligonucleotides used in the present study 
namea sequenceb positionc or reference 
S579 GACCGCATTTGCCGTTCTAC CFT073 c1956: 603 to 584 
S580 CGCCAGCCACCATATTTTGT CFT073 c1955: 440-421 
S581 GCCGTAAAACAGAAGTCAGCATC CFT073 c1956:1102-1080 
S586 GGTTCTTTGGGTGATAATACATCCA MG1655 yieI: 111-135 
S587 CTTTTGGTAATAATACAGGTACTTCCATTGT CFT073 yieI: 115-145 
S588 CCGGTTACCGAAGATGTTCCA MG1655 bgl: +7930 to 
+7950  
S589 CATTTTTGTGGCAATCTGCCA CFT073 bgl:  +7692 to 
+7712 
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Table 5: E.coli K-12 strains used in the study 
straina relevant genotype or structureb constructionc/ 
reference 
 
S49 
 
CSH50 bgl° ∆ (lac-pro) ara thi 
 
(Miller, 1972) 
S157 CSH50 bglR::IS1  (Schnetz, 1992) 
S162 CSH50 ∆ bgl-AC11 (caramel and Schnetz, 1998) 
S432 CSH50 (=S49) Bgl+ bgl-CAP-C234 (C-66ÆT) (Schnetz, 2002) 
S484 CSH50 bgl° ∆ (argF-lac) U169 Pro+ (Dole et al., 2002) 
S486 CSH50 (gpt-lac)-positive (Dole et al., 2002) 
S524 = S486 ∆ lacZ-Y217 (Dole et al., 2002) 
S527 MG1655 laboratory strain K-12 (Blattner et al., 1997) 
S541 CSH50 ∆bgl-AC11 ∆lacZ (Dole et al., 2002) 
S614 = S541 hns::ApR lab collection 
S632 = lambda-, e14-, relA1, spoT1, ∆(cyaA1400)::kan thi-1 (Shah and  Peterkofsky, 
1991) 
S887 =S541 rpoS::Tn10   (Dole et al., 2002) 
S996 = S524 ∆crp zhd::Tn10  lab collection 
S2180/1 =S541 attB:: specR Ec93-Pc1955-c1960-lacZ x pKEGN46 
S2182/3 =S541attB:: specR Ec134-Pc1955-c1960-lacZ x pKEGN48 
S2184/5 =S541 attB:: specR Ec93-c1960-Pc1955-c1960-lacZ x pKEGN51 
S2186/7 =S541attB:: specR Ec134-c1960-Pc1955-c1960-lacZ x pKEGN52 
S2272/3 =S2180 ∆cyaA::kan  x T4GT7 S632 kanR 
S2274/5 =S2182 ∆cyaA::kan  x T4GT7 S632 kanR 
S2276/7 =S2184 ∆cyaA::kan  x T4GT7 S632 kanR 
S2278/9 =S2186 ∆cyaA::kan  x T4GT7 S632 kanR 
 
a: Strain names in the lab collection. Strain numbers of duplicates of the respective strains are indicated with /.  
 
b: The relevant genotype of the constructed CSH50 derivatives refers to the bgl, lac, c1955-c1960, cyaA, crp, hns 
and rpoS loci. Mutations causing activation of the silent bgl operon include bgl-CRP (a C to T exchange in the CRP 
binding site at position -66, relative to the transcription start), bglR::IS1 (integration of IS1 in orientation II 
generating a target site duplication from -88 to -80). Pc1955-c1960 indicates the putative promoter region from c1955-
c1960 system (position relative to CFT073 AE016760: 292674-292476).  
 
c: Transductants (using T4GT7) of cyaA::kan alleles were selected on LB plates containing kanamycin. Integrations 
into attB were performed as described (see materials and methods) (Diederich et al., 1992). 
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Table 6a: clinical E.coli isolates used in the study 
Straina original 
strain 
nameb 
strain 
typec 
typingd bgl/Z5211-
Z5214 
upstream 
sequencee 
bgl/Z5211-
Z5214 
locusf 
yieJ 
PCRg 
5'-yieI h bgl/Z5211-
Z5214 
downstream 
sequencei  
mutationsj Sal 
Phenotype 
37°Ck 
  
 
28°C 
c1955-
c1960l 
Lac 
Phenotype 
37°Cm 
lac 
genotypen 
Ec1 i484  sept CFT073 CFT073 CFT073 CFT073 CFT073 CFT073   +++ ++ + +  
Ec9 F1 sept CFT073 CFT073 CFT073 CFT073 CFT073    +++   + +  
Ec11 F385 sept CFT073 CFT073 CFT073 CFT073 CFT073    +++   + +  
Ec13 F560 sept CFT073 CFT073 CFT073 CFT073 CFT073    +++   + +  
Ec28 W7483 sept CFT073 CFT073 CFT073 CFT073 CFT073    +++   + +  
Ec35 U2388 uro CFT073 CFT073 CFT073 CFT073 CFT073    +++   + +  
Ec36 U2873 uro CFT073 CFT073 CFT073 CFT073 CFT073    +++   ∆ c1956-
c1960 
+  
Ec42 U3362 uro CFT073 CFT073 CFT073 CFT073 CFT073    +++   + +  
Ec49 U4437 uro CFT073 CFT073 CFT073 CFT073 CFT073    +++   + +  
Ec59 E10079 com CFT073 CFT073 CFT073 CFT073 CFT073    +++   + +  
Ec73 E10091 com CFT073 CFT073 CFT073 CFT073 CFT073    +++   + +  
Ec111 E182 com CFT073 CFT073 CFT073 CFT073 CFT073    +++   + +  
Ec126 E175 com CFT073 CFT073 CFT073 CFT073 CFT073    +++   + +  
Ec116 E452 com CFT073 CFT073 CFT073 CFT073 CFT073    +++   + +  
Ec23 St5119 sept CFT073 CFT073 CFT073 CFT073 CFT073    ++   + +  
Ec38 U3145 uro CFT073 CFT073 CFT073 CFT073 CFT073    ++   + +  
Ec125 E176 com CFT073 CFT073 CFT073 CFT073 CFT073    ++   + +  
Ec129 E471 com CFT073 CFT073 CFT073 CFT073 CFT073    ++   + +  
Ec43 U3454 uro CFT073 CFT073 CFT073 CFT073 CFT073    +   + +  
Ec40 U3407 uro CFT073 CFT073 CFT073 CFT073 CFT073    +   + +  
Ec66 E10094 com CFT073 CFT073 CFT073 CFT073 CFT073    +   + +  
Ec117 E478 com CFT073 CFT073 CFT073 CFT073 CFT073  +58ct +   - +  
Ec118 E457 com CFT073 CFT073 CFT073 CFT073 CFT073    +   + +  
Ec119 E177 com CFT073 CFT073 CFT073 CFT073 CFT073    +   + +  
Ec120 E178 com CFT073 CFT073 CFT073 CFT073 CFT073    +   + +  
Ec127 E464 com CFT073 CFT073 CFT073 CFT073 CFT073    +   c1955::IS1 +  
Ec128 E466 com CFT073 CFT073 CFT073 CFT073 CFT073    +   c1955::IS1 +  
Ec100 E475 com CFT073 CFT073 CFT073 CFT073 CFT073    none ++ + +  
Ec114 E422 com CFT073 CFT073 CFT073 CFT073 CFT073 CFT073 +9ga, bglK-
::IS1397-yieI  
+   + +  
Ec20 F911 sept CFT073 CFT073 CFT073 CFT073 CFT073 CFT073 +26ca, ∆ (bglF-
yieH) ::IS1294 
none + + +  
Ec18 F785 sept MG1655 MG1655 MG1655 MG1655 MG1655    +   - +  
Ec58 E10097 com MG1655 MG1655 MG1655 MG1655 MG1655    +   - +  
Ec64 E10099 com MG1655 MG1655 MG1655 MG1655 MG1655    +   - +  
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Table 6a: clinical E.coli isolates used in the study 
Straina original 
strain 
nameb 
strain 
typec 
typingd bgl/Z5211-
Z5214 
upstream 
sequencee 
bgl/Z5211-
Z5214 
locusf 
yieJ 
PCRg 
5'-yieI h bgl/Z5211-
Z5214 
downstream 
sequencei  
mutationsj Sal 
Phenotype 
37°Ck 
  
 
28°C 
c1955-
c1960l 
Lac 
Phenotype 
37°Cm 
lac 
genotypen 
Ec69 E10082 com MG1655 MG1655 MG1655 MG1655 MG1655    +   - +  
Ec72 E10085 com MG1655 MG1655 MG1655 MG1655 MG1655    +   - -  
Ec105 E167 com MG1655 MG1655 MG1655 MG1655 MG1655  bglH::IS2 +   - +  
Ec106 E166 com MG1655 MG1655 MG1655 MG1655 MG1655    +   - +  
Ec115 E444 com MG1655 MG1655 MG1655 MG1655 MG1655    +   - +  
Ec121 E180 com MG1655 MG1655 MG1655 MG1655 MG1655    +   - +  
Ec10 F287 sept MG1655 MG1655 MG1655 MG1655 MG1655  +55at  ++   - +  
Ec21 F1215 sept MG1655 MG1655 MG1655 MG1655 MG1655  +55at, t1 (t105a) ++   - +  
Ec102 E476 com MG1655 MG1655 MG1655 MG1655 MG1655    ++   - +  
Ec70 E10090 com MG1655 MG1655 MG1655 MG1655 MG1655    none none - +  
Ec63 E10096 com MG1655 MG1655 MG1655 MG1655 MG1655 MG1655 yieJ::ISEc8 region +   - +  
Ec109 E345 com MG1655 MG1655 MG1655 MG1655 MG1655 MG1655 ∆(bglI-
bglK)::IS629, 
yieJ::IS629 
+   - +  
Ec108 E292 com MG1655 MG1655 MG1655  MG1655 MG1655 ∆(yieJ-yieI)::IS629 +   - +  
Ec44 U3633 uro MG1655 MG1655 MG1655 MG1655 MG1655 MG1655 yieJ::ISEc8 region ++   - +  
Ec48 U4418 uro MG1655 MG1655 MG1655 MG1655 MG1655 MG1655 yieJ::IS1, 
yieJ::ISEc8 region 
++   - +  
Ec52 U5107 uro MG1655 MG1655 MG1655  MG1655 MG1655 t1 ('+103tg), 
∆(bglK-
yieJ)::IS629  
++   - +  
Ec103 E164 com MG1655 MG1655 MG1655  MG1655 MG1655 ∆(bglI-yieH)::IS1 ++   - +  
Ec34 U2366 uro MG1655 MG1655 MG1655 MG1655 MG1655   bglB::IS186 none none - +  
Ec107 E291 com MG1655 MG1655 MG1655 MG1655 MG1655 MG1655 yieJ::IS629 none none - +  
Ec12 F557 sept fourth O157 MG1655 MG1655 CFT073 MG1655 +784ag (BglG-
E218G) 
+   + +  
Ec16 F742 sept fourth O157 MG1655 MG1655 CFT073 MG1655   +   + +  
Ec25 V9261 sept fourth O157 MG1655 MG1655 CFT073 MG1655   +   + +  
Ec27 V10744 sept fourth O157 MG1655 MG1655 CFT073 MG1655 +165ag (BglG-
N12D), '+784ag 
(BglG-E218G) 
+   + +  
Ec45 U3622 uro fourth O157 MG1655 MG1655 CFT073 MG1655   +   + +  
Ec47 U4252 uro fourth O157 MG1655 MG1655 CFT073 MG1655   +   - +  
Ec53 U5033 uro fourth O157 MG1655 MG1655 CFT073 MG1655   +   - +  
Ec60 E10087 com fourth O157 MG1655 MG1655 CFT073 MG1655   +   + +  
Appendix                                                                                                                      97 
 
Table 6a: clinical E.coli isolates used in the study 
Straina original 
strain 
nameb 
strain 
typec 
typingd bgl/Z5211-
Z5214 
upstream 
sequencee 
bgl/Z5211-
Z5214 
locusf 
yieJ 
PCRg 
5'-yieI h bgl/Z5211-
Z5214 
downstream 
sequencei  
mutationsj Sal 
Phenotype 
37°Ck 
  
 
28°C 
c1955-
c1960l 
Lac 
Phenotype 
37°Cm 
lac 
genotypen 
Ec46 U4191 uro fourth O157 MG1655 MG1655 CFT073 MG1655   ++   - +  
Ec37 U3104 uro fourth O157 MG1655 MG1655 CFT073 MG1655   ++   + +  
Ec32 W9887 sept fourth O157 MG1655 MG1655 CFT073 MG1655 +546ag (BglG-
T139A), bglH::IS1 
++   - +  
Ec62 E10077 com fourth O157 MG1655 MG1655 CFT073 MG1655 +273ag (BglG-
K48E) 
late late + +  
Ec14 F569 sept fourth O157 MG1655 MG1655 CFT073 MG1655   late   + +  
Ec39 U3372 uro fourth O157 MG1655 MG1655 CFT073 MG1655 +594ga (BglG-
G155S) 
late + - +  
Ec22 St4723 sept fourth O157 MG1655 MG1655 CFT073 MG1655   none none ∆ c1955-
c1956 
+  
Ec26 V9343 sept fourth O157 MG1655 CFT073 CFT073 MG1655 +378ga (BglG-
A83T), +546ag 
(BglG-T139A) 
late   + +  
Ec33 U2183 uro fourth O157 MG1655 CFT073 CFT073 MG1655   +   + +  
Ec31 W9763 sept fifth MG1655 MG1655 MG1655 CFT073  t1(+102ga) +   + +  
Ec124 E174 com fifth MG1655 MG1655 MG1655 CFT073    +   + +  
Ec57 E10092 com fifth MG1655 MG1655 MG1655 CFT073    +   - +  
Ec17 F775 sept fifth MG1655 MG1655 MG1655 CFT073    ++   - +   
Ec30 W8987 sept fifth MG1655 MG1655 MG1655 CFT073  t1(+102ga) ++   - - ∆lac 
Ec110 E294 com fifth MG1655 MG1655 MG1655 CFT073    ++   - +  
Ec50 U4417 uro fifth MG1655 MG1655  CFT073 MG1655 ∆(bglG-yieI)::IS1  none none + +  
Ec61 E10086 com fifth MG1655 MG1655 CFT073 CFT073 MG1655   +   + +  
Ec104 E165 com mixed MG1655 MG1655 CFT073 CFT073 CFT073   +   + +  
Ec112 E7370 com mixed CFT073 CFT073 CFT073 MG1655 CFT073   +++   - +  
Ec130 E467 com mixed CFT073 CFT073 MG1655 CFT073 MG1655   +   + +  
Ec67 E10083 com mixed O157 O157 O157 O157 MG1655 ∆Z5211-Z5214 none none - +  
Ec15 F645 sept O157 O157 O157 O157 O157 O157   none none c1956::IS1 - lacY- 
Ec19 F905 sept O157 O157 O157 O157 O157 O157   none none - +  
Ec24 St5679 sept O157 O157 O157 O157 O157 O157   none none + +  
Ec41 U3292 uro O157 O157 O157 O157 O157 O157   none none - +  
Ec51 U4409 uro O157 O157 O157 O157 O157 O157   none none - - lacY- 
Ec54 U5070 uro O157 O157 O157 O157 O157 O157   none none - +  
Ec55 E10093 com O157 O157 O157 O157 O157 O157   none none + +  
Ec74 E10098 com O157 O157 O157 O157 O157 O157   none none - +  
Ec101 E460 com O157 O157 O157 O157 O157 O157   none none + +  
Ec123 E173 com O157 O157 O157 O157 O157 O157   none none - - lacY- 
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Table 6a: clinical E.coli isolates used in the study 
Straina original 
strain 
nameb 
strain 
typec 
typingd bgl/Z5211-
Z5214 
upstream 
sequencee 
bgl/Z5211-
Z5214 
locusf 
yieJ 
PCRg 
5'-yieI h bgl/Z5211-
Z5214 
downstream 
sequencei  
mutationsj Sal 
Phenotype 
37°Ck 
  
 
28°C 
c1955-
c1960l 
Lac 
Phenotype 
37°Cm 
lac 
genotypen 
Ec65 E10100 com O157 O157 O157 O157 O157 O157   late none + +  
Ec99 E472 com O157 O157 O157 O157 O157 O157   late none + +  
Ec68 E10084 com O157 O157 O157 O157 O157 O157   late + + - lacY::IS1 
Ec113 E424 com O157 O157 O157 O157 O157 O157   late late + +  
Ec56 E10089 com O157 O157 O157 O157 O157 O157   none none - +  
Ec71 E10095 com O157 O157 O157 O157 O157 O157   none none - +  
Ec122 E179 com O157 O157 O157 O157 O157 O157   none none - - lacY- 
Ec29 W7716 sept O157 O157 O157 O157 O157 O157 ∆ Z5211-
Z5214::IS1 
none late + +  
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Table 6b: ECOR strains analyzed in the study 
Straina original 
strain 
nameb 
strain 
source 
strain 
typec 
Phylo-
genetic 
groups 
Herzer 
et.al., 
1990o 
bgl- 
Hall, 
1988p 
typingd bgl/Z5211-
Z5214 
upstream 
sequencee 
bgl/Z5211  
- Z5214 
locusf 
yieJ 
PCRg 
5'-yieIh bgl/Z5211-
Z5214 
downstream 
sequencei 
mutationsj Sal 
Phenotype 
37°Ck 
c1955-
c1960l 
Lac 
Phenotype 
37°Cm 
Ec173 ECOR23 Elephant healthy A + CFT073 CFT073 CFT073 CFT073 CFT073    +++ + + 
Ec182 ECOR32 Giraffe healthy B1 + CFT073 CFT073 CFT073 CFT073 CFT073    +++ + + 
Ec201 ECOR51 Human healthy B2 + CFT073 CFT073 CFT073 CFT073 CFT073    +++ + + 
Ec202 ECOR52 Orangutan healthy B2 + CFT073 CFT073 CFT073 CFT073 CFT073    +++ + + 
Ec203 ECOR53 Human healthy B2 + CFT073 CFT073 CFT073 CFT073 CFT073    +++ + + 
Ec204 ECOR54 Human healthy B2 + CFT073 CFT073 CFT073 CFT073 CFT073    +++ + + 
Ec205 ECOR55 Human UTI (P) B2 + CFT073 CFT073 CFT073 CFT073 CFT073    +++ + + 
Ec207 ECOR57 Gorilla healthy B2 + CFT073 CFT073 CFT073 CFT073 CFT073    +++ + + 
Ec210 ECOR60 Human UTI(C) B2 + CFT073 CFT073 CFT073 CFT073 CFT073    +++ + + 
Ec213 ECOR63 Human healthy B2 + CFT073 CFT073 CFT073 CFT073 CFT073    +++ ∆ (c1958-
c1959) + 
Ec206 ECOR56 Human healthy B2 + CFT073 CFT073 CFT073 CFT073 CFT073    ++ + + 
Ec209 ECOR59 Human healthy B2 + CFT073 CFT073 CFT073 CFT073 CFT073    + + + 
Ec211 ECOR61 Human healthy B2 + CFT073 CFT073 CFT073 CFT073 CFT073    + + + 
Ec212 ECOR62 Human UTI (P) B2 + CFT073 CFT073 CFT073 CFT073 CFT073    + + + 
Ec214 ECOR64 Human UTI 
(C) 
B2 + CFT073 CFT073 CFT073 CFT073 CFT073    + 
+ + 
Ec215 ECOR65 Ape healthy B2 + CFT073 CFT073 CFT073 CFT073 CFT073 CFT073   + + + 
Ec152 ECOR2 Human healthy A + MG1655 MG1655 MG1655 MG1655 MG1655    ++ - + 
Ec155 ECOR5 Human healthy A + MG1655 MG1655 MG1655 MG1655 MG1655    ++ - + 
Ec162 ECOR12 Human healthy A + MG1655 MG1655 MG1655 MG1655 MG1655  bglH::IS2 ++ - + 
Ec163 ECOR13 Human healthy A + MG1655 MG1655 MG1655 MG1655 MG1655    ++ - + 
Ec160 ECOR10 Human healthy A + MG1655 MG1655 MG1655 MG1655 MG1655    + - + 
Ec161 ECOR11 Human UTI(C) A + MG1655 MG1655 MG1655 MG1655 MG1655    + - + 
Ec175 ECOR25 Dog healthy A + MG1655 MG1655 MG1655 MG1655 MG1655    + - + 
Ec151 ECOR1 Human healthy A + MG1655 MG1655 MG1655 MG1655 MG1655    none - + 
Ec153 ECOR3 Dog healthy A + MG1655 MG1655 MG1655 MG1655 MG1655    none - + 
Ec158 ECOR8 Human healthy A + MG1655 MG1655 MG1655 MG1655 MG1655    none - + 
Ec164 ECOR14 Human UTI (P) A + MG1655 MG1655 MG1655 MG1655 MG1655    none - + 
EC169 ECOR19 Ape healthy A + fourth O157 MG1655 MG1655 CFT073 MG1655   ++ - + 
Ec195 ECOR45 Pig healthy B1 + fourth O157 MG1655 MG1655 CFT073 MG1655   ++ + + 
Ec217 ECOR67 Goat healthy B1 + fourth O157 MG1655 MG1655 CFT073 MG1655   ++ + + 
Ec157 ECOR7 Orangutan healthy A + fourth O157 MG1655 MG1655 CFT073 MG1655   + + + 
Ec176 ECOR26 Human healthy B1 + fourth O157 MG1655 MG1655 CFT073 MG1655   + - + 
Ec177 ECOR27 Giraffe healthy B1 + fourth O157 MG1655 MG1655 CFT073 MG1655   + + + 
Ec178 ECOR28 Human healthy B1 + fourth O157 MG1655 MG1655 CFT073 MG1655   + + + 
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Table 6b: ECOR strains analyzed in the study 
Straina original 
strain 
nameb 
strain 
source 
strain 
typec 
Phylo-
genetic 
groups 
Herzer 
et.al., 
1990o 
bgl- 
Hall, 
1988p 
typingd bgl/Z5211-
Z5214 
upstream 
sequencee 
bgl/Z5211  
- Z5214 
locusf 
yieJ 
PCRg 
5'-yieIh bgl/Z5211-
Z5214 
downstream 
sequencei 
mutationsj Sal 
Phenotype 
37°Ck 
c1955-
c1960l 
Lac 
Phenotype 
37°Cm 
Ec220 ECOR70 Gorilla healthy B1 + fourth O157 MG1655 MG1655 CFT073 MG1655   + - + 
Ec221 ECOR71 Human ABU B1 + fourth O157 MG1655 MG1655 CFT073 MG1655   + - + 
Ec222 ECOR72 Human UTI (P) B1 + fourth O157 MG1655 MG1655 CFT073 MG1655   + + + 
Ec171 ECOR21 Cow healthy A + fourth O157 MG1655 MG1655 CFT073 MG1655 bglB::IS1 none - + 
Ec170 ECOR20 Cow healthy A + fourth O157 MG1655 MG1655 CFT073 MG1655 t1 
(+102gt), 
bglB::IS1 
 
none 
- + 
Ec167 ECOR17 Pig healthy A ∆ fourth O157 MG1655 MG1655 CFT073 MG1655 ∆ (bglt1-
bglK)::IS1 
 
none ∆ (c1956-c1957)::IS1 + 
Ec168 ECOR18 Ape healthy A + fourth O157 MG1655 MG1655 CFT073 MG1655 ∆ (Pbgl-
bglF)::IS1 
 
none - + 
Ec159 ECOR9 Human healthy A + fourth O157 MG1655 MG1655 CFT073 MG1655 ∆ (bglB-
bglH)::IS1 
 
none - + 
Ec219 ECOR69 Ape healthy B1 + fourth 
O157 
MG1655 CFT073 CFT073 MG1655    
+ + + 
Ec208 ECOR58 Lion healthy B1 + fourth O157 MG1655 CFT073 CFT073 MG1655   + + + 
Ec218 ECOR68 Giraffe healthy B1 + fifth MG1655 MG1655 MG1655 CFT073    + + + 
Ec165 ECOR15 Human healthy A + fifth MG1655 MG1655 MG1655 CFT073    + - + 
Ec172 ECOR22 Cow healthy A + fifth MG1655 MG1655 MG1655 CFT073    + + + 
Ec180 ECOR30 Bison healthy B1 + fifth MG1655 MG1655 MG1655 CFT073 MG1655   + + + 
Ec183 ECOR33 Sheep healthy B1 + fifth MG1655 MG1655 MG1655 CFT073    + + + 
Ec184 ECOR34 Dog healthy B1 + fifth MG1655 MG1655 MG1655 CFT073    + + + 
Ec174 ECOR24 Human healthy A + fifth MG1655 MG1655 MG1655 CFT073 MG1655   late - + 
Ec166 ECOR16 Leopard healthy A + fifth MG1655 MG1655 MG1655 CFT073    late + + 
Ec179 ECOR29 Kangaroo 
rat 
healthy B1 + fifth 
 
MG1655 MG1655 MG1655 CFT073    late 
+ + 
Ec156 ECOR6 Human healthy A + fifth MG1655 MG1655 MG1655 CFT073    none - - 
Ec181 ECOR31 Leopard healthy E + fifth MG1655 MG1655 CFT073 CFT073 MG1655 t1 
(+102gt) 
++ 
- + 
Ec154 ECOR4 Human healthy A + fifth MG1655 MG1655 CFT073 CFT073 MG1655   ++ + + 
Ec216 ECOR66 Ape healthy B2 + mixed CFT073 CFT073 CFT073 MG1655 CFT073   +++ - + 
Ec185 ECOR35 Human healthy D  ∆,  R O157 O157 O157 O157 O157 O157   late + + 
Ec186 ECOR36 Human healthy D  ∆,  R O157 O157 O157 O157 O157 O157   late + + 
Ec192 ECOR42 Human healthy E  ∆,  R O157 O157 O157 O157 O157 O157   late - + 
Ec196 ECOR46 Ape healthy D  ∆,  R O157 O157 O157 O157 O157 O157   late + + 
Ec191 ECOR41 Human healthy D  ∆,  R O157 O157 O157 O157 O157 O157   late - + 
Ec187 ECOR37 Marmoset healthy E  ∆,  R O157 O157 O157 O157 O157 O157   none - + 
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Table 6b: ECOR strains analyzed in the study 
Straina original 
strain 
nameb 
strain 
source 
strain 
typec 
Phylo-
genetic 
groups 
Herzer 
et.al., 
1990o 
bgl- 
Hall, 
1988p 
typingd bgl/Z5211-
Z5214 
upstream 
sequencee 
bgl/Z5211  
- Z5214 
locusf 
yieJ 
PCRg 
5'-yieI h bgl/Z5211-
Z5214 
downstream 
sequencei 
mutationsj Sal 
Phenotype 
37°Ck 
c1955-
c1960l 
Lac 
Phenotype 
37°Cm 
Ec188 ECOR38 Human healthy D  ∆,  R O157 O157 O157 O157 O157 O157   none + + 
Ec189 ECOR39 Human healthy D  ∆,  R O157 O157 O157 O157 O157 O157    none + + 
Ec190 ECOR40 Human UTI (P) D  ∆,  R O157 O157 O157 O157 O157 O157   none + + 
Ec193 ECOR43 Human healthy E  ∆ O157 O157 O157 O157 O157 O157   none - - 
Ec194 ECOR44 Cougar healthy D + O157 O157 O157 O157 O157 O157   none - + 
Ec197 ECOR47 Sheep healthy D  ∆,  R O157 O157 O157 O157 O157 O157   none - + 
Ec198 ECOR48 Human UTI(C) D  ∆,  R O157 O157 O157 O157 O157 O157   none - + 
Ec200 ECOR50 Human UTI (P) D  ∆,  R O157 O157 O157 O157 O157 O157   none + + 
Ec199 ECOR49 Human healthy D  ∆,  R O157 O157 O157 O157 O157 O157   weak Sal+ + + 
 
Table 6a and Table 6b: Isolates in Table 6a are obtained from Dr. Georg Plum, Institute for Medical Microbiology, University of Cologne, Cologne, Germany and 
isolates in Table 6b are obtained from STEC Center, Michigan State University, MI, USA. a: name of the strain in lab collection. b: original strain name c: All the isolates 
in Table 6a are isolated from human source. septicemic strains (sept) are isolates from the blood of the patients with septicaemia. Uropathogenic strains (uro) are isolates 
from urine samples of patients with urinary tract infections and commensal (com) strains are isolates from the stool samples of healthy individuals. Commensal E.coli 
isolates in Table 6b are from human/animal sources and pathogenic isolates are from human sources. UTI (C)- symptomatic urinary tract infection with acute cystitis, UTI 
(P)-urinary tract infection with acute pyelonephritis, ABU-asymptomatic bacteriuria, healthy-isolates from healthy humans/animas. d: Typing of the E.coli isolates based 
on the nucleotide sequences at the upstream, bgl/Z5211-Z5214 and downstream regions. e: sequence group with respect to the nucleotide sequence alignment of upstream 
sequences (phoU region). f: types based on the nucleotide sequence alignment of bgl operon or Z5211-Z5214. g: yieJ PCR-MG1655 refers to the presence of yieJ gene as 
like in strain MG1655, CFT073 refers to the absence of yieJ gene as in strain CFT073, O157 refers to absence of yieJ gene as in strain O157. h: nucleotide sequence at the 
5’ end of the yieI gene determined by PCR and sequencing (for fourth and fifth type strains) i: sequence groups with respect to the nucleotide sequence alignment of 
downstream sequences (yieJIH region). j: mutations seen in the bgl/Z5211-Z5214 region. k: phenotypes on BTB salicin indicator plates at 37°C and at 28°C. +++ 
indicates relaxed phenotype, ++ more papillae, + MG1655 like papillae, none-no papillae and late-late papillation seen after day5 incubation, weak sal+-Bgl+ phenotype at 
day 2 incubation. l: c1955-c1960 locus analysis-+ indicates presence of c1955-c1960 region, - indicates absence. Alterations/mutations within the c1955-c1960 region are 
shown. m: phenotypes on MacConkey lactose plates at 37°C. + indicates Lac+, - indicates Lac-. n: genotypes relative to the lac operon is shown.  o: Phylogenetic groups 
of ECOR strains based on Herzer et.al., 1990. p: bgl  region analysis of the ECOR strains reported earlier by Hall., 1988. + indicates presence of bgl operon, - absence, ∆-
carries bgl deletion, R-carries replacement in the bgl region.  For more details see results section.  
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Table 7: miniTn10-CmR mutants and Sal+ mutants analyzed in this study 
straina relevant genotype or structureb constructionc/ 
reference 
Ec2 i484 Bgl+#1, ∆47 bgl results section 1.11, Fig. 16 
Ec3 i484 Bgl+#2, bgl-CRP-C234 (C-66ÆT) results section 1.11, Fig. 16 
Ec4 i484 Bgl+#3, no change in bgl promoter region results section 1.11, Fig. 16 
Ec5 i484 Bgl+#4, no change in bgl promoter region results section 1.11, Fig. 16 
Ec6 i484 Bgl+#5, no change in bgl promoter region results section 1.11, Fig. 16 
Ec7 i484 Bgl+#6, no change in bgl promoter region results section 1.11, Fig. 16 
Ec8 i484 Bgl+#7, no change in bgl promoter region results section 1.11, Fig. 16 
Ec93 i484 ∆bgl results section 2.2, Fig. 23 
Ec131 =Ec93 Sal+, Cel+, Arb+, Esc+ at 28˚C and Sal-, Cel-, Arb-, Esc- at 
37˚C 
results section 2.2, Fig. 23 
Ec132 =Ec93 Sal+, Cel+, Arb+, Esc+ at 28˚C and Sal-, Cel-, Arb-, Esc- at 
37˚C 
results section 2.2, Fig. 23 
Ec133 =Ec93 Sal+, Cel+, Arb+, Esc+ at 28˚C and Sal-, Cel-, Arb-, Esc- at 
37˚C 
results section 2.2, Fig. 23 
Ec134 =Ec93 Sal+, Cel+, Arb+, Esc+ at 28˚C and Sal-, Cel-, Arb-, Esc- at 
37˚C 
results section 2.2, Fig. 23 
Ec135 Ec131 c1958::mTn10-cmR, AE016760: 291472-291480 results section 2.2, Fig. 23 
Ec136 Ec131 c1957::mTn10-cmR, AE016760: 291646-291654 results section 2.2, Fig. 23 
Ec137 Ec131 c1957::mTn10-cmR, AE016760: 291646-291654 results section 2.2, Fig. 23 
Ec138 Ec131 mTn10-cmR  results section 2.2, Fig. 23 
Ec139 Ec132 c1958::mTn10-cmR, AE016760: 291205-291213 results section 2.2, Fig. 23 
Ec140 Ec132 pyrD::mTn10-cmR, AE016758: 147545-147553 results section 2.2, Fig. 23 
Ec141 Ec132 mTn10-cmR  results section 2.2, Fig. 23 
Ec142 Ec132 mTn10-cmR  results section 2.2, Fig. 23 
Ec143 Ec133 c1956::mTn10-cmR, AE016760:288797-288805 results section 2.2, Fig. 23 
Ec144 Ec133 c1956::mTn10-cmR, AE016760:290312-290320 results section 2.2, Fig. 23 
Ec145 Ec133 mTn10-cmR  results section 2.2, Fig. 23 
Ec146 Ec133 mTn10-cmR  results section 2.2, Fig. 23 
Ec147 Ec134 c1959::mTn10-cmR, AE016760: 292417-292425 results section 2.2, Fig. 23 
Ec148 Ec134 (dksA-sfsA)::mTn10-cmR, AE016760: 171175-171183 results section 2.2, Fig. 23 
Ec149 Ec133 mTn10-cmR  results section 2.2, Fig. 23 
Ec150 Ec133 mTn10-cmR  results section 2.2, Fig. 23 
Ec223 i484 bgl::mTn10-cmR results section 1.15, Fig. 21 
Ec224 i484 bgl::mTn10-cmR results section 1.15, Fig. 21 
Ec225 i484 cysJ::mTn10-cmR, AE016765: 141948 results section 1.15, Fig. 21 
Ec226 i484 cysN::mTn10-cmR, AE016765: 135774 results section 1.15, Fig. 21 
Ec227 i484 purC::mTn10-cmR, AE016764: 146222 results section 1.15, Fig. 21 
Ec228 i484 bgl::mTn10-cmR results section 1.15, Fig. 21 
Ec229 i484 bgl::mTn10-cmR results section 1.15, Fig. 21 
Ec230 i484 ybdM::mTn10-cmR, AE016762: 215048 results section 1.15, Fig. 21 
Ec231 i484 bgl::mTn10-cmR results section 1.15, Fig. 21 
Ec232 i484 cysH::mTn10-cmR, AE016765: 139681 results section 1.15, Fig. 21 
Ec233 i484 cysH::mTn10-cmR, AE016765: 139499 results section 1.15, Fig. 21 
Ec234 i484 bgl::mTn10-cmR results section 1.15, Fig. 21 
Ec235 i484 purL::mTn10-cmR, AE016764: 235798 results section 1.15, Fig. 21 
Ec236 i484 bgl::mTn10-cmR results section 1.15, Fig. 21 
Ec237 i484 bgl::mTn10-cmR results section 1.15, Fig. 21 
Ec238 i484 cysH::mTn10-cmR, AE016765: 139681 results section 1.15, Fig. 21 
Ec239 i484 bgl::mTn10-cmR results section 1.15, Fig. 21 
Ec240 i484 mixed phenotype Sal+Cel- #1 results section 1.16, Fig. 22 
Ec241 i484 mixed phenotype Sal+Cel- #2 results section 1.16, Fig. 22 
Ec242 Ec240 ybdM::mTn10-cmR, AE016762: 215064 results section 1.16, Fig. 22 
Ec243 Ec240 bglF::mTn10-cmR results section 1.16, Fig. 22 
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Table 7: miniTn10-CmR mutants and Sal+ mutants analyzed in this study 
straina relevant genotype or structureb constructionc/ 
reference 
Ec244 Ec240 (bglG-bglF):: mTn10-cmR results section 1.16, Fig. 22 
Ec245 Ec241 bglF::mTn10-cmR results section 1.16, Fig. 22 
Ec246 Ec241 pgi::mTn10-cmR, AE016770: 235679 results section 1.16, Fig. 22 
Ec247 Ec241 bglF::mTn10-cmR results section 1.16, Fig. 22 
Ec248 Ec241 bglF::mTn10-cmR results section 1.16, Fig. 22 
Ec249 Ec241 pgi::mTn10-cmR, AE016770: 236173 results section 1.16, Fig. 22 
Ec250 Ec241 bglF::mTn10-cmR results section 1.16, Fig. 22 
Ec251 Ec241 bglF::mTn10-cmR results section 1.16, Fig. 22 
Ec252 Ec241 bglG::mTn10-cmR results section 1.16, Fig. 22 
Ec253 Ec241 bglF::mTn10-cmR results section 1.16, Fig. 22 
Ec254 E7370 mixed phenotype Sal+Cel+ #1 results section 1.16, Fig. 22 
Ec255 E7370 mixed phenotype Sal+Cel+ #2 results section 1.16, Fig. 22 
Ec256 Ec254 cysG:: mTn10-cmR, AE016767: 299877 results section 1.16, Fig. 22 
Ec257 Ec254 bglF::mTn10-cmR results section 1.16, Fig. 22 
Ec258 Ec254 bglB::mTn10-cmR results section 1.16, Fig. 22 
Ec259 Ec254 bglF::mTn10-cmR results section 1.16, Fig. 22 
Ec260 Ec255 serC:: mTn10-cmR, AE016758:108192 results section 1.16, Fig. 22 
Ec261 Ec255 bglB::mTn10-cmR results section 1.16, Fig. 22 
Ec262 Ec255 bglB::mTn10-cmR results section 1.16, Fig. 22 
Ec263 Ec255 bglB::mTn10-cmR results section 1.16, Fig. 22 
Ec264 Ec255 bglF::mTn10-cmR results section 1.16, Fig. 22 
Ec265 Ec255 bglF::mTn10-cmR results section 1.16, Fig. 22 
Ec266 Ec255 carB:: mTn10-cmR, AE016755: 35300 results section 1.16, Fig. 22 
Ec267 Ec255 bglB::mTn10-cmR results section 1.16, Fig. 22 
Ec268 U3454 Bgl+#1, bglR::IS1 results section 1.11,  Fig. 16 
Ec269 U3454 Bgl+#2, bglR::IS1 results section 1.11,  Fig. 16 
Ec270 U3454 Bgl+#3, bglR::IS629 results section 1.11,  Fig. 16 
Ec271 U3454 Bgl+#4, bglR::IS1 results section 1.11,  Fig. 16 
Ec272 U3454 Bgl+#5, bglR::IS1 results section 1.11,  Fig. 16 
Ec273 U3454 Bgl+#6, bglR::IS1 results section 1.11,  Fig. 16 
Ec274 U3454 Bgl+#7, bglR::IS1 results section 1.11,  Fig. 16 
Ec275 W7483 Bgl+#1, no change in the promoter region results section 1.11,  Fig. 16 
Ec276 W7483 Bgl+#2, no change in the promoter region results section 1.11,  Fig. 16 
Ec277 W7483 Bgl+#3, no change in the promoter region results section 1.11,  Fig. 16 
Ec278 W7483 Bgl+#4, ∆72 bgl results section 1.11,  Fig. 16 
Ec279 W7483 Bgl+#5, no change in the promoter region results section 1.11,  Fig. 16 
Ec280 W7483 Bgl+#4, ∆72 bgl results section 1.11,  Fig. 16 
Ec281 E10091 Bgl+#1, no change in the promoter region results section 1.11,  Fig. 16 
Ec282 E10091 Bgl+#2, no change in the promoter region results section 1.11,  Fig. 16 
Ec283 E10091 Bgl+#3, no change in the promoter region results section 1.11,  Fig. 16 
Ec284 E176 Bgl+#1, no change in the promoter region results section 1.11,  Fig. 16 
Ec285 U3372 Bgl+#1, bglR::IS1 results section 1.11,  Fig. 16 
Ec286 U3372 Bgl+#2, bglR::IS1 results section 1.11,  Fig. 16 
 
a: strain names in the lab collection.  
 
b: The relevant genotype of the constructed derivatives refers to the bgl, c1955-c1960, cysH, cysN, cysJ, cysG, serC, 
pgi, purC, purL, carB, and ybdM loci. Mutations causing activation of the silent bgl operon include bgl-CRP (a C to 
T exchange in the CRP binding site at position -66, relative to the transcription start), bglR::IS1 (integration of IS1), 
bglR::IS629 (integration of IS629). Position of mn10-cmR insertions are shown in GenBank Accession numbers.  
 
c: details of the construction and isolation of mutants are schematically shown in the respective figures indicated. 
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pLDR8 λ-repressor, ts-cI-857, int under-λ-PR, 
pSC101-rep ts-kanR 
(Diederich et al., 1992) 
pKES15 MG1655-Pbgl +54-lacZ Lab collection 
pKES65 F742-Pbgl-t1-bglG-lacZ Lab collection 
pKES66 F775-Pbgl-t1-bglG-lacZ Lab collection 
pKES67 F785-Pbgl-t1-bglG-lacZ Lab collection 
pKES71 W7483-Pbgl-t1-bglG-lacZ Lab collection 
pKES73 W9763-Pbgl-t1-bglG-lacZ Lab collection 
pKES75 F1-Pbgl-t1-bglG-lacZ Lab collection 
pKES76 F287-Pbgl-t1-bglG-lacZ Lab collection 
pKES77 F385-Pbgl-t1-bglG-lacZ Lab collection 
pKES78 F557-Pbgl-t1-bglG-lacZ Lab collection 
pKES79 F911-Pbgl-t1-bglG-lacZ Lab collection 
pKES80 F1215-Pbgl-t1-bglG-lacZ Lab collection 
pKES81 V9343-Pbgl-t1-bglG-lacZ Lab collection 
pKES82 V10744-Pbgl-t1-bglG-lacZ Lab collection 
pKES83 MG1655-Pbgl-t1-bglG-lacZ Lab collection 
pKES84 i484--Pbgl-t1-bglG-lacZ Lab collection 
pKEKB30 MG1655-Pbgl +25-lacZ (Dole et al., 2004) 
pKESK18 cI-857-Tn10 transposase-miniTn10-
cmR in rep-ts-kanR 
Lab collection 
pKESK22 lacI-q-lacO3-Ptac-lacO1-MCS-in 
pACYC-kanR 
Lab collection 
pKESK24 attB integration vector (single BamHI 
and BglII site) 
Lab collection 
pKESK25 attB integration vector (single BamHI 
and BglII site) 
Lab collection 
pKESD8 wt-Pbgl-bglG-lacZ (Dole et al., 2002) 
pKESD9 CRP+-Pbgl-bglG-lacZ (Dole et al., 2002) 
pKESD20 lacUV5-Pbgl-bglG-lacZ (Dole et al., 2002) 
pFDY52 wt-bgl region in pUC12 lab collection 
pFDY284 pACYC kanR vector lab collection 
pFDY217 lacI-lacOP-lacY in rep-ts tetR (Dole et al., 2002) 
pFMAC11 repts-tetR, ∆bgl in bgl region (Caramel and Schnetz, 1998) 
pFDX733 wt-bgl operon, kan (Schnetz et al., 1987) 
pBR322 cloning vector  (Bolivar, 1978) 
pHPΩ-Tc cloning vector carrying-Ω-tet cassette (Fellay et al., 1987) 
pKEGN1 E10085-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  E10085, PCR S145/S201, SalI-XbaI 
pKEGN2 U5107-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  U5107, PCR S145/S201, SalI-XbaI 
pKEGN3 F1215-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  F1215, PCR S145/S201, SalI-XbaI 
pKEGN4 E10077-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  E10077, PCR S145/S201, SalI-XbaI 
pKEGN5 U2183-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  U2183, PCR S145/S201, SalI-XbaI 
pKEGN6 W9887-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  W9887, PCR S145/S201, SalI-XbaI 
pKEGN7 E10091-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  E10091, PCR S145/S201, SalI-XbaI 
pKEGN8 U3454-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  U3454, PCR S145/S201, SalI-XbaI 
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pKEGN9 W7483-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  W7483, PCR S145/S201, SalI-XbaI 
pKEGN10 E10077-Pbgl +25-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  pKEGN4, PCR S145/S212, SalI-XbaI 
pKEGN11 E422-Pbgl +25-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  E422, PCR S145/S212, SalI-XbaI 
pKEGN12 E475-Pbgl +25-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  E475, PCR S145/S212, SalI-XbaI 
pKEGN13 E7370-Pbgl +25-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  E7370, PCR S145/S212, SalI-XbaI 
pKEGN14 E478-Pbgl +25-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  E478, PCR S145/S212, SalI-XbaI 
pKEGN15 U3372-Pbgl +25-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  U3372, PCR S145/S212, SalI-XbaI 
pKEGN16 F560-Pbgl +25-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  F560, PCR S145/S212, SalI-XbaI 
pKEGN17 i484-Pbgl +25-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  pKES84, PCR S145/S212, SalI-XbaI 
pKEGN32 i484-bglH-yieH-pBR-ampR V: pBR322, EcoRI-EcoRV, phosphatase 
F: i484, PCR S253/S336, EcoRI-Bst1107I 
pKEGN33 U3372-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  U3372, PCR S145/S201, SalI-XbaI 
pKEGN34 F911-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  F911, PCR S145/S201, SalI-XbaI 
pKEGN35 E478-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  E478, PCR S145/S201, SalI-XbaI 
pKEGN36 E10094-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  E10094, PCR S145/S201, SalI-XbaI 
pKEGN37 E475-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  E475, PCR S145/S201, SalI-XbaI 
pKEGN38 E7370-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  E7370, PCR S145/S201, SalI-XbaI 
pKEGN39 E422-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  E422, PCR S145/S201, SalI-XbaI 
pKEGN40 W9887-Pbgl-t1-bglG-lacZ V: pKES15, SalI-XbaI, phosphatase 
F:  W9887, PCR S145/S212, SalI-XbaI 
pKEGN41 Ec93 (i484 ∆bgl)-c1955-c1960-kanR V: pFDY284, SalI-EcoRI 
F: Ec93, PCR S367/S368, 6370bp, XhoI-EcoRI 
pKEGN42 Ec131 (Ec93 Sal+ Cel+ Arb+ Esc+)-
c1955-c1960-kanR 
V: pFDY284, SalI-EcoRI 
F: Ec131, PCR S367/S368, 6370bp, XhoI-EcoRI 
pKEGN43 Ec132 (Ec93 Sal+ Cel+ Arb+ Esc+)-
c1955-c1960-kanR 
V: pFDY284, SalI-EcoRI 
F: Ec132, PCR S367/S368, 6370bp, XhoI-EcoRI 
pKEGN44 Ec133 (Ec93 Sal+ Cel+ Arb+ Esc+) 
c1955-c1960-kanR 
V: pFDY284, SalI-EcoRI 
F: Ec133, PCR S367/S368, 6370bp, XhoI-EcoRI 
pKEGN45 Ec134 (Ec93 Sal+ Cel+ Arb+ Esc+) 
c1955-c1960-kanR 
V: pFDY284, SalI-EcoRI 
F: Ec134, PCR S367/S368, 6370bp, XhoI-EcoRI 
pKEGN46 Ec93-Pc1955-c1960-lacZ  V: pKES15, SalI-XbaI 
F: Ec93, PCR S432/S433, SalI-XbaI 
pKEGN47 Ec93-c1960-Pc1955-c1960-lacZ  V: pKES15, SalI-XbaI 
F: Ec93, PCR S432/S368, SalI-XbaI 
pKEGN48 Ec134-Pc1955-c1960-lacZ  V: pKES15, SalI-XbaI 
F: Ec134, PCR S432/S433, SalI-XbaI 
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pKEGN49 Ec134-c1960-Pc1955-c1960-lacZ  V: pKES15, SalI-XbaI 
F: Ec134, PCR S432/S368, SalI-XbaI 
pKEGN50 E10085-lacI, lacZ-kanR V: pFDY284, SalI-BamHI  
F: PCR E10085 with S435/S436, SalI-BamHI, 
pKEGN51 i484 ∆bgl-c1960-Pc1955-c1960-lacZ  V: pKEGN47, SalI-XbaI 
F: pKEGN29, SalI-XbaI 
pKEGN52 Ec134-c1960-Pc1955-c1960-lacZ  V: pKEGN49, SalI-XbaI 
F: pKEGN29, SalI-XbaI 
pKEGN53 Ec132-lacIq-Ptac-c1959-c1955  V: pKESK22, EcoRI-XbaI 
F: Ec132, PCR S490/S491, EcoRI-XbaI 
pKEGN54 Ec132- lacIq-Ptac-c1959-c1955  V: pKESK22, EcoRI-XbaI 
F: Ec134, PCR S490/S491, EcoRI-XbaI 
pKEGN55 Ec93- lacIq-Ptac-c1959-c1955  V: pKESK22, EcoRI-XbaI 
F: i484 ∆bgl, PCR S490/S491, EcoRI-XbaI 
 
a: name of the plasmid in the lab collection  
 
b: Number stated in the Pbgl-lacZ fusions is relative to the transcription start site of the bgl operon. t1 indicates bgl 
terminator t1. Mutations causing activation of the silent bgl operon include bgl-CRP+ (a C to T exchange in the CRP 
binding site at position -66, relative to the transcription start) and bgl-∆ (a deletion of the upstream silencer, 
extending from position -77). Strain names shown are listed as in Table 5 and 6 (for e.g. pKEGN1 carries Pbgl 
fragment from strain E10085). Unless otherwise indicated plasmids are pACYC derivatives (Chang and Cohen, 
1978) carrying a neo (kanR), attP for integration into the K-12 chromosome and Ω specR cassette. Pc1955-c1960 indicates 
the putative promoter region from c1955-c1960 system (position relative to CFT073 AE016760: 292674-292476). 
Expression of the Constructs carrying the constitutive promoter Ptac can be induced with IPTG. The inducible 
promoter Ptac is in between lac operator’s lacO3 and lacO1 and is under the control of lacI gene. Plasmids carrying 
pSC101 replication origin (Hashimotoh-Gotoh et al., 1981) or pBR replication origin (Bolivar, 1978) and 
chloramphenicol (cm) or tetracycline (tet), or ampicillin (amp) resistance markers are indicted. 
 
c: A short description of plasmid construction. V indicates the vector fragments.  F indicates the insert fragment 
preparation. PCR reactions are indicated in order, PCR, template and primers used.  Detailed plasmid construction 
descriptions are documented in lab records and all sequences are compiled in Vector NTi.  EtOH ppt indicates 
ethanol precipitation.  
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Figure 41: Southern hybridization images. Enzymes used in the genomic digestions and probes are indicated. 
Strain names are as listed in Table 6 (Appendix).  I and II) Genomic DNA digested with EcoRI and MluI and probed 
with probe A (phoU gene, NcoI-SspI fragment from pFDY52). III) EcoRI and MluI genomic digests and probed with 
probe B (phoU-Pbgl-bglG, S145/S201 PCR fragment from MG1655). IV and V) EcoRI and MluI digests probed with 
probe C (Pbgl-bglG, S157/S201 PCR fragment from MG1655). VI) EcoRI-EcoO109I genomic digests probed with 
probe D (bglF, DraI-EcoRV fragment from pFDX733) VII) EcoRI-EcoO109I genomic digests probed with probe E 
(bglF-bglB, NcoI-NcoI fragment from pFDX733) VIII) EcoRI-EcoO109I genomic digests probed with probe F 
(bglB, PvuII-HindIII fragment from pFDX733) IX) EcoRI-EcoO109I genomic digests probed with probe G (bglHIK, 
EcoRI-EcoRI fragment from pFDY52) X) EcoRI-EcoO109I genomic digests probed with probe H (bglIK, Eco81I-
PvuII fragment from pFDY52). XI, XII and XIII) EcoRI-MluI genomic digests probed with probe I (yieJIH, EcoRI-
SalI fragment from pFDY52). XIV and XV) EcoRI-MluI genomic digests probed with probe J (yieHG, PCR 
S335/S336 fragment from MG1655) XVI) EcoRI-Eco81I, EcoRI-MluI and EcoRI genomic digests of MG1655 (as 
control) and strain E291, probed with probe G. XVII) EcoRI-EcoO109I, EcoRI-NcoI and HindIII-PvuII genomic 
digests probed with probe M (bglGFBH, Eco01091-EcoRI fragment from pFDY52). XVIII)  ScaI-SalI, ScaI-HindIII-
SalI, ScaI-PstI, PstI-HindIII-SalI, EcoRI-SalI, EcoRI-PstI genomic digests from MG1655 (control) and i484 probed 
with probe K (bglH, ScaI-SapI fragment from pFDY52). XIX) ScaI-SalI, ScaI-HindIII-SalI, ScaI-PstI, PstI-HindIII-
SalI, EcoRI-SalI, EcoRI-PstI genomic digests from MG1655 (control) and i484 probed with probe L (yieIHG, BglII-
SalI fragment from pFDY52). Refer Figure 11 and 12 (Results) for detailed descriptions.  
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